Sentence,class,file
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/1/100/100198 Copyright: © 2012 Bakhtiar Y.,Non-OADS,/arxiv_data1/oa_pdf/53/ce/SNI-3-100.PMC3463838.pdf
"Surgical Neurology International 2012, 3:100  http://www.surgicalneurologyint.com/content/3/1/100CASE REPORT A 2-month-old boy with known Down syndrome (trisomy  21) was referred to our department with presentation  of rapid head enlargement.",Non-OADS,/arxiv_data1/oa_pdf/53/ce/SNI-3-100.PMC3463838.pdf
"Surgical Neurology International 2012, 3:100  http://www.surgicalneurologyint.com/content/3/1/100Figure 2: Postoperative axial (a), sagital (b), and coronal (c) MRIs revealed the total resection of tumor with improvement of the hydrocephalus  state.",Non-OADS,/arxiv_data1/oa_pdf/53/ce/SNI-3-100.PMC3463838.pdf
"Surgical Neurology International 2012, 3:100  http://www.surgicalneurologyint.com/content/3/1/100Figure 4: T wo recurrent tumors (arrows) were found on axial (a), sagital (b), and coronal (c) MRIs obtained 10 months after the first  surgery.",Non-OADS,/arxiv_data1/oa_pdf/53/ce/SNI-3-100.PMC3463838.pdf
"Surgical Neurology International 2012, 3:100  http://www.surgicalneurologyint.com/content/3/1/100syndrome is still unclear.",Non-OADS,/arxiv_data1/oa_pdf/53/ce/SNI-3-100.PMC3463838.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Ventriculoperitoneal shunting versus endoscopic third  ventriculostomy in the treatment of patients with hydrocephalus  related to metastasis  David D. Gonda1,2, Teddy E. Kim1,2, Peter C. Warnke3, Ekkehard M. Kasper4, Bob S. Carter1,2,   Clark C. Chen1,2 1Department of Neurosurgery, University of California, San Diego, 2Center for Theoretic and Applied Neuro-Oncology, University of California, San Diego,  3Department of Neurosurgery, University of Chicago Medical Center, Chicago, IL, 4Division of Neurosurgery, Beth Israel Deaconess Medical Center, Boston,   MA, USA  E-mail: David D. Gonda - dgonda@ucsd.edu; T eddy E. Kim - tekim@ucsd.edu; Peter C. Warnke - pwarnke@partners.org;   Ekkehard M. Kasper - ekasper@bidmc.harvard.edu; Bob S. Carter - bobcarter@ucsd.edu; *Clark C. Chen - clarkchen@ucsd.edu    *Corresponding author  Received: 19 March 12 Accepted: 12 July 12 Published: 27 August 12 This article may be cited as:   Gonda DD, Kim TE, Warnke PC, Kasper EM, Carter BS, Chen CC.",Non-OADS,/arxiv_data1/oa_pdf/8a/d4/SNI-3-97.PMC3463839.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/1/97/100185 Copyright: © 2012 Gonda DD.,Non-OADS,/arxiv_data1/oa_pdf/8a/d4/SNI-3-97.PMC3463839.pdf
"Surgical Neurology International 2012, 3:97  http://www.surgicalneurologyint.com/content/3/1/97INTRODUCTION Estimates suggest that 1 – 5% of the patients with  cerebral metastasis suffer from either obstructive or  communicating hydrocephalus.",Non-OADS,/arxiv_data1/oa_pdf/8a/d4/SNI-3-97.PMC3463839.pdf
"Surgical Neurology International 2012, 3:97  http://www.surgicalneurologyint.com/content/3/1/97previously described.",Non-OADS,/arxiv_data1/oa_pdf/8a/d4/SNI-3-97.PMC3463839.pdf
"Surgical Neurology International 2012, 3:97  http://www.surgicalneurologyint.com/content/3/1/97Table 1: Clinical summary of the 36 patients who underwent ventriculoperitoneal shunting Case Age/sex RPA Class Primary Site Location Leptomeningeal  SpreadPrior  HemorrhageUnfavorable  ETV AnatomySurvival  (days) 1 73 M 2 Renal Parietal No Yes No 179 2 66 F 2 Renal Frontal No Yes No 425 3 54 M 3 Renal Parietal No No Yes 58 4 63 M 2 Lung Frontal No No Yes 1479 5 59 M 1 Lung Frontal No No Yes 504 6 58 F 2 Lung Suprasellar No No Yes 1193 7 58 M 2 Lung Multiple No No Yes 930 8 53 F 3 Lung Frontal Yes No No 90 9 64 M 2 Lung Ventricular Yes No No 93 10 65 M 2 Lung Multiple No No No 159 11 48 F 1 Lung Frontal Yes No No 88 12 60 M 2 Melanoma Parietal Yes No No 47 13 61 M 2 Melanoma Cerebellum No No Yes 328 14 60 M 1 Melanoma Multiple No Yes No 256 15 78 F 2 Melanoma Brain Stem No No Yes 108 16 69 M 2 Melanoma Parietal No Yes No 58 17 62 F 2 Melanoma Frontal No Yes No 92 18 49 F 2 Melanoma Parietal No Yes No 108 19 46 M 2 Melanoma Temporal Yes No No 31 20 44 M 2 Melanoma Occipital No No Yes 178 21 66 M 2 Melanoma Frontal No Yes No 66 22 48 M 1 Lung Occipital No No Yes 378 23 58 M 2 Lung Multiple No Yes No 56 24 57 F 1 Lung Frontal No No Yes 1925 25 52 F 2 Lung Multiple Yes No No 169 26 44 F 2 Lung Multiple No Yes No 288 27 60 F 2 Colon Parietal No No Yes 297 28 61 F 1 Breast Parietal No No Yes 311 29 57 F 3 Breast Occipital No Yes No 50 30 53 F 2 Breast Ventricular Yes No No 20 31 73 F 2 Breast Cerebellum No No Yes 432 32 65 F 2 Breast Multiple No Yes No 207 33 73 F 1 Breast Ventricular Yes No No 1818 34 31 F 2 Breast Cerebellum No No No 73 35 35 F 2 Breast Occipital No No Yes 82 36 64 F 2 Breast Temporal Yes No No 99 prior interventricular hemorrhages.",Non-OADS,/arxiv_data1/oa_pdf/8a/d4/SNI-3-97.PMC3463839.pdf
"Surgical Neurology International 2012, 3:97  http://www.surgicalneurologyint.com/content/3/1/97line with other literature reports for metastasis-related  hydrocephalus.",Non-OADS,/arxiv_data1/oa_pdf/8a/d4/SNI-3-97.PMC3463839.pdf
"Surgical Neurology International 2012, 3:97  http://www.surgicalneurologyint.com/content/3/1/97Table 3: Summary of the indications, efficacy, and  morbidity in patients treated with endoscopic third  ventriculostomy.",Non-OADS,/arxiv_data1/oa_pdf/8a/d4/SNI-3-97.PMC3463839.pdf
"Surgical Neurology International 2012, 3:97  http://www.surgicalneurologyint.com/content/3/1/97terms of ETV .",Non-OADS,/arxiv_data1/oa_pdf/8a/d4/SNI-3-97.PMC3463839.pdf
Band quantiﬁcation of Ube2D3 B TAMRAubiquitin was done with the ImageJ program (http://imagej.nih.gov/ij).Loading differences were accounted for by measuring the totalamount of TAMRA signal per lane.,OADS,/arxiv_data1/oa_pdf/98/9b/emboj2012217a.PMC3463842.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/98/9b/emboj2012217a.PMC3463842.pdf
[http://creativecommons.org/licenses/by-nc-nd/3.0]HOIP RBR-LDD module speciﬁes linear ubiquitin chains JJ Smit et al 3844 The EMBO Journal VOL 31 |NO 19 |2012 &2012 European Molecular Biology Organization,Non-OADS,/arxiv_data1/oa_pdf/98/9b/emboj2012217a.PMC3463842.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/45/52/emboj2012248a.PMC3463851.pdf
[http://creativecommons.org/ licenses/by-nc-sa/3.0/]Wg in intestinal regeneration JB Cordero et al 3917 &2012 European Molecular Biology Organization The EMBO Journal VOL 31 |NO 19 |2012,Non-OADS,/arxiv_data1/oa_pdf/45/52/emboj2012248a.PMC3463851.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2012; 107:1554–1562;  doi: 10.1038/ajg.2012.211; published online 24 July 2012                1   Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School ,  Boston ,  Massachusetts ,  USA   ;         2   Pittsburgh Gastroenterology Associates ,   Pittsburgh ,  Pennslyvania ,  USA   ;         3   Division of Gastroenterology, Mayo Clinic ,  Scottsdale ,  Arizona ,  USA   ;         4   Alba Therapeutics Corporation ,  Baltimore ,  Maryland ,  USA   ;          5   Division of Gastroenterology and Hepatology, Mayo Clinic ,  Rochester ,  Minnesota ,  USA   ;         6  Present address: Bay Area Houston Gastroenterology, Webster, Texas,  USA  ;         7  Present address: Centocor Research and Development, Chesterbrook, Pennslyvania, USA  ;         8  Present address: International Partnership for Microbicides,  Silver Spring, Maryland, USA  ;         9  Present address: The Johns Hopkins School of Medicine, Baltimore, Maryland, USA  ;         10  Present address: Bristol-Myers Squibb,  New York, New York, USA  .",Non-OADS,/arxiv_data1/oa_pdf/d9/5f/ajg2012211a.PMC3463856.pdf
"To view a copy of this license, visit http://creative-commons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/d9/5f/ajg2012211a.PMC3463856.pdf
"Statistics New Zealand, 2006. http://www.stats.govt.nz/Census/about-2006-census/2006-census- questionnaires.aspx (accessed 12 Aug 2011).",OADS,/arxiv_data1/oa_pdf/48/15/injuryprev-2011-040266.PMC3463862.pdf
2000. http://www.msd.govt.nz/aboutmsd-and-our-work/publications-resources/monitoring/living-standards/living-standards-elsi.html (accessed 29 Sep 2011).,Non-OADS,/arxiv_data1/oa_pdf/48/15/injuryprev-2011-040266.PMC3463862.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Novel preclinical antithrombotics in stroke P Kraft et al 1840 Journal of Cerebral Blood Flow & Metabolism (2012) 32, 1831–1840",Non-OADS,/arxiv_data1/oa_pdf/cd/b8/jcbfm2012108a.PMC3463876.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Pericytes and spinal cord capillary permeability EA Winkler et al 1852 Journal of Cerebral Blood Flow & Metabolism (2012) 32, 1841–1852",Non-OADS,/arxiv_data1/oa_pdf/f0/f7/jcbfm2012113a.PMC3463878.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Serum cytokines in neonatal hypothermia trial DD Jenkins et al 1896 Journal of Cerebral Blood Flow & Metabolism (2012) 32, 1888–1896",Non-OADS,/arxiv_data1/oa_pdf/f0/74/jcbfm201283a.PMC3463879.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http:// www.nature.com/jcbfm)Effects of OCT3 on ischemic brain injury P Zhu et al 1908 Journal of Cerebral Blood Flow & Metabolism (2012) 32, 1897–1908",Non-OADS,/arxiv_data1/oa_pdf/61/da/jcbfm201292a.PMC3463881.pdf
Data Analysis T1-weighted images were preprocessed using standardparameters of the VBM8 toolbox (http://dbm.neuro.uni- jena.de/vbm.html).,OADS,/arxiv_data1/oa_pdf/55/8a/jcbfm201296a.PMC3463884.pdf
"The toolbox is based on the Statistical Parametric Mapping software version 8 (SPM8,Wellcome Trust Centre for Neuroimaging, UniversityCollege London, London, UK; http://www.fil.ion.ucl.",OADS,/arxiv_data1/oa_pdf/55/8a/jcbfm201296a.PMC3463884.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Neural correlates of cerebral microangiopathy EM Quinque et al 1878 Journal of Cerebral Blood Flow & Metabolism (2012) 32, 1869–1878",Non-OADS,/arxiv_data1/oa_pdf/55/8a/jcbfm201296a.PMC3463884.pdf
"Mark Peakman Address: Department of Immunobiology, King ’s College London and National Institute for Health Research Biomedical Research Centre at Guy ’s& St Thomas ’NHS Foundation Trust and King ’s College London, 2nd Floor, Borough Wing, Guy ’s Hospital, London, SE1 9RT, UK Email: mark.peakman@kcl.ac.uk F1000 Biology Reports 2012, 4:19 (doi:10.3410/B4-19) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/biolrep-04-19.PMC3463895.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/reports/b/4/19 Abstract Vaccination is the administration of antigenic material to stimulate the immune system to develop adaptive immunity to a disease.,Non-OADS,/arxiv_data1/oa_pdf/ac/a7/biolrep-04-19.PMC3463895.pdf
"Key questions for clinical translation of vaccination for Type 1 diabetes Five key questions arise in the debate: what is the evidence that vaccination can restore immune tolerance in human Page 2 of 8 (page number not for citation purposes)F1000 Biology Reports 2012, 4:19 http://f1000.com/reports/b/4/19",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/biolrep-04-19.PMC3463895.pdf
"Page 3 of 8 (page number not for citation purposes)F1000 Biology Reports 2012, 4:19 http://f1000.com/reports/b/4/19",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/biolrep-04-19.PMC3463895.pdf
"Further encouragement isderived from unpublished reports that the heat shockprotein-derived peptide 277 (Diapep), a putative diabetes autoantigen [46], has beneficial metabolic effects when Page 4 of 8 (page number not for citation purposes)F1000 Biology Reports 2012, 4:19 http://f1000.com/reports/b/4/19",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/biolrep-04-19.PMC3463895.pdf
"The use of naturally processedand presented epitopes, for example, is a strategy thatavoids potential induction of neo-responses due topresentation of peptides that are otherwise cryptic, which can lead to the complication of priming new cohorts of Page 5 of 8 (page number not for citation purposes)F1000 Biology Reports 2012, 4:19 http://f1000.com/reports/b/4/19",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/biolrep-04-19.PMC3463895.pdf
"Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring SM, McArdle W, Pembrey ME, Strachan DP, Dunger DB, Twells RC, Clayton DG, Todd JA: Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of Page 6 of 8 (page number not for citation purposes)F1000 Biology Reports 2012, 4:19 http://f1000.com/reports/b/4/19",OADS,/arxiv_data1/oa_pdf/ac/a7/biolrep-04-19.PMC3463895.pdf
"Page 7 of 8 (page number not for citation purposes)F1000 Biology Reports 2012, 4:19 http://f1000.com/reports/b/4/19",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/biolrep-04-19.PMC3463895.pdf
"F1000 Factor 6 Evaluated by Thomas Kay 22 Sep 2011 Page 8 of 8 (page number not for citation purposes)F1000 Biology Reports 2012, 4:19 http://f1000.com/reports/b/4/19",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/biolrep-04-19.PMC3463895.pdf
"An emerging concept of vascular salt sensitivity Kristina Kusche-Vihrog and Hans Oberleithner* Address: Institute of Physiology II, Medical Faculty, University of Münster, Robert-Koch-Strasse 27, 48149 Münster, Germany * Corresponding author: Hans Oberleithner (oberlei@uni-muenster.de) F1000 Biology Reports 2012, 4:20 (doi:10.3410/B4-20) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/d7/biolrep-04-20.PMC3463896.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/reports/b/4/20 Abstract Excessive amounts of salt in food, as usually consumed worldwide, affect the vascular system, leading to high blood pressure and premature disabilities.",Non-OADS,/arxiv_data1/oa_pdf/c4/d7/biolrep-04-20.PMC3463896.pdf
"Page 2 of 7 (page number not for citation purposes)F1000 Biology Reports 2012, 4:20 http://f1000.com/reports/b/4/20",Non-OADS,/arxiv_data1/oa_pdf/c4/d7/biolrep-04-20.PMC3463896.pdf
"Page 3 of 7 (page number not for citation purposes) F1000 Biology Reports 2012, 4:20 http://f1000.com/reports/b/4/20",Non-OADS,/arxiv_data1/oa_pdf/c4/d7/biolrep-04-20.PMC3463896.pdf
"Page 4 of 7 (page number not for citation purposes)F1000 Biology Reports 2012, 4:20 http://f1000.com/reports/b/4/20",Non-OADS,/arxiv_data1/oa_pdf/c4/d7/biolrep-04-20.PMC3463896.pdf
"Page 5 of 7 (page number not for citation purposes)F1000 Biology Reports 2012, 4:20 http://f1000.com/reports/b/4/20",Non-OADS,/arxiv_data1/oa_pdf/c4/d7/biolrep-04-20.PMC3463896.pdf
"Page 6 of 7 (page number not for citation purposes)F1000 Biology Reports 2012, 4:20 http://f1000.com/reports/b/4/20",Non-OADS,/arxiv_data1/oa_pdf/c4/d7/biolrep-04-20.PMC3463896.pdf
"Page 7 of 7 (page number not for citation purposes)F1000 Biology Reports 2012, 4:20 http://f1000.com/reports/b/4/20",Non-OADS,/arxiv_data1/oa_pdf/c4/d7/biolrep-04-20.PMC3463896.pdf
"The infrastructure for the Netherlands Study of Depression and Anxiety study (http://www.nesda.nl/nl/) was supported by the Geestkracht program of the Netherlands Organization for Health Research and Development (Health Care Research the Netherlands, Medical Science, grant No.",Non-OADS,/arxiv_data1/oa_pdf/67/a1/fneur-03-00105.PMC3463899.pdf
Available at: http://www.sleepfoundation.org Frontiers in Neurology | Sleep and Chronobiology June 2012 | Volume 3 | Article 105 | 6,Non-OADS,/arxiv_data1/oa_pdf/67/a1/fneur-03-00105.PMC3463899.pdf
"Available at: http://www.sleepfoundation.org O’Doherty, J., Rolls, E. T., Francis, S., Bowtell, R., and McGlone, F. (2001).",Non-OADS,/arxiv_data1/oa_pdf/67/a1/fneur-03-00105.PMC3463899.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2012, 3: 18633 - http://dx.doi.org/10.3402/dfa.v3i0.18633",Non-OADS,/arxiv_data1/oa_pdf/8c/a9/DFA-3-18633.PMC3464045.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18633 - http://dx.doi.org/10.3402/dfa.v3i0.18633",Non-OADS,/arxiv_data1/oa_pdf/8c/a9/DFA-3-18633.PMC3464045.pdf
"The debridement extended from the area ofulceration down to the underlying bone including aportion of central cuneiform that was sent for cultureDiabetic limb salvage and amputation decision-making Citation: Diabetic Foot & Ankle 2012, 3: 18633 - http://dx.doi.org/10.3402/dfa.v3i0.18633 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8c/a9/DFA-3-18633.PMC3464045.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18633 - http://dx.doi.org/10.3402/dfa.v3i0.18633",Non-OADS,/arxiv_data1/oa_pdf/8c/a9/DFA-3-18633.PMC3464045.pdf
"He admitted to being physically and emotionally exhausted dealing with this chronic problem limb, and had a much more positiveoutlook about the idea of amputation being likely to rid him of a source of infection and allow him to start rehabilitation promptly so that he could return to work and resume his clerical responsibilities.Diabetic limb salvage and amputation decision-making Citation: Diabetic Foot & Ankle 2012, 3: 18633 - http://dx.doi.org/10.3402/dfa.v3i0.18633 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8c/a9/DFA-3-18633.PMC3464045.pdf
"6 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18633 - http://dx.doi.org/10.3402/dfa.v3i0.18633",Non-OADS,/arxiv_data1/oa_pdf/8c/a9/DFA-3-18633.PMC3464045.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2012, 3: 18977 - http://dx.doi.org/10.3402/dfa.v3i0.18977",Non-OADS,/arxiv_data1/oa_pdf/48/c6/DFA-3-18977.PMC3464063.pdf
"The distal bypass target site was altered inBenjamin J. Pearce and Boulos Toursarkissian 2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18977 - http://dx.doi.org/10.3402/dfa.v3i0.18977",Non-OADS,/arxiv_data1/oa_pdf/48/c6/DFA-3-18977.PMC3464063.pdf
"However, a single institution study has demonstrated that the freedom from amputation isReview of revascularization strategies in the diabetic limb Citation: Diabetic Foot & Ankle 2012, 3: 18977 - http://dx.doi.org/10.3402/dfa.v3i0.18977 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/48/c6/DFA-3-18977.PMC3464063.pdf
"J Vasc Surg 2011; 53: 651 /C17.Benjamin J. Pearce and Boulos Toursarkissian 4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18977 - http://dx.doi.org/10.3402/dfa.v3i0.18977",Non-OADS,/arxiv_data1/oa_pdf/48/c6/DFA-3-18977.PMC3464063.pdf
"*Benjamin J. Pearce Department of Surgery University of Texas Health Science Center San Antonio7703 Floyd Curl Drive, MSC 7741 San Antonio, TX 78229 USAEmail: pearceb3@uthscsa.eduReview of revascularization strategies in the diabetic limb Citation: Diabetic Foot & Ankle 2012, 3: 18977 - http://dx.doi.org/10.3402/dfa.v3i0.18977 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/48/c6/DFA-3-18977.PMC3464063.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"2 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"Developed with reference to (3, 18, 20, 29/C131, 33).Assessing health provider motivation in sub-Saharan Africa Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"4 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"Although the peer that filled out this instrument did so anonymously, the issue of confidentiality was questionedAssessing health provider motivation in sub-Saharan Africa Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"6 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"The preliminary qualitative researchendorses this view with some of the respondents inall three countries underlining that this was absolutelynot the reason that they took up a health profession, whilst others blamed the providers they consideredAssessing health provider motivation in sub-Saharan Africa Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"8 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"These items came from a variety of sources including having been developed by authors.Table 2 (Continued ) Construct Item Source How they did not perform Satisfaction My expectations of this job have largely not been metDeveloped with reference to qualitative findings, which indicatedthat when providers described their expectations of their work as having been clear at the outset, theirdescribed levels of motivation werehigherDid not load to any factor to the minimum of 0.3 Timeliness I am often absent from work Adapted from (30) as used by (19) Most respondents (strongly) disagreed with this statement atpretest Even if I am called to take a delivery at night, I go to work the next dayDeveloped with reference to qualitative research that absenteeism is a problem at facilities in all threecountries, and that being disturbed fora delivery a night was cited as areason for needing time offMost respondents (strongly) agreed with this statement at pretest Behavior to patients I always welcome and praise women who come to deliver atthe facilityDeveloped with reference to qualitative research that indicated thatnot all staff appreciated the difficulties women faced to come and deliver at a healthMost respondents (strongly) agreed with this statement at pretest I may be rude to the patients if they don’t do what I askDeveloped with reference to qualitative research that gaveexamples that ‘not all staff’ are politeto the patients, particularly if theyconsider they do not accept what aprovider suggestsMost respondents (strongly) disagreed with this statement atpretest I usually allow companions to stay with women in laborDeveloped with reference to WHO MNH recommendationsMost respondents (strongly) disagreed with this statement atpretest Conscientiousness I am reliable and dependable at work(30) Most respondents (strongly) agreed with this statement At work I do things that needdoing without being told(19, 30) Most respondents (strongly) agreed with this statement Cooperativeness I sometimes find it hard to get on with the staff that have a different training to meDeveloped based on qualitative research that indicated divisions existed between more highly andlesser trained staffDid not load to any factor to the minimum of 0.3Assessing health provider motivation in sub-Saharan Africa Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"10 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"This was the only item that waschanged to fit the different countries 7 I often feel left alone when I have to make difficult decisions about a patient’s careDeveloped by authors with reference to the CDSS 8 I regularly have access to relevant trainings to keep my skills up to dateDeveloped by authors Role of performance 9 My performance is appraised regularly Developed by authors with reference to incentives package 10 Promotions do not depend on how well or badly one works on the jobAdapted from (30) Self-efficacy 11 It is difficult for me to speak openly to my superiors about how things are really going at workAdapted from (30) 12 Suggestions made by health workers on how to improve the facility are generally ignored(30, 31) Provider feels valued/exploited13 The facility management shows very little concern for me(30) 14 Our rights as health workers are generally not respectedDeveloped by authors Section III Performance Aspects Competence strengthening1 I do not get feedback from my superiors so it is hard to improve my performanceAdapted from (30, 47) 2 The feedback I get from my co-workers helps me to improve my workAdapted from (30)Assessing health provider motivation in sub-Saharan Africa Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"12 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"Table 4 .Effect of time in current position on mean responses to the three main aspects in Burkina Faso R-quadrat f(1, 81) p Non-standardized coefficient Management aspects 0.065 5.59 0.020* /C280.023 Performance aspects 0.018 1.45 0.233 /C280.010 Individual aspects 0.001 0.09 0.770 0.003 F-values have been rounded up to two decimal places, * /C30p50.05.Assessing health provider motivation in sub-Saharan Africa Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"14 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"Table 10 .Differences between self and peer responses to the items about provider behavior from all three countries Self-assessment Peer assessment f-test Country Nr Mean SD Mean SD fp Partial h2 Burkina Faso 83 1.43 0.34 1.69 0.49 (1, 82) 19.26 0.000* 0.190 Ghana 50 1.86 0.36 1.62 0.45 (1, 49) 11.65 0.001* 0.192Tanzania 58 1.51 0.33 1.72 0.41 (1, 57) 16.62 0.001* 0.226 Mean, standard deviation and F-values have been rounded up to two decimal places, * /C30p50.05.Assessing health provider motivation in sub-Saharan Africa Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
Available from: http://www.hciproject.org/sites/default/ﬁles/Measuring%20the%20Competence%20of% 20HC%20Providers_QAP_2001.pdf [cited 23 March 2012].Helen Prytherch et al.,OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"16 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
Available from: http://www.eric.ed.gov/PDFS/ED316767.pdf [cited 24 June 2012].,OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
Available from: http://www.who.int/whr/2006/whr06_en.pdf [cited 24 June2012].,OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"Bethesda, MD: Partner-ships for Health Reform Project, Abt Associates Inc; 2001.Available from: http://phrplus.org/Pubs/m5tp2.pdf [cited 24 June 2012].",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
Available from: http://www.popcouncil.org/pdfs/frontiers/FR_FinalReports/SA_QOC.pdf [cited 24 June2012].,Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"Bethesda, MD: Partner-ships for Health Reform Project, Abt Associates Inc; 1999.Available from: http://www.hrhresourcecenter.org/node/1095[cited 24 June 2012].Assessing health provider motivation in sub-Saharan Africa Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120 17 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
Availablefrom: http://upetd.up.ac.za/thesis/available/etd-08042008-192827/ unrestricted/dissertation.pdf [cited 23 March 2012].,Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
Available from: http://hdptz.esealtd.com/ﬁleadmin/ documents/Key_Sector_Documents/HRH_Documents/Human_ Resources_for_Health_Strategic_Plan-_2008 /C12013_.pdf [cited 24 June 2012].,Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"18 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 19120 - http://dx.doi.org/10.3402/gha.v5i0.19120",Non-OADS,/arxiv_data1/oa_pdf/11/b9/GHA-5-19120.PMC3464065.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2012, 3: 18809 - http://dx.doi.org/10.3402/dfa.v3i0.18809",Non-OADS,/arxiv_data1/oa_pdf/4c/c2/DFA-3-18809.PMC3464066.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18809 - http://dx.doi.org/10.3402/dfa.v3i0.18809",Non-OADS,/arxiv_data1/oa_pdf/4c/c2/DFA-3-18809.PMC3464066.pdf
"Surgical resection and debridement of infected metatarsal and phalangeal bones (A, B).Diabetic foot infections with osteomyelitis Citation: Diabetic Foot & Ankle 2012, 3: 18809 - http://dx.doi.org/10.3402/dfa.v3i0.18809 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4c/c2/DFA-3-18809.PMC3464066.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18809 - http://dx.doi.org/10.3402/dfa.v3i0.18809",Non-OADS,/arxiv_data1/oa_pdf/4c/c2/DFA-3-18809.PMC3464066.pdf
"Expert Rev Anti Infect Ther 2007; 5: 117 /C127.Table 1 .Comparison between diabetic foot ulcerations with osteomyelitis (study group) and without osteomyelitis (control group) Study group Control group Tests of significance and risk ratio Mean age (years) /C27standard deviation 56.7 /C2711 56.3 /C2712.1 Male:female ratio 3:1 1:1.3Type of diabetes Yates x 2/C305.13;P/C300.0235 Type 2 N/C30267 (80.7%) N/C301350 (74.7%) Type 1 N/C3064 (19.3%) N/C30458 (25.3%) Duration of wound healing Yates x2/C3020.02; P/C300.0002 B3 months 42.4% 72.7% 3/C16 months 30.6% 17.2% 6 months to 1 year 18.8% 7.9% /C211 year 8.2% 2.2% Outcome Yates x2/C3085.41; PB0.0001 Limb salvage N/C30270 (81.8%) N/C301735 (96%) Major amputation N/C3052 (15.8%) N/C3061 (3.4%) Deaths N/C308 (2.4%) N/C3012 (0.7%) Wound recurrence N/C3040 (12.1%) N/C30218 (12.1%) P/C300.97; odds ratio /C301.005; CI /C300.732/C11.378Diabetic foot infections with osteomyelitis Citation: Diabetic Foot & Ankle 2012, 3: 18809 - http://dx.doi.org/10.3402/dfa.v3i0.18809 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4c/c2/DFA-3-18809.PMC3464066.pdf
"6 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18809 - http://dx.doi.org/10.3402/dfa.v3i0.18809",Non-OADS,/arxiv_data1/oa_pdf/4c/c2/DFA-3-18809.PMC3464066.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2012, 3: 18978 - http://dx.doi.org/10.3402/dfa.v3i0.18978",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/DFA-3-18978.PMC3464067.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18978 - http://dx.doi.org/10.3402/dfa.v3i0.18978",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/DFA-3-18978.PMC3464067.pdf
"/C1Post-traumatic; TMA /C1transmetatarsal amputation; Prox /C1proximal.Propeller perforator flaps for the diabetic foot and ankle Citation: Diabetic Foot & Ankle 2012, 3: 18978 - http://dx.doi.org/10.3402/dfa.v3i0.18978 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/DFA-3-18978.PMC3464067.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18978 - http://dx.doi.org/10.3402/dfa.v3i0.18978",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/DFA-3-18978.PMC3464067.pdf
"Post-operative clinical views at 2 weeks (d) and 1 year follow-up (e, f).Propeller perforator flaps for the diabetic foot and ankle Citation: Diabetic Foot & Ankle 2012, 3: 18978 - http://dx.doi.org/10.3402/dfa.v3i0.18978 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/DFA-3-18978.PMC3464067.pdf
"6 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18978 - http://dx.doi.org/10.3402/dfa.v3i0.18978",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/DFA-3-18978.PMC3464067.pdf
"Plast Reconstr Surg 1985; 75: 627/C1 41.Propeller perforator flaps for the diabetic foot and ankle Citation: Diabetic Foot & Ankle 2012, 3: 18978 - http://dx.doi.org/10.3402/dfa.v3i0.18978 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/DFA-3-18978.PMC3464067.pdf
"8 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18978 - http://dx.doi.org/10.3402/dfa.v3i0.18978",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/DFA-3-18978.PMC3464067.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2012, 3: 18693 - http://dx.doi.org/10.3402/dfa.v3i0.18693",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/DFA-3-18693.PMC3464072.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18693 - http://dx.doi.org/10.3402/dfa.v3i0.18693",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/DFA-3-18693.PMC3464072.pdf
"(B) Compartment surgically resected.Diabetic foot infections Citation: Diabetic Foot & Ankle 2012, 3: 18693 - http://dx.doi.org/10.3402/dfa.v3i0.18693 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/DFA-3-18693.PMC3464072.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18693 - http://dx.doi.org/10.3402/dfa.v3i0.18693",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/DFA-3-18693.PMC3464072.pdf
"Flexor hallucis longus involvement in a case of sesamoid osteomyelitis.Diabetic foot infections Citation: Diabetic Foot & Ankle 2012, 3: 18693 - http://dx.doi.org/10.3402/dfa.v3i0.18693 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/DFA-3-18693.PMC3464072.pdf
"6 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18693 - http://dx.doi.org/10.3402/dfa.v3i0.18693",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/DFA-3-18693.PMC3464072.pdf
"*Javier Arago ´n-Sa´nchez 35002 Las Palmas de Gran CanariaCanary Islands Spain Email: javiaragon@telefonica.netDiabetic foot infections Citation: Diabetic Foot & Ankle 2012, 3: 18693 - http://dx.doi.org/10.3402/dfa.v3i0.18693 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fe/aa/DFA-3-18693.PMC3464072.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"Subchondral marrow edema at intertarsal joints is a result of neuroarthropathy.Imaging of the diabetic foot Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"In the chronic stage, there is no substantial soft tissue edema or osseousImaging of the diabetic foot Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"6 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"Furthermore, ﬂuid collections (white arrows), that show peripheral enhancement (black arrows) and accompanying subcutaneous tissue, fascial and muscular enhancement (asterisk) are present.Imaging of the diabetic foot Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"8 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"Anteroposterior (A), and lateral non-weight bearing (B) views show osseous and articular disorganization, midfoot collapse, and talar plantarﬂexion (arrow) with development of a rocker-bottom deformity.Imaging of the diabetic foot Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"10 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"Clinical evaluation revealed no signs ofinfection.Imaging of the diabetic foot Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"12 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"There is a synovial enhancement (arrowhead) and abnormal intramedullary signal (thick white arrow) that is extending from the joint surface in pre-(C) and post- contrast T1-weighted (D) images consistent with septic arthritis and accompanying osteomyelitis.Imaging of the diabetic foot Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"14 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"*S. Eser Sanverdi Hacettepe University School of Medicine Department of Radiology 06310 Sihhiye AnkaraTurkeyTel:/C2790 31 2495 2885 Email: esersanverdi@yahoo.comImaging of the diabetic foot Citation: Diabetic Foot & Ankle 2012, 3: 18754 - http://dx.doi.org/10.3402/dfa.v3i0.18754 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/25/49/DFA-3-18754.PMC3464078.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2012, 3: 19577 - http://dx.doi.org/10.3402/dfa.v3i0.19577",Non-OADS,/arxiv_data1/oa_pdf/09/ab/DFA-3-19577.PMC3464080.pdf
"We suggested that acquired lower eyelid epi - blepharon could develop through a different mechanism  from congenital form, and lower eyelid retraction might  play an important role in developing acquired lower eyelid  319Original Article Outcomes of Various Surgical Procedures on Acquired Lower Eyelid  Epiblepharon in Thyroid Associated Ophthalmopathy     Sung Wook Park1, Namju Kim2, Ho-Kyung Choung3, Sang In Khwarg1 1Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea 2Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Korea 3Department of Ophthalmology, SMG-SNU Boramae Medical Center, Seoul, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):319-323 http://dx.doi.org/10.3341/kjo.2012.26.5.319 © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : September 9, 2011     Accepted : November 17, 2011 Corresponding Author: Namju Kim, MD.",Non-OADS,/arxiv_data1/oa_pdf/5e/3f/kjo-26-319.PMC3464314.pdf
"The re - 324Original Article Correlations between Magnitude of Refractive Error and Other Optical Components in Korean Myopes     Sangkyu Lee, Boyun Kim, Tae-Hoon Oh, Hyun Seung Kim Department of Ophthalmology, St. Mary’s Hospital, The Catholic University of Korea School of Medicine, Seoul, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):324-330 http://dx.doi.org/10.3341/kjo.2012.26.5.324 © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : January 27, 2011     Accepted : November 10, 2011 Corresponding Author: Hyun Seung Kim, MD, PhD.",Non-OADS,/arxiv_data1/oa_pdf/da/ff/kjo-26-324.PMC3464315.pdf
"Despite the very high success  331Original Article Satisfaction Level of Physicians Who Have Undergone   Corneal Refractive Surgery     Eun Kyoung Lee1, Ji-Won Kwon2, Joon Young Hyon3, Young Keun Han1,4 1Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 2Department of Ophthalmology, Myongji Hospital, Kwandong University College of Medicine, Goyang, Korea 3Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea 4Department of Ophthalmology, Seoul National University Boramae Hospital, Seoul National University College of Medicine,  Seoul, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):331-338 http://dx.doi.org/10.3341/kjo.2012.26.5.331 © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : February 1, 2012     Accepted : February 21, 2012 Corresponding Author: Young Keun Han, MD, PhD.",Non-OADS,/arxiv_data1/oa_pdf/aa/34/kjo-26-331.PMC3464316.pdf
"339Original Article Comparison of Efficacy and Safety between Transconjunctival  23-Gauge and Conventional 20-Gauge Vitrectomy Systems   in Macular Surgery     Tugba Goncu1, Gokhan Gurelik2, Berati Hasanreisoglu2 1Ophthalmology Department, Nevsehir Goverment Hospital, Nevsehir, Turkey 2Ophthalmology Department, Gazi University School of Medicine, Ankara, TurkeypISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):339-346 http://dx.doi.org/10.3341/kjo.2012.26.5.339 © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : May 14, 2011     Accepted : October 21, 2011 Corresponding Author: Tugba Goncu, MD.",Non-OADS,/arxiv_data1/oa_pdf/aa/e4/kjo-26-339.PMC3464317.pdf
"Recently, spectral domain OCT (SD- OCT) was introduced for advanced imaging that reduces  acquisition time and allows for high resolution imaging of  347Original Article Morphologic Changes in Acute Central Serous Chorioretinopathy Using Spectral Domain Optical Coherence Tomography     Hyung Chan Kim, Won Bin Cho, Hyewon Chung Department of Ophthalmology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):347-354 http://dx.doi.org/10.3341/kjo.2012.26.5.347 © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : May 4, 2011     Accepted : November 17, 2011 Corresponding Author: Hyung Chan Kim, MD, PhD.",Non-OADS,/arxiv_data1/oa_pdf/85/79/kjo-26-347.PMC3464318.pdf
"Recently, the incidence  of macular pucker formation after pars plana vitrectomy  (PPV) alone as retinal reattachment surgery has been re - 355Original Article The Clinical Features of Macular Pucker Formation after Pars Plana  Vitrectomy for Primary Rhegmatogenous Retinal Detachment Repair     Moon Soo Heo1, Hyun Woong Kim1, Joo Eun Lee2, Sang Joon Lee3, Il Han Yun1 1Department of Ophthalmology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea 2Department of Ophthalmology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea 3Department of Ophthalmology, Gospel Hospital, Kosin University College of Medicine, Busan, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):355-361 http://dx.doi.org/10.3341/kjo.2012.26.5.355 © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : August 29, 2011     Accepted : December 6, 2011 Corresponding Author: Il Han Yun, MD, PhD.",Non-OADS,/arxiv_data1/oa_pdf/ec/e3/kjo-26-355.PMC3464319.pdf
"In a randomized, multicenter clinical trial, the Diabetic  Retinopathy Clinical Research (DRCR) Network showed  362Original Article A Three-year Follow-up of Intravitreal Triamcinolone Acetonide   Injection and Macular Laser Photocoagulation for Diffuse   Diabetic Macular Edema     Hee Yoon Cho1, Se Woong Kang2, Yun Taek Kim3, Song Ee Chung2, Seung Woo Lee4 1Department of Ophthalmology, Hanyang University School of Medicine, Seoul, Korea 2Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 3Department of Ophthalmology, Ewha Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea 4Department of Ophthalmology, Dongguk University Geyongju Hospital, Dongguk University College of Medicine, Gyeongju, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):362-368 http://dx.doi.org/10.3341/kjo.2012.26.5.362 © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : September 1, 2011     Accepted : November 11, 2011 Corresponding Author: Se Woong Kang, MD.",Non-OADS,/arxiv_data1/oa_pdf/ab/c3/kjo-26-362.PMC3464320.pdf
"Recently,  OCT technology has advanced considerably and now in - 369Original Article A Formula to Predict Spectral Domain Optical Coherence  Tomography (OCT) Retinal Nerve Fiber Layer Measurements   Based on Time Domain OCT Measurements     Kang Hoon Lee1, Min Gu Kang1, Hyunsun Lim2, Chan Yun Kim3, Na Rae Kim1 1Department of Ophthalmology, Inha University School of Medicine, Incheon, Korea 2Department of Research Affairs, Yonsei University College of Medicine, Seoul, Korea 3Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):369-377 http://dx.doi.org/10.3341/kjo.2012.26.5.369 © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : November 22, 2011     Accepted : December 20, 2011 Corresponding Author: Na Rae Kim, MD.",Non-OADS,/arxiv_data1/oa_pdf/0b/99/kjo-26-369.PMC3464321.pdf
"Therefore, the increase in  NO that is caused by L-arginine leads to the accumulation  378Original Article Effect of Amiloride to Retinal Toxicity Induced by Tissue Plasmino - gen Activator     Ungsoo Samuel Kim1, Hyun-Sub Oh2, Oh Woong Kwon3, In Chung4, Sung-Ho Lee5, Joon Haeng Lee6 1Department of Ophthalmology, Kim ’s Eye Hospital, Konyang University College of Medicine, Seoul, Korea 2Department of Ophthalmology, Kangbuk Samsung Medical Center, Seoul, Korea 3Department of Ophthalmology, Noone Eye Hospital, Seoul, Korea 4Jung In Eye Clinic, Seoul, Korea 5R & D Center, Eyegene Inc., Seoul, Korea 6Myung-Gok Eye Research Institute, Kim ’s Eye Hospital, Konyang University College of Medicine, Daejeon, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):378-382 http://dx.doi.org/10.3341/kjo.2012.26.5.378 © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : September 16, 2011     Accepted : October 21, 2011 Corresponding Author: Joon Haeng Lee, PhD.",Non-OADS,/arxiv_data1/oa_pdf/ed/5b/kjo-26-378.PMC3464322.pdf
"383Case Report Excision with Corneoscleral Lamellar Keratoplasty and   Amniotic Membrane Transplantation of a Corneal Displaced  Recurrent Conjunctival Melanoma     Eun Chul Kim, Man Soo Kim, Nam  Yeo Kang Department of Ophthalmology & Visual Science, The Catholic University of Korea College of Medicine, Seoul, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):383-387 http://dx.doi.org/10.3341/kjo.2012.26.5.383 Conjunctival melanomas are a rare unilateral disease  comprising 2% of all ocular melanomas [1].",Non-OADS,/arxiv_data1/oa_pdf/39/2d/kjo-26-383.PMC3464323.pdf
"© 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : November 30, 2010     Accepted : March 9, 2011 Corresponding Author: Nam  Yeo Kang, MD.",Non-OADS,/arxiv_data1/oa_pdf/39/2d/kjo-26-383.PMC3464323.pdf
"388Case Report A Case of Cystoid Macular Edema Associated with   Paclitaxel Chemotherapy     Dong Sik Ham1, Joo Eun Lee2, Hyun Woong Kim1, Il Han Yun1 1Department of Ophthalmology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea 2Department of Ophthalmology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):388-390 http://dx.doi.org/10.3341/kjo.2012.26.5.388 Macular edema is a condition that is usually secondary  to an underlying disease and that causes severe visual im - pairment.",Non-OADS,/arxiv_data1/oa_pdf/24/ed/kjo-26-388.PMC3464324.pdf
"Ophthalmic adverse effects include impaired visual  © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : October 8, 2010     Accepted : January 17, 2011 Corresponding Author: Hyun Woong Kim, MD, PhD.",Non-OADS,/arxiv_data1/oa_pdf/24/ed/kjo-26-388.PMC3464324.pdf
"391Case Report A Case of Idiopathic C entral Serous Chorior etinopathy in a 12-year-old Male  Treated with Bevacizumab     Yu Cheol Kim1, Si Dong Kim2, Kwang Soo  Kim1 1Department of Ophthalmology, Dongsan Medical Center, Keimyung University  School of Medicine, Daegu, Korea 2Department of Ophthalmology, Catholic University of Daegu  School of Medicine, Daegu, Korea pISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):391-393 http://dx.doi.org/10.3341/kjo.2012.26.5.391 Central chorioretinopathy (CSC) is a disease that can  present with either serous retinal pigment epithelial de - tachment or neurosensory retinal detachment in the macu - lar region due to the accumulation of serous fluid in the  posterior pole.",Non-OADS,/arxiv_data1/oa_pdf/cd/8a/kjo-26-391.PMC3464325.pdf
"There was no  © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : August 3, 2010     Accepted : December 21, 2010 Corresponding Author: Kwang Soo Kim, MD.",Non-OADS,/arxiv_data1/oa_pdf/cd/8a/kjo-26-391.PMC3464325.pdf
"394Case Report A Case of Paclitaxel-induced Maculopathy Treated with   Methazolamide     Nam Kyun Koo1, Yu Cheol Kim2 1Department of Ophthalmology, Dongkang Hospital, Ulsan, Korea 2Department of Ophthalmology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):394-397 http://dx.doi.org/10.3341/kjo.2012.26.5.394 Paclitaxel is well known for its treatment effect on meta - static breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/6a/f9/kjo-26-394.PMC3464326.pdf
"1B); however,  cystoid macular edema was found on optical coherence  © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : December 20, 2010     Accepted : March 2, 2011 Corresponding Author: Yu Cheol Kim, MD.",Non-OADS,/arxiv_data1/oa_pdf/6a/f9/kjo-26-394.PMC3464326.pdf
"398Case Report A Case of Tubulointerstitial Nephritis and Uveitis Syndrome in an  Elderly Patient     Jeong Mo Han1,2, Yun Jong Lee3, Se Joon Woo1 1Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea 2Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):398-401 http://dx.doi.org/10.3341/kjo.2012.26.5.398 Tubulointerstitial nephritis and uveitis (TINU) syndrome  was first described by Dobrin et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/ad/kjo-26-398.PMC3464327.pdf
"Laboratory tests conducted at the hospital showed a  blood urea nitrogen of 26 mg/dL (the upper limit of nor - mal), a serum creatinine of 2.3 mg/dL, and an estimated  © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : December 6, 2010     Accepted : January 17, 2011 Corresponding Author: Se Joon Woo, MD.",Non-OADS,/arxiv_data1/oa_pdf/9a/ad/kjo-26-398.PMC3464327.pdf
"402Case Report Cases of Pseudophakic Pseudoexfoliation in Glaucoma Patients     Hae-Young Lopilly Park, Myung Douk Ahn Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, KoreapISSN: 101 1-8942  eISSN: 2092-9382Korean J Ophthalmol 2012;26(5):402-405 http://dx.doi.org/10.3341/kjo.2012.26.5.402 Pseudophakic pseudoexfoliation is a rare condition; only  about 10 cases have been reported [1-4].",Non-OADS,/arxiv_data1/oa_pdf/8a/51/kjo-26-402.PMC3464328.pdf
"In 2009, a concentric ring of fine, spoke-like opacities  resembling the deposits seen in pseudoexfoliation were  © 2012 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received : October 8, 2010     Accepted : March 8, 2011 Corresponding Author: Myung Douk Ahn, MD, PhD.",Non-OADS,/arxiv_data1/oa_pdf/8a/51/kjo-26-402.PMC3464328.pdf
"157 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.http://dx.doi.org/10.5045/kjh.2012.47.3.157 The Korean Journal of Hematology Volume 47 ㆍNumber 3 ㆍSeptember 2012 Editorial Targeting the protein kinases for anti-cancer therapy Soo-Mee Bang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/97/e1/kjh-47-157.PMC3464329.pdf
"159 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.http://dx.doi.org/10.5045/kjh.2012.47.3.159 The Korean Journal of Hematology Volume 47 ㆍNumber 3 ㆍSeptember 2012 Perspective Celebrating the World Blood  Donor Day 2012 Sunhee Kim 2012 World Blood Donor Day Secr etariat, Blood Service HQs,  Korean Red Cross, Seoul, Korea Blood transfusion saves live s and improves health, but  not every country in the wo rld provides an adequate  environment for promoting safe  transfusion.",Non-OADS,/arxiv_data1/oa_pdf/77/3a/kjh-47-159.PMC3464330.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.161http://dx.doi.org/10.5045/kjh.2012.47.3.161 The Korean Journal of Hematology Volume 47 ㆍNumber 3 ㆍSeptember 2012 The e8a2 fusion transcript in B lymphoblastic leukemia with  BCR-ABL1  rearrangement Min Jin Kim1,2, Hwi-Joong Yoon3, Tae Sung Park2 1Department of Medicine, Gr aduate School, Kyung Hee Un iversity, Departments of  2Laboratory Medicine,  3Hematology-Oncology, School of Medici ne, Kyung Hee University, Seoul, Korea A 73-year-old man presented with fever.",Non-OADS,/arxiv_data1/oa_pdf/64/0e/kjh-47-161.PMC3464331.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.162http://dx.doi.org/10.5045/kjh.2012.47.3.162 The Korean Journal of Hematology Volume 47 ㆍNumber 3 ㆍSeptember 2012 Cutaneous plasmacytoma Ik-Chan Song, Deog-Yeon Jo Department of Internal Medicine, School of Medicine, Chungnam National University, Daejeon, Korea A 64-year-old woman having compression fractures in the fourth and fifth thoracic vertebral bodies was diagnosed  with multiple myeloma.",Non-OADS,/arxiv_data1/oa_pdf/af/e4/kjh-47-162.PMC3464332.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.VOLUME 47 ㆍNUMBER 3 ㆍSeptember 2012 THE KOREAN JOURNAL OF HEMATOLOGY REVIEW ARTICLE Castleman disease Ibrahiem Saeed-Abdul-Rahman1, Ali M. Al-Amri2 Divisions of  1Nephrology, 2Oncology, Department of Internal Medicine, King Fahd Univ ersity Hospital, Dammam University,  Al-Khobar, Saudi Arabia p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.163Korean J Hematol 2012;47:163-77.",Non-OADS,/arxiv_data1/oa_pdf/e6/07/kjh-47-163.PMC3464333.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.VOLUME 47 ㆍNUMBER 3 ㆍSeptember 2012 THE KOREAN JOURNAL OF HEMATOLOGY ORIGINAL ARTICLE Aurora A kinase expression is incr eased in leukemia stem cells, and  a selective Aurora A kinase in hibitor enhances Ara-C-induced  apoptosis in acute myeloid leukemia stem cells Soo-Jeong Kim1, Ji Eun Jang1, June-Won Cheong1, Ju-In Eom2, Hoi-Kyung Jeung2, Yundeok Kim1,  Doh Yu Hwang1, Yoo Hong Min1 1Department of Internal Medicine, Yons ei University College of Medicine, 2Medical Research Center, Yonsei University College of  Medicine, Seoul, Korea p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.178Korean J Hematol 2012;47:178-85.",Non-OADS,/arxiv_data1/oa_pdf/05/de/kjh-47-178.PMC3464334.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.VOLUME 47 ㆍNUMBER 3 ㆍSeptember 2012 THE KOREAN JOURNAL OF HEMATOLOGY ORIGINAL ARTICLE Identification of genes underlying different methylation profiles in  refractory anemia with excess blas t and refractory cytopenia with  multilineage dysplasia in  myelodysplastic syndrome Suee Lee1, Hyuk-Chan Kwon1, Sung-Hyun Kim1, Sung Yong Oh1, Ji Hyun Lee1, Yeon-Su Lee3,  Daekwan Seo4, Jin-Yeong Han2, Hyo-Jin Kim1 Departments of  1Internal Medicine, 2Laboratory Medicine, Dong-A Univ ersity Medical Center, Busan, 3Cancer Genomics Branch,  National Cancer Center, Goyang, Korea, 4Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cance r  Institute, Bethesda, MD, USA p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.186Korean J Hematol 2012;47:186-93.",Non-OADS,/arxiv_data1/oa_pdf/10/23/kjh-47-186.PMC3464335.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.VOLUME 47 ㆍNUMBER 3 ㆍSeptember 2012 THE KOREAN JOURNAL OF HEMATOLOGY ORIGINAL ARTICLE Effects of oral iron chelator deferasirox on human malignant  lymphoma cells Jong Gwon Choi1, Jung-Lim Kim2, Joohee Park1, Soonwook Lee1, Seh Jong Park1, Jun Suk Kim1,  Chul Won Choi1 1Department of Internal Medicine, Korea University Guro Hospital,  2Graduate School of Medicine, Korea University College of  Medicine, Seoul, Korea p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.194Korean J Hematol 2012;47:194-201.",Non-OADS,/arxiv_data1/oa_pdf/19/9a/kjh-47-194.PMC3464336.pdf
"Seok Jin Kim1, Yong Park2, Byung Soo Kim2, Insun Kim3, Young Hye Ko4, Won Seog Kim1 1Division of Hematology-Oncolog y, Department of Medicine, Samsung Medical Center, Sungkyunkwan Un iversity School of  Medicine, 2Division of Hematology /Oncology, Department of Internal Medicine, 3Department of Pathology, Korea University  Medical Center, 4Department of Path ology, Samsung Medical Center, Sungkyunkwan Universi ty School of Medicine, Seoul, Korea p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.202Korean J Hematol 2012;47:202-6.",Non-OADS,/arxiv_data1/oa_pdf/95/f7/kjh-47-202.PMC3464337.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.VOLUME 47 ㆍNUMBER 3 ㆍSeptember 2012 THE KOREAN JOURNAL OF HEMATOLOGY ORIGINAL ARTICLE Clinical significance of standard ized uptake value and maximum  tumor diameter in patients with primary extranodal diffuse large B  cell lymphoma Min-Young Oh, Sang-Bo Oh, Hyeog-Gyu Seoung, Ji-Hye Kim, Sang-Mi Kim, Tae-Kyun Kim,  Moo-Kon Song, Ho-Jin Shin, Joo-Seop Chung Department of Internal Medicine, Pusan Na tional University Hospital, Busan, Korea p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.207Korean J Hematol 2012;47:207-12.",Non-OADS,/arxiv_data1/oa_pdf/89/ad/kjh-47-207.PMC3464338.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.VOLUME 47 ㆍNUMBER 3 ㆍSeptember 2012 THE KOREAN JOURNAL OF HEMATOLOGY ORIGINAL ARTICLE Clinical characteristics and outcom es of primary bone lymphoma  in Korea So Yeon Kim1,#, Dong-Yeop Shin1,#, Seung-Sook Lee2, Cheolwon Suh3, Jae-Yong Kwak4, Hoon-Gu Kim5,  Jae Hoon Lee6, Soon Il Lee7, Ye Rim Lee1, Seung Hwa Kang1, Se Kwon Mun1, Min Jae Lee1,  Hyo-Rak Lee1, Sung Hyun Yang1, Hye Jin Kang1 Departments of  1Internal Medicine, 2Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences,  3Department of Oncology, Asan Medical Center, Un iversity of Ulsan Colleg e of Medicine, Seoul, 4Division of Hema tology-Oncology,  Department of Internal Medicine, Chonbuk National Univer sity Medical School and Hospital, Jeonju, 5Division of  Hematology-Oncology, Depa rtment of Internal Me dicine, Gyeongsang National University School of Medicine, Jinju, 6Department  of Internal Medicine, Gachon University Hospital, Gachon Univ ersity of Medicine and Science School of Medicine, Incheon,  7Division of Hematology-Oncology, Depa rtment of Internal Medicine, Dankook University Hospital, Cheonan, Korea p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.213Korean J Hematol 2012;47:213-8.",Non-OADS,/arxiv_data1/oa_pdf/8c/1e/kjh-47-213.PMC3464339.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.VOLUME 47 ㆍNUMBER 3 ㆍSeptember 2012 THE KOREAN JOURNAL OF HEMATOLOGY ORIGINAL ARTICLE Effects of granulocyte-colony stimulating factor and the  expression of its receptor on various malignant cells Hee Won Moon1,#, Tae Young Kim2,#, Bo Ra Oh2, Sang Mee Hwang3, Jiseok Kwon2, Ja-Lok Ku4,  Dong Soon Lee2,3 1Department of Laboratory Medicine, Ko nkuk University School of Medicine, 2Cancer Research Institute, 3Department of Laboratory  Medicine, 4Korean Cell Line Bank, Laboratory of Cell Biology, Cancer Re search Center and Cancer Research Institute, Seoul Nationa l  University College of Medicine, Seoul, Korea p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.219Korean J Hematol 2012;47:219-24.",Non-OADS,/arxiv_data1/oa_pdf/b7/69/kjh-47-219.PMC3464340.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.VOLUME 47 ㆍNUMBER 3 ㆍSeptember 2012 THE KOREAN JOURNAL OF HEMATOLOGY CASE REPORT A case of therapy-related ac ute myeloid leukemia with  inv(16)(p13.1q22) after single lo w-dose iodine-131 treatment for  thyroid cancer Ji Hun Jeong1, Jeong Yeal Ahn1, Soon Ho Park1, Mi Jung Park1, Kyung Hee Kim1, Jun Shik Hong2 Departments of  1Laboratory Medicine, 2Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.225Korean J Hematol 2012;47:225-8.",Non-OADS,/arxiv_data1/oa_pdf/3d/7d/kjh-47-225.PMC3464341.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.VOLUME 47 ㆍNUMBER 3 ㆍSeptember 2012 THE KOREAN JOURNAL OF HEMATOLOGY CASE REPORT ZBTB16-RAR α variant of acute promyelocytic leukemia with  tuberculosis: a case report  and review of literature Anshu Palta1, Pratibha Dhiman1, Sanjay D. Cruz2 Departments of  1Pathology, 2Medicine, Government Medical College and Hospital, Chandigarh, India p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.229Korean J Hematol 2012;47:229-32.",Non-OADS,/arxiv_data1/oa_pdf/fc/29/kjh-47-229.PMC3464342.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.VOLUME 47 ㆍNUMBER 3 ㆍSeptember 2012 THE KOREAN JOURNAL OF HEMATOLOGY CASE REPORT Thromboembolic events identified  during diagnosis of germ cell  tumors in 2 children Hea-Lin Oh1, Hae-Ryong Kang1, Seok-Cheol Jeon2, Young-Ho Lee1 Departments of  1Pediatrics, 2Radiology, Hany ang University Medical Center, Seoul, Korea p-ISSN 1738-7949 / e-ISSN 2092-9129 http://dx.doi.org/10.5045/kjh.2012.47.3.233Korean J Hematol 2012;47:233-6.",Non-OADS,/arxiv_data1/oa_pdf/eb/b1/kjh-47-233.PMC3464343.pdf
"Malignancies Patients, N (%) Patients with pericardial involvement, N (%) Solid tumors Lung adenocarcino ma 105 (48.8)   65 (61.9) Ductal cell carcinoma, brea st   20 (9.3)   17 (85.0) Gastric adenocarcinoma   17 (7.9)   10 (58.8)Esophageal squamous cell carcinoma   17 (7.9)     3 (17.6)Hepatocellular carcinoma   11 (5.1)     1 (9.1)Cholangiocarcinoma     3 (1.4)     0 (0.0)Thymic carcinoma     9 (4.2)     3 (33.3)Other solid tumors a)  23 (10.7)     9 (39.1) Hematological malignancies Lymphoma     6 (2.8)     5 (83.3) Other hematologic malignanciesb)    4 (1.9)     0 (0.0) Total 215 (100.0) 113 (52.6) a)Angiosarcoma (N=2), cervix cancer (N=1), colorectal cancer (N=4), embryonal carcin oma (N=1), endodermal  sinus tumor (N=2),  endomertrial cancer (N=1), glottic cancer (N=1), metastatic cancer of unknown origin (N=1), neuroblastoma (N=3), osteosarcoma ( N=1),  rhabdomyosarcoma (N=1), saivary duct carcin oma (N=1), sarcomatoid carcinoma (N=1), syno vial sarcoma (N=1), thyroid cancer (N=2) ,  b)Acute myeloid leukemia (N=2), chronic myelogenous leukemia (N=1), myelodysplastic syndrome (N=1).http://dx.doi.org/10.5045/kjh.2012.47.3.237 The Korean Journal of Hematology Volume 47 ㆍNumber 3 ㆍSeptember 2012 Letter to the Editor Prognostic relevance of pericar- dial effusion in patients with ma-lignant diseases TO THE EDITOR:  Malignancy is a common cause of peri- cardial effusion, and malignant pe ricardial effusion is a seri- ous manifestation in advanced malignancies [1].",Non-OADS,/arxiv_data1/oa_pdf/01/93/kjh-47-237.PMC3464344.pdf
"The expenditure on healthcare as a percentage of GDP was obtained for the mid-year of each study using the WHO Global Health Observatory Data Repository ( www.who.int/ gho, accessed 23 June 2012) for studies after 1995, and the Organisation for Economic Co-operation and Development Health Data ( http://stats.oecd.org , accessed 23 June 2012) for those before 1995 (when WHO data were not available).",Non-OADS,/arxiv_data1/oa_pdf/08/45/125_2012_Article_2690.PMC3464389.pdf
"Available from http://data.princeton.edu/wws509/notes/c7s6.html , accessed 11 May 2012 20.",Non-OADS,/arxiv_data1/oa_pdf/4c/c8/125_2012_Article_2668.PMC3464390.pdf
"Available from http://cancerhelp.cancerresearchuk.org/type/ bladder-cancer/treatment/bladder-cancer-statistics-and-outlook , accessed 12 December 2011 31.",Non-OADS,/arxiv_data1/oa_pdf/4c/c8/125_2012_Article_2668.PMC3464390.pdf
Acknowledgments We acknowledge the Japanese National Research Institute for Earth Science and Disaster Prevention (NIED) for making accessible the Kik-Net and K-net strong motion data through their websites http://www.kik.bosai.go.jp and http://www.k-net.bosai.go.jp.,Non-OADS,/arxiv_data1/oa_pdf/5d/0c/srep00709.PMC3464439.pdf
"The bathymetry in Figure 1a is based on the GEBCO_08 Grid, version 20100927, http://www.gebco.net.",OADS,/arxiv_data1/oa_pdf/5d/0c/srep00709.PMC3464439.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5d/0c/srep00709.PMC3464439.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Maercklin, N., Festa, G., Colombelli, S. & Zollo, A. Twin ruptures grew to build up the giant 2011 Tohoku, Japan, earthquake.",Non-OADS,/arxiv_data1/oa_pdf/5d/0c/srep00709.PMC3464439.pdf
"The multiple alignments were conducted using ClustalW2 (http:// www.ebi.ac.uk/Tools/clustalw2/index.html), and the resultant output was processedby program ESPript 2.2 (http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi), generating the final BLAST photography 42,48,49.",OADS,/arxiv_data1/oa_pdf/fe/84/srep00710.PMC3464449.pdf
"The protein sequence of the S. suis NeuB homologue was submitted to CPHmodels 3.0 Server (http://www.cbs.dtu.dk/services/CPHmodels), generating a PDB file of the modeled structure, which searchesfor a reasonable template of known structure.",OADS,/arxiv_data1/oa_pdf/fe/84/srep00710.PMC3464449.pdf
"suis NeuB was visualized using Swiss_PDBViewer 4.0.1 software from the Swiss Institute of Bioinformatics (http://spdbv.vital-it.ch/), and was superimposed on the N. meningitidis NeuB structure.",OADS,/arxiv_data1/oa_pdf/fe/84/srep00710.PMC3464449.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fe/84/srep00710.PMC3464449.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Feng, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/fe/84/srep00710.PMC3464449.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Kuroda, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/b1/66/srep00711.PMC3464454.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Sentı´s, G., Calsamiglia, J., Mun ˜oz-Tapia, R. & Bagan, E. Quantum learning without quantum memory.",Non-OADS,/arxiv_data1/oa_pdf/73/d5/srep00708.PMC3464493.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Pappalardo, L. & Mastrolorenzo, G. Rapid differentiation in a sill-like magma reservoir: a case study from the campi flegrei caldera.",Non-OADS,/arxiv_data1/oa_pdf/38/85/srep00712.PMC3464501.pdf
"The atomic coordinates and structure factors (codes 2l96 ,2l99 , and 2l9a ) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioin-formatics, Rutgers University, New Brunswick, NJ ( http://www.rcsb.org/ ).",OADS,/arxiv_data1/oa_pdf/b1/9c/zbc34120.PMC3464521.pdf
"The atomic coordinates and structure factors (codes 4FNH and 4FNI ) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioin-formatics, Rutgers University, New Brunswick, NJ ( http://www.rcsb.org/ ).",OADS,/arxiv_data1/oa_pdf/21/22/zbc34179.PMC3464526.pdf
"In all samples tested (passage 20), whole genome array analysis did not identify any aberrations larger than 100 kb, besides known benign  copy number variations (http://projects.tcag.ca/variation/) indi-cating karyotypic normality and stability after long-term in vitro   cell expansion (Supplementary Figure S2e).",OADS,/arxiv_data1/oa_pdf/94/16/mt2012117a.PMC3464631.pdf
"The DAVID platform version 6.7 was used to perform  functional annotation and signaling pathway and tissue expression enrich- ment analyses (http://david.abcc.ncifcrf.gov/home.jsp)  (Huang et al., 2009).",OADS,/arxiv_data1/oa_pdf/94/16/mt2012117a.PMC3464631.pdf
The  microarray data for AFSC discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus (Ref: GSE 26940) and are accessible through the GEO Series accession number GSE26940 (http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/94/16/mt2012117a.PMC3464631.pdf
In silico  identification of common  exonic SNPs in the H19 gene was carried out using the UCSC Genome  Browser dbSNP (http://genome.ucsc.edu/cgi-bin/hgGateway).,OADS,/arxiv_data1/oa_pdf/94/16/mt2012117a.PMC3464631.pdf
"RT-PCR  was carried out, products sequenced, and analyzed using the 4Peaks soft-ware (http://mekentosj.com/).",OADS,/arxiv_data1/oa_pdf/94/16/mt2012117a.PMC3464631.pdf
fCambridge University Press 2012 doi:10.1017/S0950268811002846 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/61/34/S0950268811002846a.PMC3464717.pdf
"http://www.mindgarden.com/products/staisad.htm Mind Garden Inc Srikandarajah S, Gilron I (2011) Systematic review of movement-evoked pain vspain at rest in postsurgical clinical trials and meta-analyses: a fundamental distinction requiring standardized measurement.",Non-OADS,/arxiv_data1/oa_pdf/ba/7e/bjc2012341a.PMC3464763.pdf
"FDA (2006) http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm127073.pdf Freidlin B, Korn EL, Gray R (2010) A general inefficacy interim monitoring rule for randomized clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/a9/bb/bjc2012344a.PMC3464764.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ APPENDIX 1 Equation for calculating conditional power (CP) (Proschan et al , 2006) used in (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/a9/bb/bjc2012344a.PMC3464764.pdf
"Analysis of expression data CEL file data were subjected to normalisation by GCRMA.Hierarchical clustering and principal component analysis (PCA) were conducted with GenePattern (http://www.broad.mit.edu/cancer/software/genepattern/) (Reich et al , 2006).",OADS,/arxiv_data1/oa_pdf/d0/22/bjc2012302a.PMC3464765.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, Burnet NG (2009) Normal tissue reactions to radiotherapy: towardstailoring treatment dose by genotype.",Non-OADS,/arxiv_data1/oa_pdf/d0/22/bjc2012302a.PMC3464765.pdf
We present the prediction model as nomogram and provide a web-based risk calculator (http://www.ccc.ac.at/gcu).,Non-OADS,/arxiv_data1/oa_pdf/7d/45/bjc2012340a.PMC3464766.pdf
"The model was developed in a relatively large European, mainly Caucasian, cohort and can beapplied for prediction by means of the presented nomogram or,more conveniently, by an online prediction tool (available at http://www.ccc.ac.at/gcu).",Non-OADS,/arxiv_data1/oa_pdf/7d/45/bjc2012340a.PMC3464766.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Ali SM, Carney WP, Esteva FJ, Fornier M, Harris L, Kostler WJ, Lotz JP, Luftner D, Pichon MF, Lipton A (2008) Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/46/98/bjc2012353a.PMC3464767.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Bashamboo A, Taylor AH, Samuel K, Panthier JJ, Whetton AD, Forrester LM (2006) The survival of differentiating embryonic stem cells isdependent on the SCF-KIT pathway.",Non-OADS,/arxiv_data1/oa_pdf/49/21/bjc2012356a.PMC3464768.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Agarwal R, Kaye SB (2003) Ovarian cancer: strategies for overcoming resistance to chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/96/7e/bjc2012343a.PMC3464770.pdf
"Available at http://www.hesonline.nhs.uk/ Hirte HW, Miller D, Tonkin K, Findlay B, Capstick V, Murphy J, Buckman R, Carmichael J, Levine M, Hill W (1997) A randomized trial ofparacentesis plus intraperitoneal tumor necrosis factor-alpha versus paracentesis alone in patients with symptomatic ascites from recurrent ovarian carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/96/7e/bjc2012343a.PMC3464770.pdf
"Available at http://www.dh.gov.uk/en/Publ icationsandstatistics/Pu blications/Publications PolicyAndGuidance/DH_123459 Numnum TM, Rocconi RP, Whitworth J, Barnes MN (2006) The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/96/7e/bjc2012343a.PMC3464770.pdf
"Available athttp://guidance.nice.org.uk/MT/131/Consultation/ExternalAssessment/pdf/English White MA, Agle SC, Padia RK, Zervos EE (2011b) Denver peritoneovenous shunts for the management of malignant ascites: a review of the literaturein the post LeVeen Era.",Non-OADS,/arxiv_data1/oa_pdf/96/7e/bjc2012343a.PMC3464770.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Barone I, Brusco L, Fuqua SA (2010) Estrogen receptor mutations and changes in downstream gene expression and signaling.",Non-OADS,/arxiv_data1/oa_pdf/0d/00/bjc2012351a.PMC3464772.pdf
"12HOIA is largely based on the existing North American Association of Central Cancer Registries (NAACCR) Hispanic Identiﬁcation Algorithm (NHIA).18HOIA takes into account all information routinely available to cancer registries, and in addition, all non-Hispanic cases are matched to a Hispanic surname list.19HOIA is available online at http://fcds.med.miami.edu and has beendescribed in detail in previous publications.",OADS,/arxiv_data1/oa_pdf/4d/42/ctg201215a.PMC3464804.pdf
"The joinpoint analyses wereperformed using the Joinpoint software, version 3.3, from the Surveillance Research Program of the US National Cancer Institute (available at http://srab.cancer.gov/joinpoint).Trends in Colorectal Cancer Among Florida Hispanics Hernandez et al.",OADS,/arxiv_data1/oa_pdf/4d/42/ctg201215a.PMC3464804.pdf
Available from: http://www.census.gov/Press-Release/www/releases/archives/population (cited 5 June 2010).,OADS,/arxiv_data1/oa_pdf/4d/42/ctg201215a.PMC3464804.pdf
Available from: http://pewhispanic.org/factsheets/factsheet.php?FactsheetID 1 446 (cited 29 July 2009).,Non-OADS,/arxiv_data1/oa_pdf/4d/42/ctg201215a.PMC3464804.pdf
Available at: http://www.cancer.org/downloads/STT/CAFF2006Hisp PWSecured.pdf (cited 16 September 2007).,Non-OADS,/arxiv_data1/oa_pdf/4d/42/ctg201215a.PMC3464804.pdf
Available at: http://edr.state.ﬂ.us/Content/population-demographics/ index.cfm (cited 30 March 2010).,OADS,/arxiv_data1/oa_pdf/4d/42/ctg201215a.PMC3464804.pdf
Available at: http://www.seer.cancer.gov.,Non-OADS,/arxiv_data1/oa_pdf/4d/42/ctg201215a.PMC3464804.pdf
Available from: http://www.doh.state.ﬂ.us/Disease_ctrl/epi/brfss/ reports.htm (cited 22 February 2011).,OADS,/arxiv_data1/oa_pdf/4d/42/ctg201215a.PMC3464804.pdf
Available from: http://www.doh.state.ﬂ.us/Disease_ctr l/epi/brfss/reports.htm (cited 22 February 2011).,OADS,/arxiv_data1/oa_pdf/4d/42/ctg201215a.PMC3464804.pdf
Available from: http://seer.cancer.gov/csr/1975_2007 (cited 22 February 2011).,Non-OADS,/arxiv_data1/oa_pdf/4d/42/ctg201215a.PMC3464804.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/CXCR4 Expression Predicts Poor Survival in Pancreatic Cancer Liao et al .",Non-OADS,/arxiv_data1/oa_pdf/03/19/ctg201218a.PMC3464805.pdf
±10.9) from the VICTOR and QUASAR2 (http://www.octo-oxford.org.uk/alltrials/infollowup/q2.html) trials.,OADS,/arxiv_data1/oa_pdf/55/e7/bjc2012329a.PMC3464867.pdf
The Colon Cancer Family Registry (CFR1) data set comprised 1290 familial CRC cases and 1055 controls CFR (Colon-CFR)(http://epi.grants.cancer.gov/CFR/about_colon.html).,OADS,/arxiv_data1/oa_pdf/55/e7/bjc2012329a.PMC3464867.pdf
CFR2 comprised an additional 796 cases ascertained through the CFR (http://epi.grants.cancer.gov/CFR/about_colon.html).,Non-OADS,/arxiv_data1/oa_pdf/55/e7/bjc2012329a.PMC3464867.pdf
A fulllist of the investigators who contributed to the generation of the data is available at http://www.wtccc.org.uk/.,OADS,/arxiv_data1/oa_pdf/55/e7/bjc2012329a.PMC3464867.pdf
"Web addresses 1000genomes: http://www.1000genomes.org/IMPUTE: http://mathgen.stats.ox.ac.uk/impute/SNPTEST: https://mathgen.stats.ox.ac.uk/genetics_software/snptest/ META: http://www.stats.ox.ac.uk/ Bjsliu/meta.html SNAP http://www.broadinstitute.org/mpg/snap/R project: http://www.r-project.org/dbSNP: http://www.ncbi.nlm.nih.gov/projects/SNP/ TFSearch: http://www.cbrc.jp/research/db/TFSEARCH.html deCode ECR Browser: http://ecrbrowser.dcode.org/UCSC genome browser: http://genome.ucsc.edu/ Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Aaltonen L, Johns L, Jarvinen H, Mecklin JP, Houlston R (2007) Explaining the familial colorectal cancer risk associated with mismatch repair(MMR)-deficient and MMR-stable tumors.",Non-OADS,/arxiv_data1/oa_pdf/55/e7/bjc2012329a.PMC3464867.pdf
"Gel images were taken with LAS- 4000 mini image analyzer (FUJIFILM, Tokyo, Japan) and the intensity of bands was measured by using Image J software (http://rsbweb.nih.gov/ij/) freely available on the Internet.",OADS,/arxiv_data1/oa_pdf/b1/47/mtna201232a.PMC3464879.pdf
"Images of  each western blot were taken with a LAS-4000 mini image  analyzer (FUJIFILM), and the intensity of each band was measured using Image J software (http://rsbweb.nih.gov/ij/), which is freely available on the Internet.",OADS,/arxiv_data1/oa_pdf/b1/47/mtna201232a.PMC3464879.pdf
"This work is   licensed under the Creative Commons Attribution-Noncommercial-No   Derivative Works 3.0 Unported License.To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/b1/47/mtna201232a.PMC3464879.pdf
"11 For  2OMePS AONs, exon skipping after systemic AON treatment of mdx mice can be achieved with a dose of 50 mg/kg/week,  but the optimal dose appears to be 200 mg/kg/week, 14 which  would correspond to a dose of 16 mg/kg in humans after cor-recting for differences in body surface area between small  and large animals (http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm078932.pdf).",Non-OADS,/arxiv_data1/oa_pdf/21/e6/mtna201238a.PMC3464881.pdf
"However, a correction factor applies when  translating doses between small and larger animals based on normalization to body surface area (http://www.fda.gov/   downloads/Drugs/GuidanceComplianceRegulatoryInforma- tion/Guidances/ucm078932.pdf).",Non-OADS,/arxiv_data1/oa_pdf/21/e6/mtna201238a.PMC3464881.pdf
"This work is   licensed under the Creative Commons Attribution-Noncommercial-No   Derivative Works 3.0 Unported License.To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/21/e6/mtna201238a.PMC3464881.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/3d/b0/mtna201239a.PMC3464882.pdf
Available at http://www.ncbi.nlm.nih.gov/books/NBK1125 (accessed 14 September 2012).,Non-OADS,/arxiv_data1/oa_pdf/09/07/ijos201259a.PMC3464985.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Chemical composition of GCE and the effect XL Huang et al 151 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/4a/41/ijos201244a.PMC3464986.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Effects of sleep bruxism MA Ommerborn et al 145 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/e4/e7/ijos201248a.PMC3464987.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,provided the original work is properly cited.J Antimicrob Chemother 2012; 67: 2213–2221 doi:10.1093/jac/dks207 Advance Access publication 11 June 2012 2213",Non-OADS,/arxiv_data1/oa_pdf/10/da/dks207.PMC3465101.pdf
2004. http://www.who.int/hiv/pub/prev_care/malariahiv.,Non-OADS,/arxiv_data1/oa_pdf/10/da/dks207.PMC3465101.pdf
"899. http://www.astmh.org/AM/Template.cfm?Section=Abstracts_and_Education1&Template=/CM/ContentDisplay.cfm&ContentID=3722 (25 May 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/10/da/dks207.PMC3465101.pdf
Authors can directly submit the manuscripts through our journal site http://www.jpionline.org.,Non-OADS,/arxiv_data1/oa_pdf/43/39/IJPI-1-1.PMC3465114.pdf
Available from: http://www.who.int/cancer/palliative.,Non-OADS,/arxiv_data1/oa_pdf/b0/bc/IJPI-1-48.PMC3465115.pdf
"Received :  15-11-10, Accepted: 02-12-10 Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/d0/21/IJPI-1-10.PMC3465117.pdf
" International Journal of Pharmaceutical Investigation  | January 2011 | Vol 1 | Issue 1 53Upcoming events: Jan–Mar 2011 Pharmapack Date : February 23–24, 2011, Place : Paris, France Details : Pharmapack is the platform for exchanges dedicated  to packaging and drug delivery systems innovations for the pharmaceutical industry .Useful link: http://www.canontradeshows.com/expo/pharmafr10/index_en.html  BIOMEDevice Date : February 23–24, 2011, Place : Paris, France Details : BIOMEDevice is the first European event to focus on the  development of the next generation of combination products.",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/IJPI-1-53.PMC3465118.pdf
"As drug delivery systems continue to evolve and the medical device, biopharmaceutical, and pharmaceutical industries converge, BIOMEDevice is dedicated to key executives, engineers, and researchers looking for new partnering opportunities and enabling technologies.Useful link: http://www.canontradeshows.com/expo/biofrance10/index_en.html  CHI's Inaugural Delivery of Biologics (part of the  Molecular Tri-Conference)  Date : February 23–25, 2011, Place : San Francisco, CA, USA Details : The conference will focus on almost all the aspects of  delivery of biologics.Useful link: http://www.triconference.com/bdl.asp  Pharma World Expo Date : February 23–26, 2010, Place : Mumbai, India Details : Being organized by Chemtech Foundation, Pharma Bio  World Expo is one of the foremost shows for pharma and biotech industry in India.",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/IJPI-1-53.PMC3465118.pdf
"V esting on an area more than 30,000 m2.Useful link: http://www.chemtech-online.com/events/chemtech/chemtech_history .html  46th Annual Arden Conference: Pharmaceutical  Development of Biologics: Fundamentals, Challenges, and Recent Advances Date : March 6–10, 2011, Place : W est Point, NY , USADetails : This program is designed to provide a comprehensive  review of biologic drug development, commonly encountered issues, challenges, and recent advances in bioprocess, formulation,  delivery , and manufacturing technologies.",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/IJPI-1-53.PMC3465118.pdf
"Useful link: http://www.aerosol-forum.com/en/  Second World Conference on Nanomedicine and  Drug Delivery (WCN) 2011 Date : March 11–13, 2011, Place : Kottayam, Kerala, IndiaUpcoming Events",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/IJPI-1-53.PMC3465118.pdf
"Useful link: http://www.nanomedicine.macromol.in/  Injectable Drug Delivery—Devices, Technology and Development Date : March 24–25, 2011, Place : London, UK Details : It will provide an extremely valuable update on the  advances in injection technology , an opportunity to keep abreast of business opportunities in the market and the chance to develop significant business partnerships.Useful link: http://www.management-forum.co.uk/medical/eventid/1475  Skin Forum, 12th Annual Meeting Date : March 28–29, 2011, Place : Frankfurt, Germany Details : The conference organized by APV International  Association for Pharmaceutical T echnology in partnership with skin forum, includes scientific lectures, poster show, and exhibition.",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/IJPI-1-53.PMC3465118.pdf
"Main topics include the following: structure of the barrier stratum corneum, barrier functions, protection of the barrier, transdermal drug delivery , and new methods.Useful link: http://www.apv-mainz.de/index.php?id=359  IPAC-RS 2011 Conference: Bringing Value to the Patient in a Changing World  Date : March 29–31, 2011, Place : Rockville, MD, USA Details : Conference will focus on ways the industry increases the value to the patients using orally inhaled and nasal drug  products (OINDPs).",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/IJPI-1-53.PMC3465118.pdf
"After 2 days of the plenary Conference talks, 3 specialty workshops will be offered on the 3rd day .Useful link: http://www.ipacrs.com/2011%20Conference.html  8th Conference on Controlled Release Date : March 30–31, 2011, Place : London, UK Details : SMi's 8th conference on Controlled Release builds  on the successes of the previous years in bringing together leading industry figures and tackling some of the most current and pressing issues faced by this important branch of drug development.",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/IJPI-1-53.PMC3465118.pdf
"By addressing a wide range of topics relating to the research, commercialization, manufacture, and sale affecting both drug delivery and controlled release, this event promises to deliver a unique chance to gather knowledge and network with a world class line up of speakers.Useful link: http://www.smi-online.co.uk/events/overview.asp?is=4andref=3458Upcoming events: Jan–Mar 2011",Non-OADS,/arxiv_data1/oa_pdf/c2/5b/IJPI-1-53.PMC3465118.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/a5/58/IJPI-1-88.PMC3465122.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/35/d4/IJPI-1-75.PMC3465123.pdf
Start a QR-code  reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code  printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/08/3d/IJPI-1-62.PMC3465125.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for  the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/08/3d/IJPI-1-62.PMC3465125.pdf
"Useful link: http://www.management-forum.co.uk/medical/ eventid/1477 Integrated Tablet Formulation Development Date:  April 7-8, 2011.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://pharma-training-courses.com/integrated- tablet-formulation-development.html Tablet Process Development, Validation and  Application of QbD Date:  April 11-12, 2011, Place:  NJ, USA Details:  This interactive workshop provides up-to-date,  relevant and detailed information on the impact of Quality  by Design (QbD) on the development and validation of tablet  manufacturing processes.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://pharma-training-courses.com/tablet-process- development-and-validation.html PDA Annual Meeting Date:  April 11-15, 2011, Place:  San Antonio, TX, US Details:  The meeting is dedicated to advancing the careers of  pharmaceutical and biopharmaceutical professionals by focusing  program content on science and technology innovation as well as  optimized performance, offering extensive formal and informal  networking opportunities and providing a forum to contribute to and  influence the advancement of science and regulation in the industry .",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://pdaannualmeeting.org/ APV Experts’ Workshop on Hot-Melt Extrusion and  Its Use in the Manufacturing of Pharmaceutical  Dosage Forms Date:  April 12-13, 2011, Place:  New Y ork, USA Details:  The workshop’s main intention is the increase of  expertise and the update of existing knowledge for all those  who already have basic experience in the use of hot-melt  extrusion technologies.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://www.apv-mainz.de/fileadmin/Pdf_ Programme_Sept_2010/6368_Hot_melt.pdf UKICRS Symposium 2011 Date:  April 13, 2011, Place:  Belfast, UK Details:  The symposium is focused on encouraging participation  of postgraduate students within the fields of controlled release  and drug delivery .",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://www.ukicrs.org/symposium/ Oral Delivery Strategies Date:  April 14-15, 2011, Place:  Baltimore, MD, USA Details:  The workshop objectives and benefits to the attendees  include better understanding of drivers, challenges and the  unmet needs in modern drug discovery , development and  learning state-of the-art of enabling drug delivery technologies,  selection criteria, in vitro/in vivo methodologies and evaluation  tools.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://www.flemingeurope.com/pharmaceuticals- conferences/europe/pharma-think-tank-2011 Drug Delivery and Formulation America 2011 Date:  April 27-28, 2011, Place:  San Diego, US Details:  Drug Delivery and Formulation America is a  networking opportunity for both scientific and business Upcoming events",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://www.ddfsummit.com/ Solubility and Solubilization in Aqueous Media Date:  May 2-5, 2011, Place:  T ucson, AZ, USA Details:  It will provide a working knowledge of the various means  of controlling the solubility and dissolution rate of a drug or other  solute in an aqueous medium.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://www.pharmacy .arizona.edu/solubility Pharmaceutical and Medical Packaging 2011 Date:  May 3-4, 2011, Place:  Copenhagen, Denmark Details:  The program is directed to those in the pharmaceutical  and medical device industry who are involved in packaging  and distribution; professionals who are responsible for the  development of new products and their packaging and labeling,  quality assurance and regulatory affairs managers, purchasing  managers, production managers, GMP audits, supervisors and  advisors from the public sector, as well as those in the packaging  manufacturing industry .",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://www.hexagon.dk/Pharmaceutical/ ParticipantsInfo.htm RDD Europe 2011 Date:  May 3-6, 2011, Place:  Berlin, Germany Details:  The meeting will include podium sessions, scientific  poster sessions, technology exhibition and workshop sessions  covering all aspects of respiratory drug delivery .",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://www.rddonline.com/rdd/rdd.php?id = 6 Technology Transfer Date:  May 9-10, 2011, Place:  London, UK Details:  The two-day interactive workshop is intended to  provide an overview of the challenges that must be overcome in  transferring technology and to highlight some proven techniques  for overcoming those challenges.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://pharma-training-courses.com/technology- transfer-for-pharmaceutical-products.html Prefilled Syringes and Advanced Injection  Technologies Date:  May 10-11, 2011, Place:  London, UK Details:  This conference is recommended for technical,  regulatory and management representatives of companies involved in the supply of prefilled technologies as well as  those developing products that could be presented in these  formats.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://www.management-forum.co.uk/medical/ eventid/1506 Blood-Brain Barrier Date:  May 14-15, 2011, Place:  San Francisco, CA, USA Details:  The workshop will provide an overview of the current  literature and thinking regarding the nature of the BBB and  transport of biotherapeutics, provide an overview of various  technologies that are available to be employed for the delivery  of various modalities of biotherapeutics, identify issues faced by  academia and small biotech industry during the development  of BBB penetrating methodologies, identify challenges  encountered in the development of appropriate methodologies  and technologies for BBB penetration and share during the  translation of in vivo  methodologies from animal models to  the clinic.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://www.appelconsulting.co.uk/events/drug- delivery-1 Integrated Tablet Formulation Development Date:  June 9-10, 2011, Place:  New Jersey , USA Details:  This two day course introduces and integrates the key  elements of tablet development with the principles of Quality by  Design (QbD).",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://pharma-training-courses.com/integrated- tablet-formulation-development.html Tablet Process Development, Validation and the  Application of QbD Date:  June 13-14, 2011, Place:  London, UK Details:  This interactive workshop provides up-to-date,  relevant and detailed information on the impact of Quality by",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://pharma-training-courses.com/tablet-process- development-and-validation.html Pharmaceutical Nanotechnology: Applications and  Commercialization Date:  June 27-28, 2011, Place:  London, UK Details:  The conference will address engineering, formulation  and drug delivery , nano-enabled nucleic acid therapeutic delivery ,  translating discoveries into commercial successes, regulatory  considerations and intellectual property issues and partnering  opportunities.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
Useful link: http://www.smi-online.co.uk/events/overview.,Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
"Useful link: http://www.management-forum.co.uk/medical/ eventid/1507 Access this article online Quick Response Code: Website:  www.jpionline.org New features on the journal’s website Optimized content for mobile and hand-held devices HTML pages have been optimized for mobile and other hand-held devices (such as iPad, Kindle, iPod) for faster browsing speed.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/IJPI-1-126.PMC3465126.pdf
Available from: http://www.drugdeliverytechnology.,OADS,/arxiv_data1/oa_pdf/b2/0c/IJPI-1-99.PMC3465128.pdf
Available from: http://en.wikipedia.org/wiki/Levocetirizine.,Non-OADS,/arxiv_data1/oa_pdf/b2/0c/IJPI-1-99.PMC3465128.pdf
Available from: http://www.freepatentsonline.,Non-OADS,/arxiv_data1/oa_pdf/b2/0c/IJPI-1-99.PMC3465128.pdf
Available from: http://www.onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/34/3c/IJPI-1-64.PMC3465129.pdf
Available from: http://www.bentham.org/ddf/samples/ ddf%201-1/Amiji.pdf [Last accessed on 2010 Jan 25].,OADS,/arxiv_data1/oa_pdf/34/3c/IJPI-1-64.PMC3465129.pdf
Available from: http://www.faqs.org/patents/ app/20100004390#ixzz0y6Sf8jdT.,Non-OADS,/arxiv_data1/oa_pdf/34/3c/IJPI-1-64.PMC3465129.pdf
Available from: http://www.bentham.org/ddf/ samples/ddf%201-1/Amiji.pdf [Last accessed on 2010 Jan 25].,OADS,/arxiv_data1/oa_pdf/34/3c/IJPI-1-64.PMC3465129.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/19886668 [Last accessed on 2010 Dec 27].,OADS,/arxiv_data1/oa_pdf/34/3c/IJPI-1-64.PMC3465129.pdf
Available from: http://www.freepatentsonline.,Non-OADS,/arxiv_data1/oa_pdf/34/3c/IJPI-1-64.PMC3465129.pdf
Available from: http://www.hdl.handle.,Non-OADS,/arxiv_data1/oa_pdf/34/3c/IJPI-1-64.PMC3465129.pdf
Available from: http://www.iptonline.com/articles/public/ page78nonprint.pdf [Last accessed on 2010 Dec 27].,Non-OADS,/arxiv_data1/oa_pdf/34/3c/IJPI-1-64.PMC3465129.pdf
Benefits of chewing gum Available from: http://www.wrigley.com/ global/benefits-of-chewing.aspx .,Non-OADS,/arxiv_data1/oa_pdf/4b/4d/IJPI-1-131.PMC3465133.pdf
A Conjugate Of Insulin and Vitamin B12 For Oral Delivery:  Available from: http://www.wipo.int/pctdb/en/wads.jsp?ia=us200 8002846andlanguage=enandid=id00000008122115andvol=92an ddoc=0544a5andwo=08/109068andweek=18/2009andtype=a1a nddoc_type=pamphandpage=html .,Non-OADS,/arxiv_data1/oa_pdf/4b/4d/IJPI-1-131.PMC3465133.pdf
Available from: http://www.chewinggumfacts.,Non-OADS,/arxiv_data1/oa_pdf/4b/4d/IJPI-1-131.PMC3465133.pdf
Available from: http://www.astrogyan.com/ herbal_cure_info/herbID-228/herb_name_tukmalanga.html [Last  accessed on 2010 Nov 13].,Non-OADS,/arxiv_data1/oa_pdf/07/00/IJPI-1-192.PMC3465134.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/5d/17/IJPI-1-129.PMC3465135.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.AnnouncementHow to cite this article: Ali J. Plagiarism: An editor's concern.,Non-OADS,/arxiv_data1/oa_pdf/5d/17/IJPI-1-129.PMC3465135.pdf
Available from: http://www.inchem.org/ documents/ehc/ehc/ehc89.htm.,Non-OADS,/arxiv_data1/oa_pdf/c6/4c/IJPI-1-172.PMC3465138.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/44/44/IJPI-1-148.PMC3465140.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/8e/95/IJPI-1-247.PMC3465142.pdf
Available from:  http://www.ondrugdelivery.com [Last Cited on 2007 Oct 10].,OADS,/arxiv_data1/oa_pdf/0d/08/IJPI-1-200.PMC3465144.pdf
Available  from: http://www.ondrugdelivery.com.,Non-OADS,/arxiv_data1/oa_pdf/0d/08/IJPI-1-200.PMC3465144.pdf
Available from: http://www.ondrugdelivery.com [Last Cited on  2007 October 10].,Non-OADS,/arxiv_data1/oa_pdf/0d/08/IJPI-1-200.PMC3465144.pdf
Available from:  http://www.westpfssolutions.com/en/prefsys .,Non-OADS,/arxiv_data1/oa_pdf/0d/08/IJPI-1-200.PMC3465144.pdf
Available from: http://www.medicinenet.com/interferon_beta-1a- prefilled inj syringe/page3.htm  [Last accesssed on 2011 Jul 14].,Non-OADS,/arxiv_data1/oa_pdf/0d/08/IJPI-1-200.PMC3465144.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/0d/08/IJPI-1-200.PMC3465144.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/0d/08/IJPI-1-200.PMC3465144.pdf
Available from: http://www.sigmaaldrich.,Non-OADS,/arxiv_data1/oa_pdf/6d/ad/IJPI-1-214.PMC3465145.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/6d/ad/IJPI-1-214.PMC3465145.pdf
Most of the software like iThenticate ( http://www.ithenticate.,Non-OADS,/arxiv_data1/oa_pdf/ef/2b/IJPI-1-255.PMC3465149.pdf
"com ), Viper ( http://www.scanmyessay .com/plagiarism-free- software ), T urnitin (https://turnitin.com/static/index) available  for detecting plagiarism do not actually detect plagiarism  rather detect similarity index.",Non-OADS,/arxiv_data1/oa_pdf/ef/2b/IJPI-1-255.PMC3465149.pdf
Available from: https://www.turnitin.com/static/helpCenter/ viewing_the_overall_similarity_index.php  [Last accessed on  2011 Nov 19].,OADS,/arxiv_data1/oa_pdf/ef/2b/IJPI-1-255.PMC3465149.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/a4/8c/IJPI-2-18.PMC3465153.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/d8/cd/IJPI-2-2.PMC3465154.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/d8/cd/IJPI-2-2.PMC3465154.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/68/a3/IJPI-2-26.PMC3465157.pdf
The authors are requested to comply with the  instructions to authors (http://www.jpionline.org/contributors.,Non-OADS,/arxiv_data1/oa_pdf/74/8f/IJPI-2-1.PMC3465158.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/ab/b1/IJPI-2-12.PMC3465159.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/ab/b1/IJPI-2-12.PMC3465159.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/uk/) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS 2012 : pls025; doi:10.1093/aobpla/pls025, available online at www.aobplants.oxfordjournals.org &The Authors 2012 1",Non-OADS,/arxiv_data1/oa_pdf/82/a4/pls025.PMC3465559.pdf
Lipid nomenclature according to Lipids Maps database ( http://www.lipid maps.org/ ) was used.,OADS,/arxiv_data1/oa_pdf/8a/37/11306_2011_Article_384.PMC3465648.pdf
"9, 521-528, September 2012 Copyright ⓒ 2012 by the Korean Society for Biochemistry and Mol ecular Biology This is an open-access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distr ibution, and reproduction in any medium, provided the original work is properly cited.Staurosporine and cytochalasin D induce chondrogenesis by  regulation of actin dynamics in different way Minjung Kim1, Kyung Song2,  Eun-Jung Jin3 and Jongkyung Sonn1,4 1Department of Biology College of Natural Sciences Kyungpook National University Daegu 702-701, Korea 2Department of Pharmacy College of Pharmacy 3Department of Biological Science  College of Natural Sciences Wonkwang UniversityIksan 570-749, Korea  4Corresponding author: Tel, 82-53-950-7368;  Fax, 82-53-953-3066; E-mail, sonnjk@knu.ac.krhttp://dx.doi.org/10.38 58/emm.2012.44.9.059 Accepted 22 May 2012 Available Online 8 June 2012 Abbreviations: CD, cytochalasin D; CIN, chronophin; F-actin,  filamentous actin; G-actin, globular actin; MLC, myosin light  chain; ROCK, Rho-associated kinase; SSH, slingshot; STSN,  staurosporine; TESK, testicular kinases Abstract Actin cytoskeleton has been known to control and/or  be associated with chondrogenesis.",Non-OADS,/arxiv_data1/oa_pdf/3f/f5/emm-44-521.PMC3465745.pdf
")*These authors contributed equally to this work.http://dx.doi.org/10.38 58/emm.2012.44.9.060 Accepted 4 June 2012 Available Online 21 June 2012 Abbreviations: CIA, collagen induced arthritis; EC-SOD, ex- tracellular superoxide dismutase; FLS, fibroblast-like synovio- cyte; MEF, mouse embryonic fibroblast; RA, rheumatoid arthr itis;  ROS, reactive oxygen species  Abstract Oxidative stress such as reactive oxygen species  (ROS) within the inflamed joint have been indicated as  being involved as inflammatory mediators in the in- duction of arthritis.",Non-OADS,/arxiv_data1/oa_pdf/87/22/emm-44-529.PMC3465746.pdf
"44(9), 529-535, 2012 Supplemental data Supplemental data include a table and can be found with  this article online at http://e-emm.or.kr/article/article_files/  SP-44-9-02.pdf.",OADS,/arxiv_data1/oa_pdf/87/22/emm-44-529.PMC3465746.pdf
"9, 536-544, September 2012 Copyright ⓒ 2012 by the Korean Society for Biochemistry and Mol ecular Biology This is an open-access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distr ibution, and reproduction in any medium, provided the original work is properly cited.Cyclooxygenase-2 inhibitors modulate skin aging in a catalytic  activity-independent manner Mi Eun Lee1, So Ra Kim1, Seungkoo Lee2,  Yu-Jin Jung3, Sun Shim Choi4,  Woo Jin Kim5 and Jeong A Han1,6 1Department of Biochemistry and Molecular Biology Institute of Medical Sciences 2Department of Anatomic Pathology Kangwon National University HospitalKangwon National University School of Medicine 3Department of Biological Sciences College of Natural Sciences 4Department of Medical Biotechnology College of Biomedical ScienceInstitute of Bioscience and BiotechnologyKangwon National University 5Department of Internal Medicine Kangwon National University School of MedicineChuncheon 200-701, Korea 6Corresponding author: Tel, 82-33-250-8832;  Fax, 82-33-255-8809; E-mail, gshja@kangwon.ac.kr http://dx.doi.org/10.38 58/emm.2012.44.9.061 Accepted 29 June 2012 Available Online 6 July 2012 Abbreviations: COX-2, cyclooxygenase-2; NSAID, non-steroidal  anti-inflammatory drug Abstract It has been proposed that the pro-inflammatory  catalytic activity of cyclooxygenase-2 (COX-2) plays a  key role in the aging process.",Non-OADS,/arxiv_data1/oa_pdf/60/5a/emm-44-536.PMC3465747.pdf
"9, 545-553, September 2012 Copyright ⓒ 2012 by the Korean Society for Biochemistry and Mol ecular Biology This is an open-access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distr ibution, and reproduction in any medium, provided the original work is properly cited.Inhibition of mouse brown adipocyte differentiation by  second-generation antipsychotics Jee-Eun Oh1, Yoon Mi Cho1, Su-Nam Kwak1,  Jae-Hyun Kim2, Kyung Won Lee1, Hyosan Jung1,  Seong-Whan Jeong1 and Oh-Joo Kwon1,3 1Department of Biochemistry College of MedicineThe Catholic University of KoreaSeoul 137-701, Korea 2Department of Psychiatry Wonkwang University School of MedicineSanbon HospitalGunpo 435-040, Korea 3Corresponding author: Tel, 82-2-2258-7292;  Fax, 82-2-596-4435; E-mail, ojkwon@catholic.ac.kr http://dx.doi.org/10.38 58/emm.2012.44.9.062 Accepted 13 June 2012 Available Online 19 July 2012 Abbreviations: ACC, acetyl-CoA carboxylase; aP2, adipocyte prot ein  2; BAT, brown adipose tissue; CD36, cluster of differentiation 36;  C/EBPβ, CCAAT-enhancer-binding protein beta; Cidea, cell  death–inducing DFFA-like effector a; CYP, cytochrome P450; FAS,  fatty acid synthase; GLUT4, glucose transporter 4; PGC-1 α,  peroxisome proliferator-activated receptor gamma coactivator-1  alpha; PKC- β, protein kinase C-beta; PPAR γ, peroxisome proliferator-  activated receptor gamma; PRDM16, PR domain containing 16; qRT-PCR, quantitative real-time polymerase chain reaction; SCD1 ,  stearyl-CoA desaturase 1; SGA, second-generation antipsychotics ;  TRR, therapeutic reference ranges; UCP-1, uncoupling protein-1 Abstract Brown adipose tissue is specialized to burn lipids for  thermogenesis and energy expenditure.",Non-OADS,/arxiv_data1/oa_pdf/ac/26/emm-44-545.PMC3465748.pdf
Supplemental data Supplemental data include four figures and a table and can be found with this article online at http://e-emm.or.kr/article/  article_files/SP-44-9-04.pdf.,OADS,/arxiv_data1/oa_pdf/ac/26/emm-44-545.PMC3465748.pdf
"9, 554-561, September 2012 Copyright ⓒ 2012 by the Korean Society for Biochemistry and Mol ecular Biology This is an open-access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distr ibution, and reproduction in any medium, provided the original work is properly cited.Cotinine-conjugated aptamer/anti-cotinine antibody  complexes as a novel affinity unit for use in biological assays Sunyoung Park1,2, Dobin Hwang1,2  and Junho Chung1,2,3 1Department of Biochemistry and Molecular Biology Seoul National University College of MedicineSeoul 110-799, Korea 2Cancer Research Institute Seoul National UniversitySeoul 110-799, Korea 3Corresponding author: Tel, 82-2-3668-7441;  Fax, 82-2-747-5769; E-mail, jjhchung@snu.ac.krhttp://dx.doi.org/10.38 58/emm.2012.44.9.063 Accepted 2 July 2012 Available Online 18 July 2012 Abstract Aptamers are synthetic, relatively short (e.g., 20-80  bases) RNA or ssDNA oligonucleotides that can bind  targets with high affinity and specificity, similar to anti- bodies, because they can fold into unique, three-di-mensional shapes.",Non-OADS,/arxiv_data1/oa_pdf/d6/14/emm-44-554.PMC3465749.pdf
"9, 562-570, September 2012 Copyright ⓒ 2012 by the Korean Society for Biochemistry and Mol ecular Biology This is an open-access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distr ibution, and reproduction in any medium, provided the original work is properly cited.Mitochondrial dysfunction and activation of iNOS are  responsible for the palmitate-induced decrease in adiponectin synthesis in 3T3L1 adipocytes Min Jae Jeon1*, Jaechan Leem2*,  Myoung Seok Ko1, Jung Eun Jang2,  Hye-Sun Park1, Hyun Sik Kim1,  Mina Kim1, Eun Hee Kim2, Hyun Ju Yoo1,  Chul-Ho Lee3, In-Sun Park4, Ki-Up Lee2 and Eun Hee Koh2,5 1Asan Institute for Life Sciences  Seoul 138-736, Korea 2Department of Internal Medicine  University of Ulsan College of Medicine Seoul 138-736, Korea 3Korea Research Insti tute of Biosci ence and Biotechnology  Daejeon 305-333, Korea 4Department of Anatomy  College of MedicineInha University Incheon 401-103, Korea 5Corresponding author: Tel, 82-2-3010-3248;  Fax, 82-2-3010-6962; E-mail, ehk@amc.seoul.kr*These authors contributed equally to this work.http://dx.doi.org/10.38 58/emm.2012.44.9.064 Accepted 17 July 2012 Available Online 19 July 2012 Abbreviations: ATF3, activating transcription factor 3; CCCP,  carbonyl cyanide m-chlorophenyl hydrazone; CHOP, CCAAT/  enhancer-binding protein; eNOS, endothelial nitric oxide  synthase; ER, endoplasmic reticulum; ETC, electron transport chain; FFA, free fatty acid; JNK, c-Jun N-terminal kinases; iNOS,  inducible nitric oxide synthase; mtDNA, mitochondrial DNA;  mtTFA, mitochondrial transcription factor A; NO, nitric oxide; NRF-1, nuclear respiratory factor-1; PPAR γ, peroxisome  proliferator-activated receptor- γ; ROS, reactive oxygen  species; SMT, S-methylisothiourea sulfate; TNF- α, tumor  necrosis factor- α; XBP1, X-box binding protein 1 Abstract Mitochondrial dysfunction and endoplasmic retic- ulum (ER) stress are considered the key determinants of insulin resistance.",Non-OADS,/arxiv_data1/oa_pdf/bf/05/emm-44-562.PMC3465750.pdf
Supplemental data Supplemental data include a figure and can be found with  this article online at http://e-emm.or.kr/article/article_files/  SP-44-9-06.pdf.,OADS,/arxiv_data1/oa_pdf/bf/05/emm-44-562.PMC3465750.pdf
"We present a conceptual framework and a set of ideas for consideration in future studies.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/74/51/czr083.PMC3465752.pdf
bOnline at: http://www.oecd.org/dataoecd/35/9/2488552.pdf MeSH is a controlled vocabulary produced by the National Library of Medicine used for indexing articles and booksCOMMUNITY ACCOUNTABILITY AT PERIPHERAL HEALTH FACILITIES 543,Non-OADS,/arxiv_data1/oa_pdf/74/51/czr083.PMC3465752.pdf
"Received January 28, 2012; Revised February 20, 2012; Accepted March 4, 2012Correspondence to : Prof. Bong-Hae ChoDepartment of Oral and Maxillofacial Radiology, Pusan National University Dental Hospital, Beomeo-ri, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do 626-787, KoreaTel) 82-55-360-5261,  Fax) 82-55-360-5029,  E -mail) bhjo@pusan.ac.krImaging Science in Dentistry 2012; 42 : 121-7 http://dx.doi.org/10.5624/isd.2012.42.3.121 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/2a/isd-42-121.PMC3465753.pdf
"( Imaging Sci Dent 2012; 42 : 129-37 ) KEY WORDS : Root Canal Therapy; Radiography, Dental; Cone -Beam Computed Tomography Received March 1, 2012; Revised June 11, 2012; Accepted June 30, 2012 Correspondence to : Dr. Kivanç Kamburo ̆glu  Department of Dentomaxillofacial Radiology, Faculty of Dentistry, AnkaraUniversity, 06500, Be sevler, Ankara, Turkey Tel) 90 -312-2965632,  Fax) 90 -312-2123954,  E -mail) dtkivo@yahoo.comImaging Science in Dentistry 2012; 42 : 129-37 http://dx.doi.org/10.5624/isd.2012.42.3.129 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/cb/isd-42-129.PMC3465754.pdf
"Received March 20, 2012; Revised June 1, 2012; Accepted June 16, 2012 Correspondence to : Prof. Soon-Chul ChoiDepartment of Oral and Maxillofacial Radiology, School of Dentistry, Seoul NationalUniversity, 28 Yeongeon-dong, Jongno-gu, Seoul 110-768, KoreaTel) 82-2-2072-2622,  Fax) 82-2-744-3919,  E -mail) raychoi@snu.ac.krImaging Science in Dentistry 2012; 42 : 139-46 http://dx.doi.org/10.5624/isd.2012.42.3.139 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/87/isd-42-139.PMC3465755.pdf
"( Imaging Sci Dent 2012; 42 : 147-54 ) KEY WORDS : Root Resorption; Radiography, Dental; Orthodontics Received April 11, 2012; Revised July 12, 2012; Accepted August 3, 2012 Correspondence to : Dr. Kamonporn Nanekrungsan Department of Dentistry, Overbrook Hospital, 17 Singhaklai Road, Chiangrai 57000,ThailandTel) 66-53-711366,  Fax) 66-53-711367,  E -mail) kamo_nan@hotmail.comImaging Science in Dentistry 2012; 42 : 147-54 http://dx.doi.org/10.5624/isd.2012.42.3.147 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/85/isd-42-147.PMC3465756.pdf
"Dental Collegeand Hospital, Tatul, Solan, Himachal Pradesh, IndiaTel) 91-94182-28882,  Fax) 91-1792-252809,  E -mail) munbhawni@gmail.comImaging Science in Dentistry 2012; 42 : 155-61 http://dx.doi.org/10.5624/isd.2012.42.3.155 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/09/isd-42-155.PMC3465757.pdf
"( Imaging Sci Dent 2012; 42 : 163-7 ) KEY WORDS : Composite Resins; Radiography, Dental, Digital; Dental Materials; Linear Models Received April 12, 2012; Revised June 15, 2012; Accepted July 23, 2012 Correspondence to : Dr. Arash Poorsattar Bejeh Mir Dentistry Student Research Committee (DSRC), Dental Materials Research Center, Babol University of Medical Sciences, Ganj Afrooz Ave., Babol, Mazandaran Province, IranTel) 98 -151-321-6383,  Fax) 98 -151-321-6383, E -mail) arashpoorsattar@yahoo.comImaging Science in Dentistry 2012; 42 : 163-7 http://dx.doi.org/10.5624/isd.2012.42.3.163 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/cf/isd-42-163.PMC3465758.pdf
"Received May 16, 2012; Revised June 7, 2012; Accepted June 14, 2012 Correspondence to : Dr. Yun-Hoa Jung Department of Oral and Maxillofacial Radiology, School of Dentistry, PusanNational University, Beomeo-ri, Mulgeum-eup, Yangsan, Gyeongsangnam-do 626-870, KoreaTel) 82-55-360-5255,  Fax) 82-55-360-5029,  E -mail) yhjung@pusan.ac.krImaging Science in Dentistry 2012; 42 : 169-74 http://dx.doi.org/10.5624/isd.2012.42.3.169 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/b6/isd-42-169.PMC3465759.pdf
"( Imaging Sci Dent 2012; 42 : 175-82 ) KEY WORDS : Three -Dimensional Image; Mandible; Cephalometry; Principal Component Analysis *This work was supported by the Industrial Strategic Technology Development Program (10038695) funded by the Ministry of Knowledge Economy (MKE, Korea).Received May 23, 2012; Revised June 11, 2012; Accepted June 23, 2012Correspondence to : Prof. Won-Jin YiDepartment of Oral and Maxillofacial Radiology, School of Dentistry, Seoul NationalUniversity, 28 Yeongeon-dong, Jongno-gu, Seoul 110-768, KoreaTel) 82-2-2072-3049,  Fax) 82-2-744-3919,  E-mail) wjyi@snu.ac.kr Imaging Science in Dentistry 2012; 42 : 175-82 http://dx.doi.org/10.5624/isd.2012.42.3.175 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/0e/isd-42-175.PMC3465760.pdf
"( Imaging Sci Dent 2012; 42 : 183-90 ) KEY WORDS : Quality Control; Radiography, Panoramic; Image Quality Enhancement, Quality Assurance Received June 12, 2012; Revised June 23, 2012; Accepted June 25, 2012 Correspondence to : Prof. Sam-Sun Lee Department of Oral and Maxillofacial Radiology, School of Dentistry, Seoul NationalUniversity, 28 Yeongeon-dong, Jongno-gu, Seoul 110-768, KoreaTel) 82-2-2072-3978,  Fax) 82-2-744-3919,  E -mail) raylee@snu.ac.krImaging Science in Dentistry 2012; 42 : 183-90 http://dx.doi.org/10.5624/isd.2012.42.3.183 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/5f/isd-42-183.PMC3465761.pdf
Available from: http://ec.europa.eu/energy/ nuclear/radiation_protection/publications_en.htm.,Non-OADS,/arxiv_data1/oa_pdf/02/5f/isd-42-183.PMC3465761.pdf
"( Imaging Sci Dent 2012; 42 : 191-5 ) KEY WORDS : Hemifacial Myohyperplasia; Lipomatosis; Facial Asymmetry Received March 13, 2012; Revised June 5, 2012; Accepted June 14, 2012 Correspondence to : Dr. Preeti Chawla Arora Department of Oral Medicine, Diagnosis and Radiology, Sri Guru Ram Das Instituteof Dental Sciences and Research, Amritsar, Punjab, 143006, IndiaTel) 98 -814-642-5170,  E -mail) dr.preets@gmail.comImaging Science in Dentistry 2012; 42 : 191-5 http://dx.doi.org/10.5624/isd.2012.42.3.191 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/a1/isd-42-191.PMC3465762.pdf
"( Imaging Sci Dent 2012; 42 : 197-200 ) KEY WORDS : Tooth, Supernumerary; Radiography; Tooth, Impacted; Multidetector Computed Tomography Received April 15, 2012; Revised May 17, 2012; Accepted June 6, 2012 Correspondence to : Dr. Amber Ather Department of Conservative Dentistry and Endodontics, Manipal College of DentalSciences, Manipal University, Manipal-576104, Karnataka, IndiaTel) 91-900-8417793,  Fax) 91-820-2571966,  E -mail) amberather03@yahoo.co.inImaging Science in Dentistry 2012; 42 : 197-200 http://dx.doi.org/10.5624/isd.2012.42.3.197 Copyright ⓒ2012 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/a0/isd-42-197.PMC3465763.pdf
"Keywords Genetic Predisposition to Disease, Genome-Wide Association Study, Odds ratio, SexThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/33/3a/dys104.PMC3465768.pdf
"Keywords Infant body composition, ethnicity, fat mass, fat-free mass, South AsianThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b7/e5/dys139.PMC3465771.pdf
"For both (often unspecified which) /C15Mortality (rate) /C15Morbidity (rate) /C15Death rate /C15Incidence.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/dys142.PMC3465772.pdf
"Additional explanatory slides with additional material available at: http://www.medicine.mcgill.ca/epidemiology/ hanley/Reprints/ (12 July 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/97/4a/dys142.PMC3465772.pdf
"Oxford: Oxford University Press, 2008. http://jpkc.fudan .edu.cn/picture/article/189/c4/24/81c086374fd8a31d9-be7208bbb80/eb7e72b0-3b41-4b6b-8b23-168950e0e794.pdf.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/dys142.PMC3465772.pdf
"Quotes .http://en.wikiquote.org/wiki/John_ Maynard_Keynes (12 July 2102, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/97/4a/dys142.PMC3465772.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Takahashi, Y., Nakamura, K., Osada, M. & Fujiwara, T. Structural relaxation and quasi-elastic light scattering in glass: Approach by ferroelectric andion-conducting phases.",Non-OADS,/arxiv_data1/oa_pdf/06/fc/srep00714.PMC3465810.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/65/55/srep00713.PMC3465811.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Holten, V. & Anisimov, M.A.",Non-OADS,/arxiv_data1/oa_pdf/65/55/srep00713.PMC3465811.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/09/3c/srep00715.PMC3465812.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Lu, Y. et al.In Situ Ambient Pressure X-ray Photoelectron Spectroscopy Studies of Lithium-Oxygen Redox Reactions.",Non-OADS,/arxiv_data1/oa_pdf/09/3c/srep00715.PMC3465812.pdf
Available from:  http://www.measuredhs.com/aboutsurveys/dhs/start.cfm [Cited 2011  January 17].,OADS,/arxiv_data1/oa_pdf/c5/bd/TOAIDJ-6-112.PMC3465816.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/7c/TODENTJ-6-137.PMC3465817.pdf
Available at:  http://aidsinfo.nih.,Non-OADS,/arxiv_data1/oa_pdf/e6/50/TOAIDJ-6-90.PMC3465818.pdf
"Available  at: http://www.white house.gov/administration/eop/onap/nhas [Ac- cessed: February 25, 2011]  [8] Gebo KA, Fleishman JA, Conviser R, et al .",OADS,/arxiv_data1/oa_pdf/e6/50/TOAIDJ-6-90.PMC3465818.pdf
"As part of the International Collaboration for Complex Interventions (http://www.intervention-research.ca/), we conducted a pilot study to assessthe extent to which it is possible to (a) identifyhow many RCTs have been undertaken of social policy programmes in different countries and (b) interview public policy makers and advisors ina range of different countries about the use of RCTs for social programmes.",Non-OADS,/arxiv_data1/oa_pdf/a2/d4/jech-2011-200313.PMC3465834.pdf
http://www.civilservice.gov.uk/wp-content/uploads/2011/09/Analysis-for-Policy-report_tcm6-4148.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/a2/d4/jech-2011-200313.PMC3465834.pdf
"Jowell R. Trying it out: the role of “pilots” in policy-making, Government Chief Social Researchers Ofﬁce , Crown copyright, 2003. http://www.civilservice.gov.uk/wp- content/uploads/2011/09/Trying-it-Out_tcm6-36824.pdf 19.",Non-OADS,/arxiv_data1/oa_pdf/a2/d4/jech-2011-200313.PMC3465834.pdf
The trial is registered at the Dutch Trial Register (NTR) under trial registration number: NTR1240 (http://www.trialregister.nl/trialreg/admin/rctview.asp?TC ¼1240).,Non-OADS,/arxiv_data1/oa_pdf/52/be/jech-2011-200626.PMC3465836.pdf
"It is designed to study deprivation and covers a widerange of domains such as income (including various social beneﬁts), health, education, housing, demographics and employment characteristics (Eurostat website: http://epp.euro- stat.ec.europa.eu/portal/page/portal/microdata/eu_silc).",Non-OADS,/arxiv_data1/oa_pdf/01/9f/jech-2011-200311.PMC3465837.pdf
The regional capital and other major towns are divided into several IRIS and small towns form one IRIS (INSEE website: http://www.insee.fr).,Non-OADS,/arxiv_data1/oa_pdf/01/9f/jech-2011-200311.PMC3465837.pdf
"An individual is considered poor when her/his household has a standard ofliving below 60% of the median standard of living among the whole national population, as deﬁ ned by Eurostat (Eurostat website: http://epp.eurostat.ec.europa.eu/statistics_explained/ index.php/Income_distribution_statistics).",Non-OADS,/arxiv_data1/oa_pdf/01/9f/jech-2011-200311.PMC3465837.pdf
Acknowledgements French census data were provided by the Centre Maurice Halbwachs (http://www.cmh.ens.fr).,OADS,/arxiv_data1/oa_pdf/01/9f/jech-2011-200311.PMC3465837.pdf
"York: Joseph Rowntree Foundation, 2000. http://www.bris.ac.uk/poverty/pse/Poverty%20and%20Social%20Exclusion%20in%20Britain%20JRF%20Report.pdf (accessed 15Oct 2010).",Non-OADS,/arxiv_data1/oa_pdf/01/9f/jech-2011-200311.PMC3465837.pdf
"York: Joseph Rowntree Foundation, 2007. http://www.fairpaynetwork.org/ uploadedPDF/JRF_poverty_wealth_place_in_britain.pdf (accessed 15 Oct 2010).",Non-OADS,/arxiv_data1/oa_pdf/01/9f/jech-2011-200311.PMC3465837.pdf
"http://ncg.nuim.ie/ncg/GWR/GWR_WhitePaper.pdf (accessed 2 Dec 2011).Policy implications <All EDI could be appropriate ecological measures of social inequalities in health to two types of users all over Europe: epidemiological researchers in order to harmonize analyses, and health authorities to implement country-speciﬁc interven-tions and policies.",Non-OADS,/arxiv_data1/oa_pdf/01/9f/jech-2011-200311.PMC3465837.pdf
"2012, 9      http://www.medsci.org  621  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(8):621-626. doi: 10.7150/ ijms.4768   Research Paper   Correlations between Oxidative DNA Damage, Oxidative Stress and Coe n- zyme Q10 in Patients with Coronary Artery Disease   Yüksel KAYA1, Ayşegül ÇEBİ2, Nihat SÖYLEMEZ1, Halit DEMİR3, Hamit Hakan ALP4, Ebubekir BAKAN4  1.",Non-OADS,/arxiv_data1/oa_pdf/01/f3/ijmsv09p0621.PMC3465845.pdf
"2012, 9    http://www.medsci.org  622  recent studies showed that malondialdehyde (MDA)  is an important marker of lipid peroxidation and  progression of atherosclerosis is correlated with ox i- dative stress and can be followed  up by MDA mea s- urements (8).",Non-OADS,/arxiv_data1/oa_pdf/01/f3/ijmsv09p0621.PMC3465845.pdf
"2012, 9    http://www.medsci.org  623  for 10 min in ice was followed by centrifugation (10  min at 3500 rpm).",Non-OADS,/arxiv_data1/oa_pdf/01/f3/ijmsv09p0621.PMC3465845.pdf
"2012, 9    http://www.medsci.org  624  Spearman’s correlation coefficients were used to ca l- culate the association between the changes of  groups.",OADS,/arxiv_data1/oa_pdf/01/f3/ijmsv09p0621.PMC3465845.pdf
"2012, 9    http://www.medsci.org  625  enzyme may be a compensatory regulation in r e- sponse to increased oxidative stress.",Non-OADS,/arxiv_data1/oa_pdf/01/f3/ijmsv09p0621.PMC3465845.pdf
"2012, 9    http://www.medsci.org  626  and DNA damage in coronary artery disease.",Non-OADS,/arxiv_data1/oa_pdf/01/f3/ijmsv09p0621.PMC3465845.pdf
"2012, 9      http://www.medsci.org  627  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(8):627-633. doi: 10.7150/ ijms.4865   Research Paper   Haematoporphyrin Based Photodynamic Therapy Combined with Hype r- thermia Provided Effective Therapeutic Vaccine Effect against Colon Ca n- cer Growth in Mice   Yaoming He1, Haiyan Ge1, Shuping Li2  1.",Non-OADS,/arxiv_data1/oa_pdf/8f/b7/ijmsv09p0627.PMC3465846.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8f/b7/ijmsv09p0627.PMC3465846.pdf
"2012, 9    http://www.medsci.org  628  some mechanisms were mentioned.",Non-OADS,/arxiv_data1/oa_pdf/8f/b7/ijmsv09p0627.PMC3465846.pdf
"2012, 9    http://www.medsci.org  629  was also used to analyze the expression of HSP70 on  the cell s urfaces (BioLegend Inc).",OADS,/arxiv_data1/oa_pdf/8f/b7/ijmsv09p0627.PMC3465846.pdf
"2012, 9      http://www.medsci.org  630  HSP70 expression but not the presence of cell  death was associated with the anti -tumor e f- fects   PDT has been shown to promote cell death at a  dose -dependent manner and certain  photosensitizers   induce heat shock protein 70 (HS P70) expression in  treated cells  (10).",Non-OADS,/arxiv_data1/oa_pdf/8f/b7/ijmsv09p0627.PMC3465846.pdf
"2012, 9    http://www.medsci.org  631    Fig 3.",Non-OADS,/arxiv_data1/oa_pdf/8f/b7/ijmsv09p0627.PMC3465846.pdf
"2012, 9    http://www.medsci.org  632    Fig 5.",Non-OADS,/arxiv_data1/oa_pdf/8f/b7/ijmsv09p0627.PMC3465846.pdf
"2012, 9    http://www.medsci.org  633  found in HMME -PDT treated cells comparing  to cells  treated with hyperthermia alone, corresponding well  with their differen t capacity of causi ng cell damages.",Non-OADS,/arxiv_data1/oa_pdf/8f/b7/ijmsv09p0627.PMC3465846.pdf
"2012, 9      http://www.medsci.org  634  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(8):634-641. doi: 10.7150/ ijms.4969   Research Paper   Decisive I ndicator for Gastrointestinal Workup  in Anemic Patients with  Nondialysis Chronic Kidney Disease   Hyeon Seok Hwang1, Youn Mi Song2, Eun Oh Kim1, Eun Sil Koh1, Hye Eun Yoon1, Sung Jin Chung1, Sang  Ju Lee1, Yoon Kyung Chang1, Chul Woo Yang1, Yoon Sik  Chang1, Suk Young Kim1  1.",Non-OADS,/arxiv_data1/oa_pdf/0d/ad/ijmsv09p0634.PMC3465847.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0d/ad/ijmsv09p0634.PMC3465847.pdf
"2012, 9    http://www.medsci.org  635  testing, access bleeding, and surgical blood loss.",Non-OADS,/arxiv_data1/oa_pdf/0d/ad/ijmsv09p0634.PMC3465847.pdf
"2012, 9    http://www.medsci.org  636  Statistical analyses   The data are expressed as the mean  SD unless  otherwise indicated.",OADS,/arxiv_data1/oa_pdf/0d/ad/ijmsv09p0634.PMC3465847.pdf
"2012, 9    http://www.medsci.org  637  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/0d/ad/ijmsv09p0634.PMC3465847.pdf
"2012, 9    http://www.medsci.org  638  sensitivity and ne gative predictive value were poor in  patients with CKD stage 5 (0.47 and 0.50, respectiv e- ly), and were significantly lower than those of patients with CKD stage 3 ( p = 0.03 2 for sensitivity and p =  0.034 for negative predictive value ).",Non-OADS,/arxiv_data1/oa_pdf/0d/ad/ijmsv09p0634.PMC3465847.pdf
"2012, 9    http://www.medsci.org  639  Table 4.",Non-OADS,/arxiv_data1/oa_pdf/0d/ad/ijmsv09p0634.PMC3465847.pdf
"2012, 9    http://www.medsci.org  640  75 ng/mL increased the sensitivity of the detection of  anemic GI lesions by 9% (from 59% to 68%) com pared  with TSAT < 20% alone.",Non-OADS,/arxiv_data1/oa_pdf/0d/ad/ijmsv09p0634.PMC3465847.pdf
"2012, 9    http://www.medsci.org  641  28.",Non-OADS,/arxiv_data1/oa_pdf/0d/ad/ijmsv09p0634.PMC3465847.pdf
"2012, 9      http://www.medsci.org  642  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(8):642-654. doi: 10.7150/ ijms.4998   Research Paper   Effect of Different Irrigating Solutions and Endodontic Sealers on Bond  Strength of the Dentin – Post Interface with and without Defects   Felice R. Grassi1, Carmine Pappalettere2,5, Mariasevera Di Comite3, Massimo Corsalini1, Giorgio Mori4,  Andrea Ballini1,Vito Crincoli1, Francesco Pettini1, Biagio Rapone1, Antonio Boccaccio2,6,  1.",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9      http://www.medsci.org  643  Introduction   Fibre posts play a role of crucial importance in  the restoration of endodontically treated teeth.",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9    http://www.medsci.org  644  irrigated with chlorhexidine 0.2 % ( Group A and D)  or  sodium hypochlorite 5 % (Group B and C).",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9    http://www.medsci.org  645  section; according to Hashem et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9    http://www.medsci.org  646    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9      http://www.medsci.org  647  Modeling of the micro -push -out-test: Finite  Element Analysis   A finite element model was built reproducing  the micro -push -out-test (Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9    http://www.medsci.org  648    Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9      http://www.medsci.org  649  The PMMA, the dentin and the cement have  been modeled as linear -elastic, homogeneous and  isotropic materials.",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9    http://www.medsci.org  650  ular distribution of the von Mises stresses has been  computed in the case of samples without defects, local  stress peaks were predicted, instead, in the vicinity of  the defects for the defective samples.",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9    http://www.medsci.org  651    Figure 7.",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9    http://www.medsci.org  652    Figure 9.",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9    http://www.medsci.org  653  els would allow the local phenomena of defect plast i- cization and therefore, the global structural response  of the sample to be better reproduced [31].",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9    http://www.medsci.org  654  10.",Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
http://www.mcitaliasrl.com/   surgi_cem -dualflo.htm   29.,Non-OADS,/arxiv_data1/oa_pdf/ab/3f/ijmsv09p0642.PMC3465848.pdf
"2012, 9      http://www.medsci.org  655  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(8):655-664. doi: 10.7150/ ijms.5004   Research Paper   Intracranial Pressure Response to Non-Penetrating Ballistic Impact: An  Experimental Study Using a Pig Physical Head Model and Live Pigs   Hai Liu*, Jianyi Kang*, Jing Chen, Guanhua Li, Xiaoxia Li, Jianmin Wang   State Key Laboratory of  Trauma, Burn s and Combined Injury , Research Institute of Surgery, Daping Hospital,  Third Military  Medical University, Chongqing  400042, China .",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
"2012, 9    http://www.medsci.org  656  impacted by a non -penetrating 9 mm round [4,5] .",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
"2012, 9    http://www.medsci.org  657  aligned with the nominal impact location on the su b- ject.",OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
"2012, 9    http://www.medsci.org  658  0.238 ms ( p<0.01), and 0.181 ms ( p<0.01 ) for the live  pigs under low,  moderate, and high impact velocities,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
"2012, 9    http://www.medsci.org  659  parameters are provided in Table 2.",OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
"2012, 9    http://www.medsci.org  660    Fig.",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
"2012, 9    http://www.medsci.org  661    Fig.",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
"2012, 9      http://www.medsci.org  662  Discussion   Non -penetrating injuries to the head resulting  from BABT have been studied in human cadavers, dry  skulls filled with silicone  [4,5] , and finite element (FE)  models of the human head [6].",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
"2012, 9    http://www.medsci.org  663  of intracranial pressure in the brain of the physical  head model are 42 s, 32 s, and 28 s for low, mo d- erate, and high impact velocities, respectively, which  are much lower than those for the live pigs.",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
"2012, 9    http://www.medsci.org  664  6.",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ijmsv09p0655.PMC3465849.pdf
"2012, 9      http://www.medsci.org  665  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2012; 9(8):665-681. doi: 10.7150/ ijms.4520   Review  What Do We Need beyond H emoglobin  A1c to Get the Compl ete Picture of  Glycemia in People with Diabetes?",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  666  logical conditions influencing the HbA1c concentra- tion.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9      http://www.medsci.org  667  To overcome this obstacle, t wo different ap- proaches were ad opted (histo rical reviews [3,4] ).",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  668  olds,  retinopathy  prevalence inc reased  progressively.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  669  which the prevalence began to rise above background  levels turned out to be 6.5% (48 mmol/mol) [17].",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9      http://www.medsci.org  670    Figure  3: The A1c-Derived Average Glucose (ADAG) Study Group demonstrated that HbA1c correlates well with average glucose (AG)  (R2 = 0.84) [23], however, although 90% of HbA1c concentrations predicted the average measured glucose within ± 15%, significant  deviations were observed.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  671  tion, while the hem group remains unchanged.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9      http://www.medsci.org  672    Figure  5: HPLC chromatogram showing a HbE pattern hemoglobinopathy interfering with the analysis of HbA1c.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  673  with critical illness.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9      http://www.medsci.org  674  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  675  adjust.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  676  glycemic control results in  a subsequent risk reduc- tion of any cardiovascular event, non-fatal myocardial  infarction, stroke, or death from CVD many years  after the initial intervention [86,87,93].",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  677  measured with quarterly seven-point capillary-blood  glucose profiles.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  678  In contrast to conflicting data about effectiveness  of SMBG from other trials [106-114], the STeP study  results were able to demonstrate that using pattern  recognition of blood glucose levels by means of SMBG  profiles and subsequent early treatment modifications  by involving physicians or other healthcare profes- sionals lead to significant reduction of HbA1c, and  simultaneously, of glycemic variability in the study  participants.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  679  OGTT: oral glucose tolerance test; PG: plasma glu- cose; PP: per protocol; PPBG: postprandial blood  glucose; preprandial BG: preprandial blood glucose;  SMBG: self- monitoring of blood glucose; STeP:  Structured testing Program; STG: structured testing  group; ST: standard therapy; T1DM: Type 1 diabetes  mellitus; T2DM: Type 2 diabetes mellitus; TMR:  treatment modification recommendation; U: unit;  UKPDS: U nited Kingdom Prospective Diabetes  Study; VADT: Veterans Affairs Diabetes Trial; WHO:  World Health Organization.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
http://www.ifcchba1c.net  11.,Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
http://www.ngsp.org/factors.asp  41.,Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
http://diabetes.niddk.nih.gov/dm/pubs/hemovari-A1C/  index.aspx#A1CTest  44.,Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  680  Tocco G, Masin M, Plebani M, Lapolla A.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"2012, 9    http://www.medsci.org  681  91.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/ijmsv09p0665.PMC3465850.pdf
"London: Ofﬁ  ce for National Statistics,  2008. http://www.statistics.gov.uk/StatBase/Product.asp?vlnk=15187 (accessed 14 April 2010).",OADS,/arxiv_data1/oa_pdf/7e/51/annrheumdis-2011-200731.PMC3465856.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/TODENTJ-6-148.PMC3465863.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society Biochemical Journal    www.biochemj.org © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/33/bj4470353.PMC3465988.pdf
"The fragment obtained by PCR was also digested with EcoRI and XbaI and the fragment of approximately 1400 bp was recovered.The 600 and 1400 bp fragments were ligated simultaneously into p1-22–GFP that had been digested with HindIII and XbaI to give c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/33/bj4470353.PMC3465988.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/33/bj4470353.PMC3465988.pdf
"We therefore used S. cerevisiae mutants to analyse genetically the association of c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/33/bj4470353.PMC3465988.pdf
"These effects were similar to those found in previous investigations in which site-directed mutagenesis had been used c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/33/bj4470353.PMC3465988.pdf
"To confer this resistance to the growth-inhibitory effectsof alendronate on amoebae, the mutant versions of FDPS–GFP must have been catalytically active, despite lacking a functional c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/33/bj4470353.PMC3465988.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/33/bj4470353.PMC3465988.pdf
"40, 1572–1584 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/33/bj4470353.PMC3465988.pdf
"255, 491–494 Received 8 May 2012/13 July 2012; accepted 31 July 2012 Published as BJ Immediate Publication 31 July 2012, doi:10.1042/BJ20120750 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/33/bj4470353.PMC3465988.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society Biochemical Journal    www.biochemj.org © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
The blots were visualized with ECL Plus reagent (GE Healthcare) according to the manufacturer’s guide and theimmunoreactive bands were quantiﬁed by densitometry using ImageJ (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"When expressed in HEK-293 cells and subjected to co-addition of 100 nM PMA (a PKC activator) and 100 nM c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"Given that the expression levels of the wild-type AC2 and phosphomimeticS490/543D were similar (Figure 2B), the increased basal activity of the phosphomimetic S490/543D mutant seemed likely to be due to pseudo-phosphorylation, rather than increased c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"In order to conﬁrm that the changesin FRET that we were recording actually reﬂected changes in cAMP, the experiments were repeated using a version of the sensor that could not bind cAMP (Supplementary Figure S1at http://www.BiochemJ.org/bj/447/bj4470393add.htm).",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"The basal cAMP concentration in untransfected HEK-293cells was calculated as ∼250 nM, whereas the concentra- tion in the AC2-, phosphorylation-deﬁcient S490/543A- and c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"Atropine did not affect cAMP levels of untransfected HEK-293 cells c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"However, when cAMP was measured using FRET-based sensors, CCh saturated the Epac2 sensor in the wild- type HEK-293 cells overexpressing the M3 receptor (and also in the other AC2 stable cells, Supplementary Figure S2 athttp://www.BiochemJ.org/bj/447/bj4470393add.htm), indicatingthat very high cAMP concentration was produced by endogenous c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"To further conﬁrm the apparent G βγ effect, the G βγ-sequestering protein G tα (transducin) was overexpressed to inhibit by chelation the activation by G βγ.L i k et h eG βγinhibitor gallein, overexpressionof G tαprecludes the CCh-mediated cAMP decrease in cells expressing the phosphorylation-deﬁcient mutant S490/543A or phosphomimetic mutant S490/543D (Supplementary Figure S3 at http://www.BiochemJ.org/bj/447/bj4470393add.htm).",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"DISCUSSION As a potential target for G s-, G i-a n dG q-coupled receptors, AC2 is a locus at which information from multiple hormonal inputs c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"However, decreased levels of expression of the T1057A mutant compared with the wild-typeAC2 would explain an apparent decreased response to PMA and, indeed, the expression level of AC2 appeared considerably higher c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"However preclusion of the actions of PKC (bymutagenesis of AC2) allowed an inhibitory effect of G βγ,a r i s i n g from the activation of G q, to be manifest, although we cannot rule out the possibility that the mutation on Ser490or Ser543actively permitted the responsiveness of AC2 to the effects of G βγ.T h i s inhibitory effect by G βγadds a further regulatory nuance to the actions of a G q-coupled receptor on AC2 regulation, which might c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"The authors suggested that the C1b domain may act as the main G βγ-binding face, again c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"278, 4552–4560 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"Signaling 23, 1489–1495 Received 15 February 2012/18 July 2012; accepted 20 August 2012 Published as BJ Immediate Publication 20 August 2012, doi:10.1042/BJ20120279 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"Received 15 February 2012/18 July 2012; accepted 20 August 2012 Published as BJ Immediate Publication 20 August 2012, doi:10.1042/BJ20120279 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/bj4470393.PMC3465989.pdf
"This article is available online at http://www.jlr.orgFAs (LCFAs) are the main molecules detected by this sys- tem and are thought to play a signiﬁ  cant role in the spon- taneous preference for fatty foods ( 1, 2 ).",Non-OADS,/arxiv_data1/oa_pdf/b3/e1/2256.PMC3465995.pdf
"This article is available online at http://www.jlr.org Journal of Lipid Research Volume 53, 2012 2355Copyright © 2012 by the American Society for Biochemistry and Molecular Biology, Inc.  Atherosclerosis, the foremost cause of coronary heart dis- ease, is a multifactorial and multistep disease.",Non-OADS,/arxiv_data1/oa_pdf/4f/0c/2355.PMC3466004.pdf
sh.cn     The online version of this article (available at http://www.jlr.org)  contains supplementary data in the form of three tables and four ﬁ gures .,OADS,/arxiv_data1/oa_pdf/4f/0c/2355.PMC3466004.pdf
In silico analysis   We identiﬁ  ed the genes putatively targeted by miR-181a us- ing TargetScan (http://www.targetscan.org) ( 16 ) and miRanda  (http://www.microrna.org) ( 17 ).,OADS,/arxiv_data1/oa_pdf/4f/0c/2355.PMC3466004.pdf
The KEGG pathways and gene  ontology (GO) hierarchial categories analyses were carried out using the Capitalbio server (http://bioinfo.capitalbio.com/mas3/) ( 18 ).,OADS,/arxiv_data1/oa_pdf/4f/0c/2355.PMC3466004.pdf
"This article is available online at http://www.jlr.org Supplementary key words  diacylglycerol acyltransferase inhibition   glucagon-like peptide-1  GLP-1 receptor inhibition  lipoproteins  retinol absorption    Elevated levels of plasma triglyceride (TG), whether de- rived from secretion of very low density lipoproteins (VLDL) or chylomicrons, are major components of the metabolic syndrome and are important risk factors in the develop-ment of atherosclerotic cardiovascular disease ( 1 ).",Non-OADS,/arxiv_data1/oa_pdf/37/a2/2364.PMC3466005.pdf
"This article is available online at http://www.jlr.org Journal of Lipid Research Volume 53, 2012 2429Copyright © 2012 by the American Society for Biochemistry and Molecular Biology, Inc.",Non-OADS,/arxiv_data1/oa_pdf/84/fd/2429.PMC3466011.pdf
e-mail: greg.shearer@sanfordhealth.org     The online version of this article (available at http://www.jlr.org)  contains supplementary data in the form of two tables and one ﬁ  gure.,OADS,/arxiv_data1/oa_pdf/84/fd/2429.PMC3466011.pdf
"Retrieved 18 July 2012 from: http://www.ncbi.nlm.nih.gov/pub- med?term=Polydorou%202012  [17] Hahn P, Schondelmaier N, Wolkewitz M, Altenburger MJ,  Polydorou O. Efficacy of tooth bleaching with and without light ac- tivation and its effect on the pulp temperature: an in vitro  study.",Non-OADS,/arxiv_data1/oa_pdf/ab/5d/TODENTJ-6-143.PMC3466022.pdf
Available from:  http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ab/5d/TODENTJ-6-143.PMC3466022.pdf
BEKS Inc. Re- trieved 18 July 2012 from: http://www.britewhitemini.com/   [21] Commission Internationale de I’Eclairage.,Non-OADS,/arxiv_data1/oa_pdf/ab/5d/TODENTJ-6-143.PMC3466022.pdf
Available from: http://en.wikipedia.org/wiki/Light- emitting diode .,Non-OADS,/arxiv_data1/oa_pdf/ab/5d/TODENTJ-6-143.PMC3466022.pdf
"Retrieved online May 2009 from:  http://www.ada.org/ada/seal/standards/guide_home_bleach.pdf    Received: June 17, 2012 Revised: June 20, 2012 Accepted: August 20, 2012  © Hayward  et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/5d/TODENTJ-6-143.PMC3466022.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/5d/TODENTJ-6-143.PMC3466022.pdf
Regions were deﬁned using the MA- RINA software package (http://www.bion.de/).,OADS,/arxiv_data1/oa_pdf/6d/8b/S0033291712000359a.PMC3466052.pdf
"Supplementary material For supplementary material accompanying this paper, visit http://dx.doi.org/10.1017/S0033291712000359.",Non-OADS,/arxiv_data1/oa_pdf/6d/8b/S0033291712000359a.PMC3466052.pdf
"www.landesbioscience.com  Epigenetics  1079Epigenetics 7:9, 1079–1090; S eptember 2012; © 2012 Landes Bioscience RESEaRch  pap ER RESE aRch  pap ER *Correspondence to: Sandrine Barbaux; Email: sandrine.barbaux@inserm.fr Submitted: 03/20/12; Revised: 06/22/12; Accepted: 07/14/12http://dx.doi.org/10.4161/epi.21495Genomic imprinting characterizes genes with a monoallelic expression, which is dependent on the parental origin of  each allele.",Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
"1 Up to  now, about 150 imprinted genes are known in mice and humans  (http://igc.otago.ac.nz; www.geneimprint.com; www.mouse-book.org/catalog.php?catalog=imprinting).",Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
The ZFAT  gene  has been hypothesized to be a potential target of these miR30B   and miR30D genes (http://services.bio.ifi.lmu.de/mirsel).,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Primers were designed using the PRIMER3 software (http://frodo.wi.mit.edu).,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
"Various softwares were used to locate  CpG rich regions (newcpgreport, Cpgblot Cpgseek, CpGprod) at http://mobile.pasteur.fr.",OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
J Neurochem 2010; 112:1035-44; PMID:19968752; http://dx.doi.org/10.1111/j.1471-4159.2009.06525.x.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Am J Hum Genet 2008; 83:106-11; PMID:18565486; http://dx.doi.org/10.1016/j.ajhg.2008.06.001.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Cell Mol Biol Lett 2011; 16:89-100; PMID:21225468; http://dx.doi.org/10.2478/s11658-010-0041-1.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
FEBS Lett 2009; 583:568-72; PMID:19162026; http://dx.doi.org/10.1016/j.febslet.2008.12.063.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Mol Cell Biol 2009; 29:6366-79; PMID:19805515; http://dx.doi.org/10.1128/MCB.01259-09.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Diabetologia 2011; 54:2595-605; PMID:21786021; http://dx.doi.org/10.1007/s00125-011-2255-9.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Z Geburtshilfe Neonatol 2009; 213:84-8; PMID:19536707; http://dx.doi.org/10.1055/s-0029-1224143.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Curr Vasc Pharmacol 2009; 7:521-33; PMID:19485888; http://dx.doi.org/10.2174/157016109789043982.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Oncogene 2011; 30:4185-93; PMID:21625210; http://dx.doi.org/10.1038/onc.2011.131.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Cell 2011; 147:81-94; PMID:21962509; http://dx.doi.org/10.1016/j.cell.2011.08.033.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Brief Funct Genomics 2011; 10:91-7; PMID:21436305; http://dx.doi.org/10.1093/bfgp/elq030.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Development 2010; 137:891-900; PMID:20179095; http://dx.doi.org/10.1242/dev.042895.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Genes Dev 2007; 21:1125-38; PMID:17473174; http://dx.doi.org/10.1101/gad.415007.16.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Genome Res 2011; 21:465-76; PMID:21324877; http://dx.doi.org/10.1101/gr.111922.110.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Genomics 2006; 87:509-19; PMID:16455231; http://dx.doi.org/10.1016/j.ygeno.2005.12.007.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Genome Res 2003; 13:558-69; PMID:12670997; http://dx.doi.org/10.1101/gr.781503.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Hum Reprod 2010; 25:1927-41; PMID:20522441; http://dx.doi.org/10.1093/humrep/deq144.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Hum Mol Genet 2007; 16:2591-9; PMID:17704508; http://dx.doi.org/10.1093/hmg/ddm216.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Genome Res 2006; 16:331-9; PMID:16467561; http://dx.doi.org/10.1101/gr.4559106.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Cell Mol Biol Lett 2010; 15:541-50; PMID:20645017; http://dx.doi.org/10.2478/s11658-010-0028-y.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Hum Mol Genet 2004; 13:2221-31; PMID:15294872; http://dx.doi.org/10.1093/hmg/ddh245.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Nature 1985; 315:496-8; PMID:4000278; http://dx.doi.org/10.1038/315496a0.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
PLoS Genet 2009; 5:e1000790; PMID:20041224; http://dx.doi.org/10.1371/journal.pgen.1000790.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
BMC Genet 2010; 11:25; PMID:20403199; http://dx.doi.org/10.1186/1471-2156-11-25.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Science 2007; 318:1136-40; PMID:18006746; http://dx.doi.org/10.1126/science.1148910.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Hum Mol Genet 2000; 9:1587-95; PMID:10861285; http://dx.doi.org/10.1093/hmg/9.11.1587.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Hum Mol Genet 2011; 20:3188-97; PMID:21593219; http://dx.doi.org/10.1093/hmg/ddr224.References 1.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Nat Rev Genet 2001; 2:21-32; PMID:11253064; http://dx.doi.org/10.1038/35047554.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Dev Cell 2006; 11:711-22; PMID:17084362; http://dx.doi.org/10.1016/j.dev-cel.2006.09.003.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Reprod Fertil Dev 1998; 10:23-9; PMID:9727590; http://dx.doi.org/10.1071/R98014.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Mol Hum Reprod 2010; 16:960-8; PMID:20643876; http://dx.doi.org/10.1093/molehr/gaq064.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Mol Hum Reprod 2002; 8:1129-35; PMID:12468647; http://dx.doi.org/10.1093/molehr/8.12.1129.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
PLoS One 2008; 3:e3905; PMID:19079545; http://dx.doi.org/10.1371/journal.pone.0003905.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Nat Genet 2005; 37:514-9; PMID:15806103; http://dx.doi.org/10.1038/ng1541.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Mol Cell Biol 2010; 30:3357-70; PMID:20421412; http://dx.doi.org/10.1128/MCB.01355-09.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
BMC Genomics 2010; 11:649; PMID:21092170; http://dx.doi.org/10.1186/1471-2164-11-649.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Genome Res 2007; 17:1723-30; PMID:18055845; http://dx.doi.org/10.1101/gr.6584707.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Genome Res 2005; 15:875-84; PMID:15930497; http://dx.doi.org/10.1101/gr.3303505.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Hum Genet 2008; 122:625-34; PMID:17955261; http://dx.doi.org/10.1007/s00439-007-0440-1.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Genomics 2004; 83:395-401; PMID:14962665; http://dx.doi.org/10.1016/j.ygeno.2003.09.007.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Bioinformatics 2003; 19:952-5; PMID:12761057; http://dx.doi.org/10.1093/bioinformatics/btg127.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Brief Funct Genomics 2010; 9:374-84; PMID:20829207; http://dx.doi.org/10.1093/bfgp/elq020.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
PLoS One 2008; 3:e3839; PMID:19052635; http://dx.doi.org/10.1371/journal.pone.0003839.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Placenta 2010; 31:151-7; PMID:20005570; http://dx.doi.org/10.1016/j.placen-ta.2009.11.008.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Physiol Genomics 2005; 22:99-107; PMID:15797968; http://dx.doi.org/10.1152/physiol-genomics.00276.2004.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Mol Endocrinol 2008; 22:2557-62; PMID:18818281; http://dx.doi.org/10.1210/me.2008-0322.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Anal Biochem 1987; 162:156-9; PMID:2440339; http://dx.doi.org/10.1016/0003-2697(87)90021-2.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Placenta 2005; 26:601-7; PMID:16085039; http://dx.doi.org/10.1016/j.placen-ta.2004.09.009.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Nucleic Acids Res 2001; 29:e45; PMID:11328886; http://dx.doi.org/10.1093/nar/29.9.e45.54.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Mol Cell Biol 2007; 27:4388-405; PMID:17438139; http://dx.doi.org/10.1128/MCB.01901-06.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Genomics 2004; 84:47-58; PMID:15203203; http://dx.doi.org/10.1016/j.ygeno.2004.02.007.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
RNA 2010; 16:1889-901; PMID:20801769; http://dx.doi.org/10.1261/rna.2226910.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Genomics 2008; 91:451-7; PMID:18329245; http://dx.doi.org/10.1016/j.ygeno.2008.01.009.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Placenta 2005; 26(Suppl A):S10-20; PMID:15837057; http://dx.doi.org/10.1016/j.placenta.2004.12.009.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Brain Res 1998; 810:1-8; PMID:9813220; http://dx.doi.org/10.1016/S0006-8993(98)00783-5.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Endocrinology 2007; 148:1059-79; PMID:17170095; http://dx.doi.org/10.1210/en.2006-0683.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Hum Genet 2011; 130:725-33; PMID:21626137; http://dx.doi.org/10.1007/s00439-011-1009-6.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Hum Mol Genet 2012; 21:548-58; PMID:22025075; http://dx.doi.org/10.1093/hmg/ddr488.44.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Eur J Cancer 2009; 45:2212-8; PMID:19477633; http://dx.doi.org/10.1016/j.ejca.2009.05.003.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
J Biol Chem 2008; 283:6337-46; PMID:18178554; http://dx.doi.org/10.1074/jbc.M707861200.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Semin Thromb Hemost 2011; 37:158-64; PMID:21370218; http://dx.doi.org/10.1055/s-0030-1270344.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Ann N Y Acad Sci 2008; 1127:67-72; PMID:18443332; http://dx.doi.org/10.1196/annals.1434.013.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
J Hum Genet 2010; 55:681-90; PMID:20668459; http://dx.doi.org/10.1038/jhg.2010.88.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
J Hum Genet 2009; 54:749-52; PMID:19834501; http://dx.doi.org/10.1038/jhg.2009.99.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Am J Hum Genet 2010; 86:773-82; PMID:20398887; http://dx.doi.org/10.1016/j.ajhg.2010.03.010.,OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
PLoS One 2011; 6:e17121; PMID:21347206; http://dx.doi.org/10.1371/journal.pone.0017121.,Non-OADS,/arxiv_data1/oa_pdf/71/50/epi-7-1079.PMC3466192.pdf
Version 2.2011. http://www.nccn.org/professi onals/physician_gls/PDF/head- and-neck.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b8/11/12032_2012_Article_159.PMC3466428.pdf
"3band Pfam, http://pfam.sanger.",Non-OADS,/arxiv_data1/oa_pdf/19/9e/253_2012_Article_3871.PMC3466432.pdf
The constant regions that were used for amplification were then masked before mapping to themasked mouse genome (mm8 http://hgdownload.cse.ucsc.edu/ downloads.html#mouse) using BLAT 18with the following cut-off conditions: match length $30 bp and identity $95%.,OADS,/arxiv_data1/oa_pdf/56/f9/srep00691.PMC3466446.pdf
"To calculate the statistical significance of the differences in frequencies, Fisher’s exact tests were conducted using R software (R: A Language and Environment for Statistical Computing; http://www.R-project.org/).",OADS,/arxiv_data1/oa_pdf/56/f9/srep00691.PMC3466446.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.License: This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.,Non-OADS,/arxiv_data1/oa_pdf/56/f9/srep00691.PMC3466446.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Fujimori, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/56/f9/srep00691.PMC3466446.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Norris, C.E., Quideau, S.A., Landha ¨usser, S.M., Bernard, G.M.",Non-OADS,/arxiv_data1/oa_pdf/7d/c2/srep00719.PMC3466447.pdf
"Table prepared using commercial catch data from California Department of Fish and Game (http://www.dfg.ca.gov/marine/ fishing.asp#Commercial) Northern Anchovy Landings (kg) Northern Anchovy (%) Pacific Sardine Landings (kg) Pacific Sardine (%) 2006 (April only) 307,214 85.6 22,916 6.4 2006 (Entire year) 4,181,130 60.5 1,935,210 28.02000–2010 21,142,843 37.8 28,207,943 50.4www.nature.com/ scientificreports SCIENTIFIC REPORTS | 2 : 716 | DOI: 10.1038/srep00716 2",Non-OADS,/arxiv_data1/oa_pdf/24/b8/srep00716.PMC3466448.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Saba, G.K. & Steinberg, D.K.",Non-OADS,/arxiv_data1/oa_pdf/24/b8/srep00716.PMC3466448.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Masuyer, G., Schwager, S.L.U., Sturrock, E.D., Isaac, R.E.",Non-OADS,/arxiv_data1/oa_pdf/14/c5/srep00717.PMC3466449.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/92/12/PM-8-182.PMC3466451.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/94/0b/PM-8-184.PMC3466452.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/e3/8a/PM-8-192.PMC3466453.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/e3/8a/PM-8-192.PMC3466453.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/6e/d4/PM-8-209.PMC3466456.pdf
"Avon Longitudinal Study of Parents and Children, 2008. http://www.bristol.ac.uk/alspac/sci-com/resource/represent/(accessed 20 November 2011).",Non-OADS,/arxiv_data1/oa_pdf/c3/f4/ijo2012127a.PMC3466487.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on International Journal of Obesity website (http://www.nature.com/ijo)Dietary patterns and adiposity in children GL Ambrosini et al 1305 &2012 Macmillan Publishers Limited International Journal of Obesity (2012) 1299 – 1305",Non-OADS,/arxiv_data1/oa_pdf/c3/f4/ijo2012127a.PMC3466487.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Altered expression of gustatory-signaling elements P Widmayer et al 1359 International Journal of Obesity (2012) 1353 - - 1359 &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e1/81/ijo2011216a.PMC3466488.pdf
"Proc Natl Acad Sci U S A 2012; 109:1691-6; PMID:22307632; http://dx.doi.org/10.1073/pnas .1120238109.Keywords:  antibiotics, microbiota,   E. coli , disturbance, humans, agriculture Submitted: 05/11/12 Revised: 06/24/12Accepted: 06/27/12http://dx.doi.org/10.4161/gmic.21288 *Correspondence to: Heather Allen;   Email: heather.allen@ars.usda.govAntibiotics are an essential compo - nent of the modern lifestyle.",Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Clin Infect Dis 2009; 49:132-41; PMID:19489713; http://dx.doi.org/10.1086/599374.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Drug Resist Updat 2000; 3:303-11; PMID:11498398; http://dx.doi.org/10.1054/drup.2000.0167.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Science 2005; 308:1635-8; PMID:15831718; http://dx.doi.org/10.1126/science.1110591.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
MBio 2011; 2:10.1128; PMID:22128350; http://dx.doi.org/10.1128/mBio.00260-11.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Appl Environ Microbiol 2002; 68:673-90; PMID:11823207; http://dx.doi.org/10.1128/AEM.68.2.673-690.2002.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
PLoS Biol 2008; 6:e280; PMID:19018661; http://dx.doi.org/10.1371/journal.pbio.0060280.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Gut Microbes 2010; 1:279-84; PMID:20953272; http://dx.doi.org/10.4161/gmic.1.4.12614.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
ISME J 2007; 1:180-3; PMID:18043627; http://dx.doi.org/10.1038/ismej.2007.29.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Infect Immun 2009; 77:2367-75; PMID:19307217; http://dx.doi.org/10.1128/IAI.01520-08.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Genome Res 2010; 20:1411-9; PMID:20736229; http://dx.doi.org/10.1101/gr.107987.110.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Br J Nutr 2010; 104:83-92; PMID:20205964; http://dx.doi.org/10.1017/S0007114510000176.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Front Microbiol 2011; 2:228; PMID:22125551; http://dx.doi.org/10.3389/fmicb.2011.00228.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Surgery 2001; 130:65-73; PMID:11436014; http://dx.doi.org/10.1067/msy.2001.115360.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Environ Microbiol 2009; 11:1562-71; PMID:19245530; http://dx.doi.org/10.1111/j.1462-2920.2009.01883.x.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Cell Host Microbe 2007; 2:204; PMID:18030708; http://dx.doi.org/10.1016/j.chom.2007.08.002.22.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Appl Environ Microbiol 2007; 73:83-91; PMID:17056683; http://dx.doi.org/10.1128/AEM.00990-06.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Infect Immun 2010; 78:1509-19; PMID:20145094; http://dx.doi.org/10.1128/IAI.00862-09.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Vet Microbiol 2012; 159:115-22; PMID:22503601; http://dx.doi.org/10.1016/j.vetmic.2012.03.027.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Appl Environ Microbiol 2012; 78:2359-66; PMID:22286988; http://dx.doi.org/10.1128/AEM.05239-11.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Antimicrob Agents Chemother 2011; 55:1494-503; PMID:21282433; http://dx.doi.org/10.1128/AAC.01664-10.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Appl Environ Microbiol 2002; 68:3841-7; PMID:12147479; http://dx.doi.org/10.1128/AEM.68.8.3841-3847.2002.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Arch Microbiol 1985; 141:1-7; PMID:3994481; http://dx.doi.org/10.1007/BF00446731.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Am J Physiol Gastrointest Liver Physiol  2011; 300:G461-9; PMID:21163900; http://dx.doi.org/10.1152/ajpgi.00434.2010.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Nat Rev Microbiol 2009; 7:887-94; PMID:19898491; http://dx.doi.org/10.1038/nrmicro2245.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
PLoS Pathog 2012; 8:e1002681;  PMID:22615558; http://dx.doi.org/10.1371/journal.ppat.1002681.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Science 2011; 334:245-9; PMID:21998394; http://dx.doi.org/10.1126/sci - ence.1210718.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Anim Health Res Rev 2005; 6:17-39; PMID:16164007; http://dx.doi.org/10.1079/AHR2005105.40.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Nature 2008; 455:804-7; PMID:18724361; http://dx.doi.org/10.1038/nature07250.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Mucosal Immunol 2010; 3:148-58; PMID:19940845; http://dx.doi.org/10.1038/mi.2009.132.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Infect Immun 2011; 79:1536-45; PMID:21321077; http://dx.doi.org/10.1128/IAI.01104-10.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Nat Rev Immunol 2004; 4:478-85; PMID:15173836; http://dx.doi.org/10.1038/nri1373.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Mucosal Immunol 2011; 4:4-7; PMID:21150894; http://dx.doi.org/10.1038/mi.2010.79.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Nature 2006; 444:1022-3; PMID:17183309; http://dx.doi.org/10.1038/4441022a.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Nature 2006; 444:1027-31; PMID:17183312; http://dx.doi.org/10.1038/nature05414.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Environ Microbiol 2009; 11:2771-4; PMID:19878268; http://dx.doi.org/10.1111/j.1462-2920.2009.02101.x.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Biotechnol J 2007; 2:450-5; PMID:17330220; http://dx.doi.org/10.1002/biot.200600227.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
Appl Environ Microbiol 2008; 74:2950-6; PMID:18359835; http://dx.doi.org/10.1128/AEM.00189-08.,OADS,/arxiv_data1/oa_pdf/19/b2/gmic-3-463.PMC3466501.pdf
"ia n G. Cowell and Caroline a. au stin* in stitute for Cellular and Molecular Biosciences; th e Cookson Building; th e Medical School; Newcastle un iversity; Newcastle upon ty ne, uK *Correspondence to: Caroline A. Austin; Email: caroline.austin@ncl.ac.uk Submitted: 07/11/12; Accepted: 07/12/12http://dx.doi.org/10.4161/cc.21477Comment on: Cowell IG, et al.",Non-OADS,/arxiv_data1/oa_pdf/46/05/cc-11-3143.PMC3466504.pdf
PMID:22829791http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/05/cc-11-3143.PMC3466504.pdf
PMID:22108601; http://dx.doi.org/10.1038/nrm3228 3.,OADS,/arxiv_data1/oa_pdf/46/05/cc-11-3143.PMC3466504.pdf
PMID:19852969;  http://dx.doi.org/10.1016/j.jmb.2009.10.031 5.,OADS,/arxiv_data1/oa_pdf/46/05/cc-11-3143.PMC3466504.pdf
PMID:20601956; http://dx.doi.org/10.1038/ng.613 6.,OADS,/arxiv_data1/oa_pdf/46/05/cc-11-3143.PMC3466504.pdf
PMID:16794079; http://dx.doi.org/10.1126/sci-ence.1127196 7.,OADS,/arxiv_data1/oa_pdf/46/05/cc-11-3143.PMC3466504.pdf
PMID:18187655; http://dx.doi.org/10.1126/sci-ence.1147674 8.,OADS,/arxiv_data1/oa_pdf/46/05/cc-11-3143.PMC3466504.pdf
PMID:18384074; http://dx.doi.org/10.1002/jcb.21750 9.,Non-OADS,/arxiv_data1/oa_pdf/46/05/cc-11-3143.PMC3466504.pdf
PMID:16983345; http://dx.doi.org/10.1038/sj.onc.1209948 10.,Non-OADS,/arxiv_data1/oa_pdf/46/05/cc-11-3143.PMC3466504.pdf
PMID:18596031; http://dx.doi.org/10.1074/jbc.M803936200 Figure 1.  or ganization of transcription units into transcription factories and transcription factory  model for t- aL -associated chromosome translocations.,OADS,/arxiv_data1/oa_pdf/46/05/cc-11-3143.PMC3466504.pdf
"7 Thus, each of these three genotoxic  agents has distinct effects, enabling us to Turned on by genotoxic stress an na tr avesa and Curt Wittenberg* de partment of Molecular Biology; th e Scripps re search in stitute; La Jolla, C a  uSa Abbreviations:  MMS, methyl methane sulfonate; CPT, camptothecin; HU, hydroxyurea; SBF, SCB binding factor; MBF, MCB  binding factor; DNA, deoxyribonucleic acid; dNTP, deoxynucleoside triphosphate *Correspondence to: Curt Wittenberg; Email: curtw@scripps.edu Submitted: 06/14/12; Accepted: 06/15/12http://dx.doi.org/10.4161/cc.21587Comment on: Travesa A, et al.",Non-OADS,/arxiv_data1/oa_pdf/c0/a5/cc-11-3145.PMC3466505.pdf
EMBO J 2012; 31:1811-22; PMID:22333915; http://dx.doi.org/10.1038/emboj.2012.28.study the transcriptional response to three  different forms of genotoxic stress.,Non-OADS,/arxiv_data1/oa_pdf/c0/a5/cc-11-3145.PMC3466505.pdf
EMBO Rep 2003; 4:678-84;  PMID:12792653; http://dx.doi.org/10.1038/sj.embor.,OADS,/arxiv_data1/oa_pdf/c0/a5/cc-11-3145.PMC3466505.pdf
Nature 2001; 412:557-61; PMID:11484058; http://dx.doi.org/10.1038/35087613 8.,Non-OADS,/arxiv_data1/oa_pdf/c0/a5/cc-11-3145.PMC3466505.pdf
EMBO J 2012; 31:1798- 810; PMID:22333912; http://dx.doi.org/10.1038/emboj.2012.27 9.,Non-OADS,/arxiv_data1/oa_pdf/c0/a5/cc-11-3145.PMC3466505.pdf
Cell 2000; 100:57-70;  PMID:10647931; http://dx.doi.org/10.1016/S0092-8674(00)81683-9 2.,OADS,/arxiv_data1/oa_pdf/c0/a5/cc-11-3145.PMC3466505.pdf
Science 1989; 246:629-34;  PMID:2683079; http://dx.doi.org/10.1126/sci-ence.2683079 3.,OADS,/arxiv_data1/oa_pdf/c0/a5/cc-11-3145.PMC3466505.pdf
EMBO J 2012; 31:1811-22;  PMID:22333915; http://dx.doi.org/10.1038/emboj.2012.28 5.,Non-OADS,/arxiv_data1/oa_pdf/c0/a5/cc-11-3145.PMC3466505.pdf
Nature 2001; 412:553 - 7;  PMID:11484057; http://dx.doi.org/10.1038/35087607 Figure 1.,OADS,/arxiv_data1/oa_pdf/c0/a5/cc-11-3145.PMC3466505.pdf
"5 In all three cases, senescence  relies on modulating p53 levels and activ - ity and/or INK4A mediated inhibition of cyclin-dependent kinases (CDKs) and, thus, inactivation of the retinoblastoma Too much or too little Harnessing senescence to control   oncogene-driven cancer Katherine M. Hannan1,2 and r ichard B. Pearson1,2,3,* 1oncogenic Signalling and Growth Control Program; Peter MacCallum Cancer Centre; Melbourne, V iC australia; 2Sir Peter MacCallum d epartment of o ncology; t he u niversity  of Melbourne; Parkville, V iC australia; 3department of Biochemistry and Molecular Biology; u niversity of Melbourne; Parkville, V iC australia *Correspondence to: Richard B. Pearson; Email: rick.pearson@petermac.org Submitted: 06/20/12; Accepted: 06/25/12http://dx.doi.org/10.4161/cc.21588Comment on: Astle MV, et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
"Oncogene 2012; 31:1949-62.; PMID:21909130; http://dx.doi.org/10.1038/onc.2011.394.protein, RB.4 However, while elevated p53  activity alone typically promotes cell cycle  arrest or quiescence, it is the presence of a chronically stimulated, growth-promoting signaling pathway that mediates cellular senescence, which is coined geroconver - sion.",Non-OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
Nat Med 2008; 14:1351-6;  PMID:19029981; http://dx.doi.org/10.1038/nm.1890 2.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
Nat Clin Pract Oncol 2006; 3:448- 57; PMID:16894390; http://dx.doi.org/10.1038/ ncponc0558 3.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
Nat Rev Cancer 2011; 11:503-11; PMID:21701512; http://dx.doi.org/10.1038/nrc3057 5.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
Oncogene 2012; 31:1949-62; PMID:21909130; http://dx.doi.org/10.1038/ onc.2011.394 6.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
Expert Opin Ther Targets 2012; PMID:22494490; http://dx.doi.org/10.1517/1472822 2.2012.677439 9.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
T rends Cell Biol 2012; 22:211- 9; PMID:22245068; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
Sci Signal 2011; 4:ra56; PMID:21878679; http://dx.doi.org/10.1126/scisig- nal.2001754 11.,OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
Cancer Cell 2012; 22:51-65; PMID:22789538; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/cc-11-3147.PMC3466506.pdf
"C ancelas* re search di vision; Hoxworth Blood Center; un iversity of Cincinnati; Cincinnati, oH uSa  and  di vision of Experimental Hematology and Cancer Biology; Cincinnati Children’s Hospital Medical Center; Cincinnati,  oH   uSa *Correspondence to: Jose A. Cancelas; Email: jose.cancelas@uc.edu Submitted: 06/27/12; Accepted: 07/01/12http://dx.doi.org/10.4161/cc.21589Comment on: Taniguchi Ishikawa E, et al.",Non-OADS,/arxiv_data1/oa_pdf/b7/9a/cc-11-3149.PMC3466507.pdf
N ature 2009; 461:537-41;  PMID:19727075; http://dx.doi.org/10.1038/ nature08313.,Non-OADS,/arxiv_data1/oa_pdf/b7/9a/cc-11-3149.PMC3466507.pdf
Nat Med 2006; 12:446-51;  PMID:16565722; http://dx.doi.org/10.1038/nm1388.,OADS,/arxiv_data1/oa_pdf/b7/9a/cc-11-3149.PMC3466507.pdf
Science 1995; 267:104-8;  PMID:7528940; http://dx.doi.org/10.1126/sci-ence.7528940.,OADS,/arxiv_data1/oa_pdf/b7/9a/cc-11-3149.PMC3466507.pdf
N at Med 2001; 7:1111-7;  PMID:11590433; http://dx.doi.org/10.1038/nm1001-1111.,OADS,/arxiv_data1/oa_pdf/b7/9a/cc-11-3149.PMC3466507.pdf
Anat R ec 1980; 196:101-7;  PMID:7416498; http://dx.doi.org/10.1002/ar.1091960110.,Non-OADS,/arxiv_data1/oa_pdf/b7/9a/cc-11-3149.PMC3466507.pdf
Cell Stem Cell 2009; 4:37-48;  PMID:19128791; http://dx.doi.org/10.1016/j.stem.2008.11.006.,OADS,/arxiv_data1/oa_pdf/b7/9a/cc-11-3149.PMC3466507.pdf
PLoS Genet 2005; 1:e28;  PMID:16151515; http://dx.doi.org/10.1371/journal.pgen.0010028.,OADS,/arxiv_data1/oa_pdf/b7/9a/cc-11-3149.PMC3466507.pdf
Nat Immunol 2011; 12:391-8;  PMID:21441933; http://dx.doi.org/10.1038/ni.2017.,Non-OADS,/arxiv_data1/oa_pdf/b7/9a/cc-11-3149.PMC3466507.pdf
"We showed that genetic loss of p75 NTR lowered glycemic excursions  after glucose, increased the hypoglycemic Glucose homeostasis and p75NTR The sweet side of neurotrophin receptor signaling Bernat Baeza- ra ja1 and Katerina ak assoglou1,2,* 1Gladstone in stitute of Neurological di sease; un iversity of California, San Francisco; San Francisco, C a  uSa;   2de partment of Neurology; un iversity of California, San Francisco; San Francisco, C a  uSa *Correspondence to: Katerina Akassoglou; Email: kakassoglou@gladstone.ucsf.edu Submitted: 06/27/12; Accepted: 07/01/12http://dx.doi.org/10.4161/cc.21590Comment on: Baeza-Raja B, et al.",Non-OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
Proc Natl Acad Sci USA 2012;  109:5838-43; PMID:22460790; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
Mol Biol Cell 2009; 20:3620- 7; PMID:19553472; http://dx.doi.org/10.1091/mbc.E09-01-0012.,Non-OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
Science 2007; 315:1853-6;  PMID:17395831; http://dx.doi.org/10.1126/sci-ence.1137603.,OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
Nat Rev Neurosci 2003; 4:299-309;  PMID:12671646; http://dx.doi.org/10.1038/nrn1078.,Non-OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
J Cell Biol 2007; 177:1119-32;  PMID:17576803; http://dx.doi.org/10.1083/jcb.200701040.6.,OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
Mol Cell 2011; 44:476-90;  PMID:22055192; http://dx.doi.org/10.1016/j.mol-cel.2011.08.033.,OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
PMID:10595511; http://dx.doi.org/10.1016/S0896-6273(00)81114-9.,OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
Nature 2004; 427:843-8;  PMID:14985763; http://dx.doi.org/10.1038/nature02319.,Non-OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
Dev Cell 2005; 9:99-108; PMID:15992544;  http://dx.doi.org/10.1016/j.devcel.2005.04.004.,OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
Eur J Neurosci 2004; 20:2321-35;  PMID:15525274; http://dx.doi.org/10.1111/j.1460-9568.2004.03692.x.,Non-OADS,/arxiv_data1/oa_pdf/f7/23/cc-11-3151.PMC3466508.pdf
"Cell Cycle 2012; 11:2538–44;   PMID:22713238; http://dx.doi.org/10.4161/cc.20919 Simon Bekker-Jensen and Niels Mailand*; Ubiquitin Signaling Group; Department of Disease Biology; Novo Nordisk Foundation Center for Protein Research;  University of Copenhagen; Copenhagen, Denmark; *Email: niels.mailand@cpr.ku.dk; http://dx.doi.org/10.4161/cc.21718 outstanding question.7 By mass spectrometry  analysis of ubiquitylation of epitope-tagged  histones in cells overexpressing RNF168, the authors come to the surprising conclusion that the evolutionarily conserved lysine 13 and 15 residues are the chief acceptor sites of RNF8- and RNF168-catalyzed ubiquitylation on H2A-type histones.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
DNA Repair (Amst) 2010;  9:1219-28; PM i D:21035408; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Nat Cell Biol 2011; 13:1161-9;  PM i D:21968989; http://dx.doi.org/10.1038/ ncb2344.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
DNA Repair (Amst)  2004; 3:959-67; PM iD: 15279782; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
DNA Repair (Amst) 2009; 8:436- 43; PM i D:19230794; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Nat Rev Mol Cell Biol 2010; 11:479- 89; PM i D:20551964; http://dx.doi.org/10.1038/ nrm2921.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell 2010; 142:682-5; PM i D:20813257;  http://dx.doi.org/10.1016/j.cell.2010.08.011.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell Cycle 2012; 11( i ssue 13):2538- 44; PM i D:22713238; http://dx.doi.org/10.4161/ cc.20919.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell Div 2008; 3:8; PM i D:18430235;  http://dx.doi.org/10.1186/1747-1028-3-8.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
"Cell Cycle 2012; 11:2739–46;   PMID:22771961; http://dx.doi.org/10.4161/cc.21119 Matthias Stadtfeld; Skirball Institute; NYU School of Medicine; New York, NY USA; Email: matthias.stadtfeld@med.nyu.edu; http://dx.doi.org/10.4161/cc.21720 in r ecent years, a multitude of groundbreak - ing papers have demonstrated that cell fates  can be altered almost at will by the enforced expression of defined sets of transcription fac - tors.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
J Lipid Res 2007; 48:1763- 71; PM i D:17525476; http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Mol Cancer 2010; 9:159;  PM iD :20569465; http://dx.doi.org/10.1186/1476- 4598-9-159.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell Cycle 2012; 11:2660-71;  PM i D:22732497; http://dx.doi.org/10.4161/ cc.21015.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
"Science 2008; 321:1807-12;  PM i D:18772396; http://dx.doi.org/10.1126/sci- ence.1164382.Fenofibrate triggers apoptosis of glioblastoma cells in vitro:   New insights for therapy Comment on: Wilk A, et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
"Cell Cycle 2012; 11:2660–71;   PMID:22732497; http://dx.doi.org/10.4161/cc.21015 Antonio Giordano1,2 and Marcella Macaluso1,*; 1Sbarro Institute for Cancer Research and Molecular Medicine; College of Science and Technology; Temple  University; Philadelphia, PA USA; 2Department of Human Pathology and Oncology; University of Siena; Siena, Itlay;   *Email: macaluso@temple.edu; http://dx.doi.org/10.4161/cc.21719",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Genes Dev 2010; 24:2239-63;  PM i D:20952534; http://dx.doi.org/10.1101/ gad.1963910.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Nature 2009; 462:587-94;  PM i D:19956253; http://dx.doi.org/10.1038/ nature08533.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell Cycle 2012; 11:2739-46;  PM i D:22771961; http://dx.doi.org/10.4161/ cc.21119.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Nature 2009; 462:595-601;  PM i D:19898493; http://dx.doi.org/10.1038/ nature08592.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Nature 2010; 463:1035-41;  PM i D:20107439; http://dx.doi.org/10.1038/ nature08797.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell Stem Cell 2011; 9:374-82;  PM i D:21962918; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell Stem Cell 2009; 5:554- 66; PM i D:19896445; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell 2004; 117:663-76; PM i D:15163413;  http://dx.doi.org/10.1016/S0092-8674(04)00419-2.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Nucleic Acids Res  2012; 40:1954-68; PM i D:22086955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
"Cell Cycle 2012; 11:2681–90;   PMID:22751438; http://dx.doi.org/10.4161/cc.21019 Frances M. Sladek; Department of Cell Biology and Neuroscience; University of California; Riverside, CA USA; Email: frances.sladek@ucr.edu;   http://dx.doi.org/10.4161/cc.21721 expression of Ccnd1 as a liver-specific knock - out of HNF4a results in a marked increase in  cyclin D1 gene expression.2 The tumor sup - pressor p53 has also been shown to inhibit HNF4a function and downregulate the expres-sion of the HNF4A gene upon DNA damage; 6,7  decreased HNF4a  may help set the stage  for subsequent regrowth.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell Cycle 2012; 11:2681-90;  PM i D:22751438; http://dx.doi.org/10.4161/ cc.21019.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
J Biol Chem 2012; 287:7345-56;  PM i D:22241473; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell 2011; 147:1233-47;  PM i D:22153071; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cancer Res 2010; 70:7640-51;  PM iD :20876809; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0824.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Mol Endocrinol  2008; 22:78-90; PM iD :17885207; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Biochem J 2006; 400:303-13;  PM i D:16895524; http://dx.doi.org/10.1042/ BJ20060614.7.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Mol Endocrinol 2002; 16:402-10;  PM i D:11818510; http://dx.doi.org/10.1210/ me.16.2.402.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Mol Endocrinol 2007; 21:1297-311;  PM i D:17389749; http://dx.doi.org/10.1210/ me.2006-0300.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Proc Natl Acad Sci USA 2012;  109:2302-7; PM i D:22308320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
"Cell Cycle 2012; 11: 2864–75;   PMID:22801546; http://dx.doi.org/10.4161/cc.21196 Maria Castedo,1,2,3 Laura Senovilla,1,2,3 Ilio Vitale1,2,3 and Guido Kroemer1,4-7,*; 1INSERM; U848; Villejuif, France; 2Institut Gustave Roussy; Villejuif, France;  3Université Paris Sud-XI; Villejuif, France; 4Metabolomics Platform; Institut Gustave Roussy; Villejuif, France; 5Centre de Recherche des Cordeliers; Paris, France;  6Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; 7Université Paris Descartes, Paris 5; Paris, France;  *Email: kroemer@orange.fr; http://dx.doi.org/10.4161/cc.21722 One of the initiating events of oncogenesis  is tetraploidization, that is the generation of cells that contain twice as much DNA and chromosomes than their normal, diploid coun-terparts.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell Death Differ 2011; 18:1403- 13; PM i D:21072053; http://dx.doi.org/10.1038/ cdd.2010.145.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Curr Biol 2007; 17:431-7;  PM i D:17320392; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Nature 2005; 437:1043-7;  PM i D:16222300; http://dx.doi.org/10.1038/ nature04217.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell 2010; 141:81-93; PM i D:20371347;  http://dx.doi.org/10.1016/j.cell.2010.01.031.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Nat Rev Mol Cell Biol 2011; 12:385- 92; PM i D:21527953; http://dx.doi.org/10.1038/ nrm3115.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Annu Rev Cell Dev Biol 2011; 27:585- 610; PM i D:21801013; http://dx.doi.org/10.1146/ annurev-cellbio-092910-154234.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
EMBO J 2006; 25:2584-95;  PM i D:16675948; http://dx.doi.org/10.1038/ sj.emboj.7601127.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
EMBO J 2010; 29:1272-84;  PM i D:20186124; http://dx.doi.org/10.1038/ emboj.2010.11.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
Cell Cycle 2012; 11:2864-75;  PM i D:22801546; http://dx.doi.org/10.4161/ cc.21196.,OADS,/arxiv_data1/oa_pdf/b4/a2/cc-11-3153.PMC3466509.pdf
"Cell Cycle 2012; 11:2538–44;   PMID:22713238; http://dx.doi.org/10.4161/cc.20919 Simon Bekker-Jensen and Niels Mailand*; Ubiquitin Signaling Group; Department of Disease Biology; Novo Nordisk Foundation Center for Protein Research;  University of Copenhagen; Copenhagen, Denmark; *Email: niels.mailand@cpr.ku.dk; http://dx.doi.org/10.4161/cc.21718 outstanding question.7 By mass spectrometry  analysis of ubiquitylation of epitope-tagged  histones in cells overexpressing RNF168, the authors come to the surprising conclusion that the evolutionarily conserved lysine 13 and 15 residues are the chief acceptor sites of RNF8- and RNF168-catalyzed ubiquitylation on H2A-type histones.",Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
DNA Repair (Amst) 2010;  9:1219-28; PM i D:21035408; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Nat Cell Biol 2011; 13:1161-9;  PM i D:21968989; http://dx.doi.org/10.1038/ ncb2344.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
DNA Repair (Amst)  2004; 3:959-67; PM iD: 15279782; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
DNA Repair (Amst) 2009; 8:436- 43; PM i D:19230794; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Nat Rev Mol Cell Biol 2010; 11:479- 89; PM i D:20551964; http://dx.doi.org/10.1038/ nrm2921.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell 2010; 142:682-5; PM i D:20813257;  http://dx.doi.org/10.1016/j.cell.2010.08.011.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell Cycle 2012; 11( i ssue 13):2538- 44; PM i D:22713238; http://dx.doi.org/10.4161/ cc.20919.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell Div 2008; 3:8; PM i D:18430235;  http://dx.doi.org/10.1186/1747-1028-3-8.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
"Cell Cycle 2012; 11:2739–46;   PMID:22771961; http://dx.doi.org/10.4161/cc.21119 Matthias Stadtfeld; Skirball Institute; NYU School of Medicine; New York, NY USA; Email: matthias.stadtfeld@med.nyu.edu; http://dx.doi.org/10.4161/cc.21720 in r ecent years, a multitude of groundbreak - ing papers have demonstrated that cell fates  can be altered almost at will by the enforced expression of defined sets of transcription fac - tors.",Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
J Lipid Res 2007; 48:1763- 71; PM i D:17525476; http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Mol Cancer 2010; 9:159;  PM iD :20569465; http://dx.doi.org/10.1186/1476- 4598-9-159.,Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell Cycle 2012; 11:2660-71;  PM i D:22732497; http://dx.doi.org/10.4161/ cc.21015.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
"Science 2008; 321:1807-12;  PM i D:18772396; http://dx.doi.org/10.1126/sci- ence.1164382.Fenofibrate triggers apoptosis of glioblastoma cells in vitro:   New insights for therapy Comment on: Wilk A, et al.",Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
"Cell Cycle 2012; 11:2660–71;   PMID:22732497; http://dx.doi.org/10.4161/cc.21015 Antonio Giordano1,2 and Marcella Macaluso1,*; 1Sbarro Institute for Cancer Research and Molecular Medicine; College of Science and Technology; Temple  University; Philadelphia, PA USA; 2Department of Human Pathology and Oncology; University of Siena; Siena, Itlay;   *Email: macaluso@temple.edu; http://dx.doi.org/10.4161/cc.21719",Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Genes Dev 2010; 24:2239-63;  PM i D:20952534; http://dx.doi.org/10.1101/ gad.1963910.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Nature 2009; 462:587-94;  PM i D:19956253; http://dx.doi.org/10.1038/ nature08533.,Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell Cycle 2012; 11:2739-46;  PM i D:22771961; http://dx.doi.org/10.4161/ cc.21119.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Nature 2009; 462:595-601;  PM i D:19898493; http://dx.doi.org/10.1038/ nature08592.,Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Nature 2010; 463:1035-41;  PM i D:20107439; http://dx.doi.org/10.1038/ nature08797.,Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell Stem Cell 2011; 9:374-82;  PM i D:21962918; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell Stem Cell 2009; 5:554- 66; PM i D:19896445; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell 2004; 117:663-76; PM i D:15163413;  http://dx.doi.org/10.1016/S0092-8674(04)00419-2.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Nucleic Acids Res  2012; 40:1954-68; PM i D:22086955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
"Cell Cycle 2012; 11:2681–90;   PMID:22751438; http://dx.doi.org/10.4161/cc.21019 Frances M. Sladek; Department of Cell Biology and Neuroscience; University of California; Riverside, CA USA; Email: frances.sladek@ucr.edu;   http://dx.doi.org/10.4161/cc.21721 expression of Ccnd1 as a liver-specific knock - out of HNF4a results in a marked increase in  cyclin D1 gene expression.2 The tumor sup - pressor p53 has also been shown to inhibit HNF4a function and downregulate the expres-sion of the HNF4A gene upon DNA damage; 6,7  decreased HNF4a  may help set the stage  for subsequent regrowth.",Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell Cycle 2012; 11:2681-90;  PM i D:22751438; http://dx.doi.org/10.4161/ cc.21019.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
J Biol Chem 2012; 287:7345-56;  PM i D:22241473; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell 2011; 147:1233-47;  PM i D:22153071; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cancer Res 2010; 70:7640-51;  PM iD :20876809; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0824.,Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Mol Endocrinol  2008; 22:78-90; PM iD :17885207; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Biochem J 2006; 400:303-13;  PM i D:16895524; http://dx.doi.org/10.1042/ BJ20060614.7.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Mol Endocrinol 2002; 16:402-10;  PM i D:11818510; http://dx.doi.org/10.1210/ me.16.2.402.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Mol Endocrinol 2007; 21:1297-311;  PM i D:17389749; http://dx.doi.org/10.1210/ me.2006-0300.,Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Proc Natl Acad Sci USA 2012;  109:2302-7; PM i D:22308320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
"Cell Cycle 2012; 11: 2864–75;   PMID:22801546; http://dx.doi.org/10.4161/cc.21196 Maria Castedo,1,2,3 Laura Senovilla,1,2,3 Ilio Vitale1,2,3 and Guido Kroemer1,4-7,*; 1INSERM; U848; Villejuif, France; 2Institut Gustave Roussy; Villejuif, France;  3Université Paris Sud-XI; Villejuif, France; 4Metabolomics Platform; Institut Gustave Roussy; Villejuif, France; 5Centre de Recherche des Cordeliers; Paris, France;  6Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; 7Université Paris Descartes, Paris 5; Paris, France;  *Email: kroemer@orange.fr; http://dx.doi.org/10.4161/cc.21722 One of the initiating events of oncogenesis  is tetraploidization, that is the generation of cells that contain twice as much DNA and chromosomes than their normal, diploid coun-terparts.",Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell Death Differ 2011; 18:1403- 13; PM i D:21072053; http://dx.doi.org/10.1038/ cdd.2010.145.,Non-OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Curr Biol 2007; 17:431-7;  PM i D:17320392; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Nature 2005; 437:1043-7;  PM i D:16222300; http://dx.doi.org/10.1038/ nature04217.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell 2010; 141:81-93; PM i D:20371347;  http://dx.doi.org/10.1016/j.cell.2010.01.031.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Nat Rev Mol Cell Biol 2011; 12:385- 92; PM i D:21527953; http://dx.doi.org/10.1038/ nrm3115.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Annu Rev Cell Dev Biol 2011; 27:585- 610; PM i D:21801013; http://dx.doi.org/10.1146/ annurev-cellbio-092910-154234.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
EMBO J 2006; 25:2584-95;  PM i D:16675948; http://dx.doi.org/10.1038/ sj.emboj.7601127.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
EMBO J 2010; 29:1272-84;  PM i D:20186124; http://dx.doi.org/10.1038/ emboj.2010.11.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
Cell Cycle 2012; 11:2864-75;  PM i D:22801546; http://dx.doi.org/10.4161/ cc.21196.,OADS,/arxiv_data1/oa_pdf/30/63/cc-11-3154.PMC3466510.pdf
"Cell Cycle 2012; 11:2538–44;   PMID:22713238; http://dx.doi.org/10.4161/cc.20919 Simon Bekker-Jensen and Niels Mailand*; Ubiquitin Signaling Group; Department of Disease Biology; Novo Nordisk Foundation Center for Protein Research;  University of Copenhagen; Copenhagen, Denmark; *Email: niels.mailand@cpr.ku.dk; http://dx.doi.org/10.4161/cc.21718 outstanding question.7 By mass spectrometry  analysis of ubiquitylation of epitope-tagged  histones in cells overexpressing RNF168, the authors come to the surprising conclusion that the evolutionarily conserved lysine 13 and 15 residues are the chief acceptor sites of RNF8- and RNF168-catalyzed ubiquitylation on H2A-type histones.",Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
DNA Repair (Amst) 2010;  9:1219-28; PM i D:21035408; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Nat Cell Biol 2011; 13:1161-9;  PM i D:21968989; http://dx.doi.org/10.1038/ ncb2344.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
DNA Repair (Amst)  2004; 3:959-67; PM iD: 15279782; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
DNA Repair (Amst) 2009; 8:436- 43; PM i D:19230794; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Nat Rev Mol Cell Biol 2010; 11:479- 89; PM i D:20551964; http://dx.doi.org/10.1038/ nrm2921.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell 2010; 142:682-5; PM i D:20813257;  http://dx.doi.org/10.1016/j.cell.2010.08.011.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell Cycle 2012; 11( i ssue 13):2538- 44; PM i D:22713238; http://dx.doi.org/10.4161/ cc.20919.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell Div 2008; 3:8; PM i D:18430235;  http://dx.doi.org/10.1186/1747-1028-3-8.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
"Cell Cycle 2012; 11:2739–46;   PMID:22771961; http://dx.doi.org/10.4161/cc.21119 Matthias Stadtfeld; Skirball Institute; NYU School of Medicine; New York, NY USA; Email: matthias.stadtfeld@med.nyu.edu; http://dx.doi.org/10.4161/cc.21720 in r ecent years, a multitude of groundbreak - ing papers have demonstrated that cell fates  can be altered almost at will by the enforced expression of defined sets of transcription fac - tors.",Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
J Lipid Res 2007; 48:1763- 71; PM i D:17525476; http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Mol Cancer 2010; 9:159;  PM iD :20569465; http://dx.doi.org/10.1186/1476- 4598-9-159.,Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell Cycle 2012; 11:2660-71;  PM i D:22732497; http://dx.doi.org/10.4161/ cc.21015.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
"Science 2008; 321:1807-12;  PM i D:18772396; http://dx.doi.org/10.1126/sci- ence.1164382.Fenofibrate triggers apoptosis of glioblastoma cells in vitro:   New insights for therapy Comment on: Wilk A, et al.",Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
"Cell Cycle 2012; 11:2660–71;   PMID:22732497; http://dx.doi.org/10.4161/cc.21015 Antonio Giordano1,2 and Marcella Macaluso1,*; 1Sbarro Institute for Cancer Research and Molecular Medicine; College of Science and Technology; Temple  University; Philadelphia, PA USA; 2Department of Human Pathology and Oncology; University of Siena; Siena, Itlay;   *Email: macaluso@temple.edu; http://dx.doi.org/10.4161/cc.21719",Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Genes Dev 2010; 24:2239-63;  PM i D:20952534; http://dx.doi.org/10.1101/ gad.1963910.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Nature 2009; 462:587-94;  PM i D:19956253; http://dx.doi.org/10.1038/ nature08533.,Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell Cycle 2012; 11:2739-46;  PM i D:22771961; http://dx.doi.org/10.4161/ cc.21119.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Nature 2009; 462:595-601;  PM i D:19898493; http://dx.doi.org/10.1038/ nature08592.,Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Nature 2010; 463:1035-41;  PM i D:20107439; http://dx.doi.org/10.1038/ nature08797.,Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell Stem Cell 2011; 9:374-82;  PM i D:21962918; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell Stem Cell 2009; 5:554- 66; PM i D:19896445; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell 2004; 117:663-76; PM i D:15163413;  http://dx.doi.org/10.1016/S0092-8674(04)00419-2.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Nucleic Acids Res  2012; 40:1954-68; PM i D:22086955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
"Cell Cycle 2012; 11:2681–90;   PMID:22751438; http://dx.doi.org/10.4161/cc.21019 Frances M. Sladek; Department of Cell Biology and Neuroscience; University of California; Riverside, CA USA; Email: frances.sladek@ucr.edu;   http://dx.doi.org/10.4161/cc.21721 expression of Ccnd1 as a liver-specific knock - out of HNF4a results in a marked increase in  cyclin D1 gene expression.2 The tumor sup - pressor p53 has also been shown to inhibit HNF4a function and downregulate the expres-sion of the HNF4A gene upon DNA damage; 6,7  decreased HNF4a  may help set the stage  for subsequent regrowth.",Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell Cycle 2012; 11:2681-90;  PM i D:22751438; http://dx.doi.org/10.4161/ cc.21019.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
J Biol Chem 2012; 287:7345-56;  PM i D:22241473; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell 2011; 147:1233-47;  PM i D:22153071; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cancer Res 2010; 70:7640-51;  PM iD :20876809; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0824.,Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Mol Endocrinol  2008; 22:78-90; PM iD :17885207; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Biochem J 2006; 400:303-13;  PM i D:16895524; http://dx.doi.org/10.1042/ BJ20060614.7.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Mol Endocrinol 2002; 16:402-10;  PM i D:11818510; http://dx.doi.org/10.1210/ me.16.2.402.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Mol Endocrinol 2007; 21:1297-311;  PM i D:17389749; http://dx.doi.org/10.1210/ me.2006-0300.,Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Proc Natl Acad Sci USA 2012;  109:2302-7; PM i D:22308320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
"Cell Cycle 2012; 11: 2864–75;   PMID:22801546; http://dx.doi.org/10.4161/cc.21196 Maria Castedo,1,2,3 Laura Senovilla,1,2,3 Ilio Vitale1,2,3 and Guido Kroemer1,4-7,*; 1INSERM; U848; Villejuif, France; 2Institut Gustave Roussy; Villejuif, France;  3Université Paris Sud-XI; Villejuif, France; 4Metabolomics Platform; Institut Gustave Roussy; Villejuif, France; 5Centre de Recherche des Cordeliers; Paris, France;  6Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; 7Université Paris Descartes, Paris 5; Paris, France;  *Email: kroemer@orange.fr; http://dx.doi.org/10.4161/cc.21722 One of the initiating events of oncogenesis  is tetraploidization, that is the generation of cells that contain twice as much DNA and chromosomes than their normal, diploid coun-terparts.",Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell Death Differ 2011; 18:1403- 13; PM i D:21072053; http://dx.doi.org/10.1038/ cdd.2010.145.,Non-OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Curr Biol 2007; 17:431-7;  PM i D:17320392; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Nature 2005; 437:1043-7;  PM i D:16222300; http://dx.doi.org/10.1038/ nature04217.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell 2010; 141:81-93; PM i D:20371347;  http://dx.doi.org/10.1016/j.cell.2010.01.031.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Nat Rev Mol Cell Biol 2011; 12:385- 92; PM i D:21527953; http://dx.doi.org/10.1038/ nrm3115.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Annu Rev Cell Dev Biol 2011; 27:585- 610; PM i D:21801013; http://dx.doi.org/10.1146/ annurev-cellbio-092910-154234.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
EMBO J 2006; 25:2584-95;  PM i D:16675948; http://dx.doi.org/10.1038/ sj.emboj.7601127.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
EMBO J 2010; 29:1272-84;  PM i D:20186124; http://dx.doi.org/10.1038/ emboj.2010.11.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
Cell Cycle 2012; 11:2864-75;  PM i D:22801546; http://dx.doi.org/10.4161/ cc.21196.,OADS,/arxiv_data1/oa_pdf/6d/c9/cc-11-3155.PMC3466511.pdf
"Cell Cycle 2012; 11:2538–44;   PMID:22713238; http://dx.doi.org/10.4161/cc.20919 Simon Bekker-Jensen and Niels Mailand*; Ubiquitin Signaling Group; Department of Disease Biology; Novo Nordisk Foundation Center for Protein Research;  University of Copenhagen; Copenhagen, Denmark; *Email: niels.mailand@cpr.ku.dk; http://dx.doi.org/10.4161/cc.21718 outstanding question.7 By mass spectrometry  analysis of ubiquitylation of epitope-tagged  histones in cells overexpressing RNF168, the authors come to the surprising conclusion that the evolutionarily conserved lysine 13 and 15 residues are the chief acceptor sites of RNF8- and RNF168-catalyzed ubiquitylation on H2A-type histones.",Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
DNA Repair (Amst) 2010;  9:1219-28; PM i D:21035408; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Nat Cell Biol 2011; 13:1161-9;  PM i D:21968989; http://dx.doi.org/10.1038/ ncb2344.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
DNA Repair (Amst)  2004; 3:959-67; PM iD: 15279782; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
DNA Repair (Amst) 2009; 8:436- 43; PM i D:19230794; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Nat Rev Mol Cell Biol 2010; 11:479- 89; PM i D:20551964; http://dx.doi.org/10.1038/ nrm2921.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell 2010; 142:682-5; PM i D:20813257;  http://dx.doi.org/10.1016/j.cell.2010.08.011.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell Cycle 2012; 11( i ssue 13):2538- 44; PM i D:22713238; http://dx.doi.org/10.4161/ cc.20919.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell Div 2008; 3:8; PM i D:18430235;  http://dx.doi.org/10.1186/1747-1028-3-8.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
"Cell Cycle 2012; 11:2739–46;   PMID:22771961; http://dx.doi.org/10.4161/cc.21119 Matthias Stadtfeld; Skirball Institute; NYU School of Medicine; New York, NY USA; Email: matthias.stadtfeld@med.nyu.edu; http://dx.doi.org/10.4161/cc.21720 in r ecent years, a multitude of groundbreak - ing papers have demonstrated that cell fates  can be altered almost at will by the enforced expression of defined sets of transcription fac - tors.",Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
J Lipid Res 2007; 48:1763- 71; PM i D:17525476; http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Mol Cancer 2010; 9:159;  PM iD :20569465; http://dx.doi.org/10.1186/1476- 4598-9-159.,Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell Cycle 2012; 11:2660-71;  PM i D:22732497; http://dx.doi.org/10.4161/ cc.21015.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
"Science 2008; 321:1807-12;  PM i D:18772396; http://dx.doi.org/10.1126/sci- ence.1164382.Fenofibrate triggers apoptosis of glioblastoma cells in vitro:   New insights for therapy Comment on: Wilk A, et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
"Cell Cycle 2012; 11:2660–71;   PMID:22732497; http://dx.doi.org/10.4161/cc.21015 Antonio Giordano1,2 and Marcella Macaluso1,*; 1Sbarro Institute for Cancer Research and Molecular Medicine; College of Science and Technology; Temple  University; Philadelphia, PA USA; 2Department of Human Pathology and Oncology; University of Siena; Siena, Itlay;   *Email: macaluso@temple.edu; http://dx.doi.org/10.4161/cc.21719",Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Genes Dev 2010; 24:2239-63;  PM i D:20952534; http://dx.doi.org/10.1101/ gad.1963910.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Nature 2009; 462:587-94;  PM i D:19956253; http://dx.doi.org/10.1038/ nature08533.,Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell Cycle 2012; 11:2739-46;  PM i D:22771961; http://dx.doi.org/10.4161/ cc.21119.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Nature 2009; 462:595-601;  PM i D:19898493; http://dx.doi.org/10.1038/ nature08592.,Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Nature 2010; 463:1035-41;  PM i D:20107439; http://dx.doi.org/10.1038/ nature08797.,Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell Stem Cell 2011; 9:374-82;  PM i D:21962918; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell Stem Cell 2009; 5:554- 66; PM i D:19896445; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell 2004; 117:663-76; PM i D:15163413;  http://dx.doi.org/10.1016/S0092-8674(04)00419-2.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Nucleic Acids Res  2012; 40:1954-68; PM i D:22086955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
"Cell Cycle 2012; 11:2681–90;   PMID:22751438; http://dx.doi.org/10.4161/cc.21019 Frances M. Sladek; Department of Cell Biology and Neuroscience; University of California; Riverside, CA USA; Email: frances.sladek@ucr.edu;   http://dx.doi.org/10.4161/cc.21721 expression of Ccnd1 as a liver-specific knock - out of HNF4a results in a marked increase in  cyclin D1 gene expression.2 The tumor sup - pressor p53 has also been shown to inhibit HNF4a function and downregulate the expres-sion of the HNF4A gene upon DNA damage; 6,7  decreased HNF4a  may help set the stage  for subsequent regrowth.",Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell Cycle 2012; 11:2681-90;  PM i D:22751438; http://dx.doi.org/10.4161/ cc.21019.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
J Biol Chem 2012; 287:7345-56;  PM i D:22241473; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell 2011; 147:1233-47;  PM i D:22153071; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cancer Res 2010; 70:7640-51;  PM iD :20876809; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0824.,Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Mol Endocrinol  2008; 22:78-90; PM iD :17885207; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Biochem J 2006; 400:303-13;  PM i D:16895524; http://dx.doi.org/10.1042/ BJ20060614.7.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Mol Endocrinol 2002; 16:402-10;  PM i D:11818510; http://dx.doi.org/10.1210/ me.16.2.402.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Mol Endocrinol 2007; 21:1297-311;  PM i D:17389749; http://dx.doi.org/10.1210/ me.2006-0300.,Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Proc Natl Acad Sci USA 2012;  109:2302-7; PM i D:22308320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
"Cell Cycle 2012; 11: 2864–75;   PMID:22801546; http://dx.doi.org/10.4161/cc.21196 Maria Castedo,1,2,3 Laura Senovilla,1,2,3 Ilio Vitale1,2,3 and Guido Kroemer1,4-7,*; 1INSERM; U848; Villejuif, France; 2Institut Gustave Roussy; Villejuif, France;  3Université Paris Sud-XI; Villejuif, France; 4Metabolomics Platform; Institut Gustave Roussy; Villejuif, France; 5Centre de Recherche des Cordeliers; Paris, France;  6Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; 7Université Paris Descartes, Paris 5; Paris, France;  *Email: kroemer@orange.fr; http://dx.doi.org/10.4161/cc.21722 One of the initiating events of oncogenesis  is tetraploidization, that is the generation of cells that contain twice as much DNA and chromosomes than their normal, diploid coun-terparts.",Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell Death Differ 2011; 18:1403- 13; PM i D:21072053; http://dx.doi.org/10.1038/ cdd.2010.145.,Non-OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Curr Biol 2007; 17:431-7;  PM i D:17320392; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Nature 2005; 437:1043-7;  PM i D:16222300; http://dx.doi.org/10.1038/ nature04217.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell 2010; 141:81-93; PM i D:20371347;  http://dx.doi.org/10.1016/j.cell.2010.01.031.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Nat Rev Mol Cell Biol 2011; 12:385- 92; PM i D:21527953; http://dx.doi.org/10.1038/ nrm3115.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Annu Rev Cell Dev Biol 2011; 27:585- 610; PM i D:21801013; http://dx.doi.org/10.1146/ annurev-cellbio-092910-154234.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
EMBO J 2006; 25:2584-95;  PM i D:16675948; http://dx.doi.org/10.1038/ sj.emboj.7601127.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
EMBO J 2010; 29:1272-84;  PM i D:20186124; http://dx.doi.org/10.1038/ emboj.2010.11.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
Cell Cycle 2012; 11:2864-75;  PM i D:22801546; http://dx.doi.org/10.4161/ cc.21196.,OADS,/arxiv_data1/oa_pdf/b0/22/cc-11-3156.PMC3466512.pdf
"Cell Cycle 2012; 11:2538–44;   PMID:22713238; http://dx.doi.org/10.4161/cc.20919 Simon Bekker-Jensen and Niels Mailand*; Ubiquitin Signaling Group; Department of Disease Biology; Novo Nordisk Foundation Center for Protein Research;  University of Copenhagen; Copenhagen, Denmark; *Email: niels.mailand@cpr.ku.dk; http://dx.doi.org/10.4161/cc.21718 outstanding question.7 By mass spectrometry  analysis of ubiquitylation of epitope-tagged  histones in cells overexpressing RNF168, the authors come to the surprising conclusion that the evolutionarily conserved lysine 13 and 15 residues are the chief acceptor sites of RNF8- and RNF168-catalyzed ubiquitylation on H2A-type histones.",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
DNA Repair (Amst) 2010;  9:1219-28; PM i D:21035408; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Nat Cell Biol 2011; 13:1161-9;  PM i D:21968989; http://dx.doi.org/10.1038/ ncb2344.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
DNA Repair (Amst)  2004; 3:959-67; PM iD: 15279782; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
DNA Repair (Amst) 2009; 8:436- 43; PM i D:19230794; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Nat Rev Mol Cell Biol 2010; 11:479- 89; PM i D:20551964; http://dx.doi.org/10.1038/ nrm2921.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell 2010; 142:682-5; PM i D:20813257;  http://dx.doi.org/10.1016/j.cell.2010.08.011.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell Cycle 2012; 11( i ssue 13):2538- 44; PM i D:22713238; http://dx.doi.org/10.4161/ cc.20919.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell Div 2008; 3:8; PM i D:18430235;  http://dx.doi.org/10.1186/1747-1028-3-8.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
"Cell Cycle 2012; 11:2739–46;   PMID:22771961; http://dx.doi.org/10.4161/cc.21119 Matthias Stadtfeld; Skirball Institute; NYU School of Medicine; New York, NY USA; Email: matthias.stadtfeld@med.nyu.edu; http://dx.doi.org/10.4161/cc.21720 in r ecent years, a multitude of groundbreak - ing papers have demonstrated that cell fates  can be altered almost at will by the enforced expression of defined sets of transcription fac - tors.",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
J Lipid Res 2007; 48:1763- 71; PM i D:17525476; http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Mol Cancer 2010; 9:159;  PM iD :20569465; http://dx.doi.org/10.1186/1476- 4598-9-159.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell Cycle 2012; 11:2660-71;  PM i D:22732497; http://dx.doi.org/10.4161/ cc.21015.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
"Science 2008; 321:1807-12;  PM i D:18772396; http://dx.doi.org/10.1126/sci- ence.1164382.Fenofibrate triggers apoptosis of glioblastoma cells in vitro:   New insights for therapy Comment on: Wilk A, et al.",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
"Cell Cycle 2012; 11:2660–71;   PMID:22732497; http://dx.doi.org/10.4161/cc.21015 Antonio Giordano1,2 and Marcella Macaluso1,*; 1Sbarro Institute for Cancer Research and Molecular Medicine; College of Science and Technology; Temple  University; Philadelphia, PA USA; 2Department of Human Pathology and Oncology; University of Siena; Siena, Itlay;   *Email: macaluso@temple.edu; http://dx.doi.org/10.4161/cc.21719",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Genes Dev 2010; 24:2239-63;  PM i D:20952534; http://dx.doi.org/10.1101/ gad.1963910.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Nature 2009; 462:587-94;  PM i D:19956253; http://dx.doi.org/10.1038/ nature08533.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell Cycle 2012; 11:2739-46;  PM i D:22771961; http://dx.doi.org/10.4161/ cc.21119.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Nature 2009; 462:595-601;  PM i D:19898493; http://dx.doi.org/10.1038/ nature08592.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Nature 2010; 463:1035-41;  PM i D:20107439; http://dx.doi.org/10.1038/ nature08797.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell Stem Cell 2011; 9:374-82;  PM i D:21962918; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell Stem Cell 2009; 5:554- 66; PM i D:19896445; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell 2004; 117:663-76; PM i D:15163413;  http://dx.doi.org/10.1016/S0092-8674(04)00419-2.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Nucleic Acids Res  2012; 40:1954-68; PM i D:22086955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
"Cell Cycle 2012; 11:2681–90;   PMID:22751438; http://dx.doi.org/10.4161/cc.21019 Frances M. Sladek; Department of Cell Biology and Neuroscience; University of California; Riverside, CA USA; Email: frances.sladek@ucr.edu;   http://dx.doi.org/10.4161/cc.21721 expression of Ccnd1 as a liver-specific knock - out of HNF4a results in a marked increase in  cyclin D1 gene expression.2 The tumor sup - pressor p53 has also been shown to inhibit HNF4a function and downregulate the expres-sion of the HNF4A gene upon DNA damage; 6,7  decreased HNF4a  may help set the stage  for subsequent regrowth.",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell Cycle 2012; 11:2681-90;  PM i D:22751438; http://dx.doi.org/10.4161/ cc.21019.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
J Biol Chem 2012; 287:7345-56;  PM i D:22241473; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell 2011; 147:1233-47;  PM i D:22153071; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cancer Res 2010; 70:7640-51;  PM iD :20876809; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0824.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Mol Endocrinol  2008; 22:78-90; PM iD :17885207; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Biochem J 2006; 400:303-13;  PM i D:16895524; http://dx.doi.org/10.1042/ BJ20060614.7.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Mol Endocrinol 2002; 16:402-10;  PM i D:11818510; http://dx.doi.org/10.1210/ me.16.2.402.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Mol Endocrinol 2007; 21:1297-311;  PM i D:17389749; http://dx.doi.org/10.1210/ me.2006-0300.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Proc Natl Acad Sci USA 2012;  109:2302-7; PM i D:22308320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
"Cell Cycle 2012; 11: 2864–75;   PMID:22801546; http://dx.doi.org/10.4161/cc.21196 Maria Castedo,1,2,3 Laura Senovilla,1,2,3 Ilio Vitale1,2,3 and Guido Kroemer1,4-7,*; 1INSERM; U848; Villejuif, France; 2Institut Gustave Roussy; Villejuif, France;  3Université Paris Sud-XI; Villejuif, France; 4Metabolomics Platform; Institut Gustave Roussy; Villejuif, France; 5Centre de Recherche des Cordeliers; Paris, France;  6Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; 7Université Paris Descartes, Paris 5; Paris, France;  *Email: kroemer@orange.fr; http://dx.doi.org/10.4161/cc.21722 One of the initiating events of oncogenesis  is tetraploidization, that is the generation of cells that contain twice as much DNA and chromosomes than their normal, diploid coun-terparts.",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell Death Differ 2011; 18:1403- 13; PM i D:21072053; http://dx.doi.org/10.1038/ cdd.2010.145.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Curr Biol 2007; 17:431-7;  PM i D:17320392; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Nature 2005; 437:1043-7;  PM i D:16222300; http://dx.doi.org/10.1038/ nature04217.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell 2010; 141:81-93; PM i D:20371347;  http://dx.doi.org/10.1016/j.cell.2010.01.031.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Nat Rev Mol Cell Biol 2011; 12:385- 92; PM i D:21527953; http://dx.doi.org/10.1038/ nrm3115.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Annu Rev Cell Dev Biol 2011; 27:585- 610; PM i D:21801013; http://dx.doi.org/10.1146/ annurev-cellbio-092910-154234.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
EMBO J 2006; 25:2584-95;  PM i D:16675948; http://dx.doi.org/10.1038/ sj.emboj.7601127.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
EMBO J 2010; 29:1272-84;  PM i D:20186124; http://dx.doi.org/10.1038/ emboj.2010.11.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
Cell Cycle 2012; 11:2864-75;  PM i D:22801546; http://dx.doi.org/10.4161/ cc.21196.,OADS,/arxiv_data1/oa_pdf/cb/c2/cc-11-3157.PMC3466513.pdf
"A recent study has shown that expos - ing mammalian cells to osmostress resulted in a strong G 1 delay, suggesting  the existence of an osmostress-regulated A novel G1 checkpoint mediated by the p57   CDK inhibitor and p38 SAPK promotes   cell survival upon stress Manel Joaquin, a lbert Gubern and Francesc Posas* departament de Ciències Experimentals i de la Salut; Cell Signaling r esearch Group; u niversitat Pompeu Fabra; Barcelona, Spain *Correspondence to: Francesc Posas; Email: francesc.posas@upf.edu Submitted: 06/27/12; Accepted: 06/29/12http://dx.doi.org/10.4161/cc.21840Comment on: Joaquin M, et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
EMBO J 2012; 31:2952-64; PMID:22569127; http://dx.doi.org/10.1038/emboj.2012.122.,Non-OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
Biochem J 2010; 429:403-17;  PMID:20626350; http://dx.doi.org/10.1042/ BJ20100323.,OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
Mol Cell 2005; 17:37-48;  PMID:15629715; http://dx.doi.org/10.1016/j.mol-cel.2004.11.021.,OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
Cancer Cell 2007; 11:175- 89; PMID:17292828; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
Cancer Res 2009; 69:8726-32; PMID:19843869; http://dx.doi.org/10.1158/0008- 5472.CAN-09-0729.,Non-OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
Mol Cell Biol 2009; 29:4341-51; PMID:19528229; http://dx.doi.org/10.1128/ MCB.00210-09.,Non-OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
EMBO J 2012; 31:2952-64; PMID:22569127; http://dx.doi.org/10.1038/ emboj.2012.122.,Non-OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
Dev Cell 2008; 14:159-69; PMID:18267085; http://dx.doi.org/10.1016/j.dev- cel.2008.01.013.,OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
Nat Cell Biol 2004; 6:997-1002; PMID:15448699; http://dx.doi.org/10.1038/ ncb1174.,OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
Sci Signal 2011; 4:ra63;  PMID:21954289; http://dx.doi.org/10.1126/scisig-nal.2002204.,OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
Mol Cell Biol 2011; 31:4405-16; PMID:21930785; http://dx.doi.org/10.1128/MCB.06163-11.,Non-OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
BMC Genomics 2010; 11:144;  PMID:20187982; http://dx.doi.org/10.1186/1471- 2164-11-144.,OADS,/arxiv_data1/oa_pdf/4a/7a/cc-11-3339.PMC3466532.pdf
"The oncogenic transcription factor FOXM1   and anticancer therapy andrei L. Gartel department of Medicine; u niversity of i llinois at Chicago; Chicago, i L uSa Correspondence to: Andrei L. Gartel; Email: agartel@uic.edu Submitted: 07/28/12; Accepted: 07/29/12http://dx.doi.org/10.4161/cc.21841Comment on: Halasi M, et al.",Non-OADS,/arxiv_data1/oa_pdf/6e/16/cc-11-3341.PMC3466533.pdf
PLoS One 2012; 7:e31761; PMID:22393369; http://dx.doi.org/10.1371/journal.pone.0031761.,Non-OADS,/arxiv_data1/oa_pdf/6e/16/cc-11-3341.PMC3466533.pdf
Expert Opin Investig Drugs 2010;  19:235-42; PMID:20074015; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/16/cc-11-3341.PMC3466533.pdf
J Biol Chem 2011; 286:41425-33; PMID:21979956; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/6e/16/cc-11-3341.PMC3466533.pdf
PLoS One 2012; 7:e31761; PMID:22393369; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/6e/16/cc-11-3341.PMC3466533.pdf
Cancer Res 2006; 66:9731-5; PMID:17018632; http://dx.doi.org/10.1158/0008- 5472.CAN-06-1576.,Non-OADS,/arxiv_data1/oa_pdf/6e/16/cc-11-3341.PMC3466533.pdf
PLoS One 2009; 4:e5592; PMID:19440351; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/6e/16/cc-11-3341.PMC3466533.pdf
PLoS One 2009; 4:e6593; PMID:19672316; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/6e/16/cc-11-3341.PMC3466533.pdf
Mol Cancer Ther 2011; 10:2287-97; PMID:21903609; http://dx.doi.org/10.1158/1535- 7163.MCT-11-0536.,Non-OADS,/arxiv_data1/oa_pdf/6e/16/cc-11-3341.PMC3466533.pdf
"4 While  antibodies that mediate antitumor effects through antibody-dependent, cell-medi - ated cytotoxicity (ADCC) clearly require activating Fc γR engagement, whether  and how Fc γRs contribute to the in vivo  activities of agonistic antibodies is less A general requirement for FcγRIIB   co-engagement of agonistic anti-TNFR antibodies Fubin Li and Jeffrey V. r avetch* Laboratory of Molecular Genetics and i mmunology; t he r ockefeller u niversity; New y ork, N y uSa *Correspondence to: Jeffrey V. Ravetch; Email: ravetch@rockefeller.edu Submitted: 07/18/12; Accepted: 07/19/12http://dx.doi.org/10.4161/cc.21842Comment on: Li F, et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/38/cc-11-3343.PMC3466534.pdf
Nat Rev Immunol 2003; 3:745-56;  http://dx.doi.org/10.1038/nri1184; PMID:12949498.,Non-OADS,/arxiv_data1/oa_pdf/ea/38/cc-11-3343.PMC3466534.pdf
Science 2011; 333:1030-4; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ea/38/cc-11-3343.PMC3466534.pdf
Nat Rev Immunol 2008; 8:34-47;  http://dx.doi.org/10.1038/nri2206; PMID:18064051.,Non-OADS,/arxiv_data1/oa_pdf/ea/38/cc-11-3343.PMC3466534.pdf
"J Immunol 2011; 187:1754-63; http://dx.doi.org/10.4049/jimmunol.1101135;  PMID:21742972.FcγRIIB co-engagement remains to be  determined, the requirement for Fc γRIIB  co-engagement can be exploited to make  more potent agonistic antibodies.",Non-OADS,/arxiv_data1/oa_pdf/ea/38/cc-11-3343.PMC3466534.pdf
Cancer Cell 2011; 19:101-13;  http://dx.doi.org/10.1016/j.ccr.2010.11.012;  PMID:21251615.,Non-OADS,/arxiv_data1/oa_pdf/ea/38/cc-11-3343.PMC3466534.pdf
Blood 2006; 108:705-10; http://dx.doi.org/10.1182/blood-2005-11-4607; PMID:16551968.,Non-OADS,/arxiv_data1/oa_pdf/ea/38/cc-11-3343.PMC3466534.pdf
Biochem Biophys Res Commun 2010; 393:829-35; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ea/38/cc-11-3343.PMC3466534.pdf
"Our understanding of how glyco - sylases avoid acting on the huge excess of undamaged DNA remains incomplete, particularly for mismatch glycosylases How a mismatch repair enzyme balances the  needs for efficient lesion processing and minimal  action on undamaged DNA alexander C. d rohat,1,* Edwin Pozharski2 and a tanu Maiti1 1department of Biochemistry and Molecular Biology; u niversity of Maryland School of Medicine; Baltimore, M d uSa;   2department of Pharmaceutical Sciences; u niversity of Maryland School of Pharmacy; Baltimore, M d uSa *Correspondence to: Alexander C. Drohat; Email: adrohat@som.umaryland.edu Submitted: 06/26/12; Accepted: 07/20/12http://dx.doi.org/10.4161/cc.21843Comment on: Maiti A, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/0e/cc-11-3345.PMC3466535.pdf
ACS Chem Biol 2012; 7:20-30;  PMID:22004246; http://dx.doi.org/10.1021/ cb2002895.,OADS,/arxiv_data1/oa_pdf/dd/0e/cc-11-3345.PMC3466535.pdf
J Am Chem Soc 2006; 128:12510- 9; PMID:16984202; http://dx.doi.org/10.1021/ ja0634829.,OADS,/arxiv_data1/oa_pdf/dd/0e/cc-11-3345.PMC3466535.pdf
J Biol Chem 2011; 286:35334-8; PMID:21862836; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/dd/0e/cc-11-3345.PMC3466535.pdf
Science 2011; 333:1303-7; PMID:21817016; http://dx.doi.org/10.1126/sci- ence.1210944.,OADS,/arxiv_data1/oa_pdf/dd/0e/cc-11-3345.PMC3466535.pdf
Nature 2011; 470:419-23; PMID:21278727; http://dx.doi.org/10.1038/ nature09672.7.,Non-OADS,/arxiv_data1/oa_pdf/dd/0e/cc-11-3345.PMC3466535.pdf
Cell 2011; 146:67-79;  PMID:21722948; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/0e/cc-11-3345.PMC3466535.pdf
Nucleic Acids Res 2011; 39:2319- 29; PMID:21097883; http://dx.doi.org/10.1093/nar/ gkq1164.,OADS,/arxiv_data1/oa_pdf/dd/0e/cc-11-3345.PMC3466535.pdf
Mutat Res 2000; 462:137-47; PMID:10767625; http://dx.doi.org/10.1016/S1383- 5742(00)00031-4.,OADS,/arxiv_data1/oa_pdf/dd/0e/cc-11-3345.PMC3466535.pdf
"Moreover, How not to get cross(ed) A novel role for FANCM orthologs   in meiotic recombination alexander Lorenz and Matthew C. Whitby* department of Biochemistry; u niversity of o xford; o xford, u K *Correspondence to: Matthew C. Whitby; Email: matthew.whitby@bioch.ox.ac.uk Submitted: 07/21/12; Accepted: 07/27/12http://dx.doi.org/10.4161/cc.21844Comment on: Lorenz A, et al.",Non-OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
Science 2012; 336:1585-8; PMID:22723423; http://dx.doi.org/10.1126/science.1220111.,Non-OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
J Theor Biol 1976; 59:97-106;  PMID:940351; http://dx.doi.org/10.1016/S0022- 5193(76)80025-2.,Non-OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
Cell 2012; 149:334-47;  PMID:22500800; http://dx.doi.org/10.1016/j.cell.2012.03.023.,OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
Mol Cell 2012; 46:43-53;  PMID:22500736; http://dx.doi.org/10.1016/j.mol- cel.2012.02.020.,OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
Science 2010; 327:1254-8; PMID:20203049; http://dx.doi.org/10.1126/sci- ence.1183112.,OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
Science 2011; 334:1286-9; PMID:22144627; http://dx.doi.org/10.1126/sci- ence.1212424.,OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
Science 2012; 336:1588-90; PMID:22723424; http://dx.doi.org/10.1126/sci- ence.1220381.,OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
Plant Cell 2012; 24:1448-64; PMID:22547783; http://dx.doi.org/10.1105/ tpc.112.096644.,OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
Science 2012; 336:1585-8; PMID:22723423; http://dx.doi.org/10.1126/sci- ence.1220111.,OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
Mol Cell 2003; 12:761-74;  PMID:14527420; http://dx.doi.org/10.1016/S1097-2765(03)00343-5.,OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
Structure 2012; 20:440-9;  PMID:22405003; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/14/db/cc-11-3347.PMC3466536.pdf
"tan† and James L. Manley* department of Biological Sciences; Columbia u niversity; New y ork, N y uSa †Current affiliation: a ggamin Biologics; New y ork, N y uSa *Correspondence to: James L. Manley; Email: jlm2@columbia.edu Submitted: 07/0612; Accepted: 07/28/12http://dx.doi.org/10.4161/cc.21875Comment on: Tan AY, et al.",Non-OADS,/arxiv_data1/oa_pdf/ca/65/cc-11-3349.PMC3466537.pdf
J Mol Cell Biol 2009; 1:82-92;  PMID:19783543; http://dx.doi.org/10.1093/jmcb/ mjp025.,OADS,/arxiv_data1/oa_pdf/ca/65/cc-11-3349.PMC3466537.pdf
FEBS J 2011; 278:3569-77;  PMID:21810174; http://dx.doi.org/10.1111/j.1742-4658.2011.08277.x.,OADS,/arxiv_data1/oa_pdf/ca/65/cc-11-3349.PMC3466537.pdf
Cell 2009; 136:1001-4;  PMID:19303844; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ca/65/cc-11-3349.PMC3466537.pdf
Proc Natl Acad Sci USA 2012; 109:6030-5; PMID:22460799; http://dx.doi.org/10.1073/ pnas.1203028109.,OADS,/arxiv_data1/oa_pdf/ca/65/cc-11-3349.PMC3466537.pdf
Science 2006; 314:130-3; PMID:17023659; http://dx.doi.org/10.1126/sci-ence.1134108.,OADS,/arxiv_data1/oa_pdf/ca/65/cc-11-3349.PMC3466537.pdf
"Oncogene 2007; 26:2873-84; PMID:17086209; http://dx.doi.org/10.1038/ sj.onc.1210098.“TET proteins”), regulates gene expres - sion, will have implications for both  cancer and neurodegenerative diseases.",Non-OADS,/arxiv_data1/oa_pdf/ca/65/cc-11-3349.PMC3466537.pdf
Nature 2010; 467:470- 3; PMID:20835226; http://dx.doi.org/10.1038/ nature09371.,OADS,/arxiv_data1/oa_pdf/ca/65/cc-11-3349.PMC3466537.pdf
Science 2008; 320:1224-9;  PMID:18511691; http://dx.doi.org/10.1126/sci- ence.1153252.,OADS,/arxiv_data1/oa_pdf/ca/65/cc-11-3349.PMC3466537.pdf
J Biol Chem 2011; 286:1204-15; PMID:21051541; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ca/65/cc-11-3349.PMC3466537.pdf
"3 We have shown that Treg-suppressive  function can be selectively enhanced Combination of isoform-selective   histone/protein deacetylase inhibitors   improves Foxp3+ T-regulatory cell function ulf H. Beier,1,2 Liqing Wang3 and Wayne W. Hancock2,3,* 1division of Nephrology; d epartment of Pediatrics; Children’s Hospital of Philadelphia; Philadelphia, P a uSa; 2university of Pennsylvania School of Medicine;   Philadelphia, P a uSa; 3division of t ransplant i mmunology; d epartment of Pathology and Laboratory Medicine and Biesecker Center for Pediatric Liver d isease;   Children’s Hospital of Philadelphia; Philadelphia, P a uSa *Correspondence to: Wayne W. Hancock; Email: whancock@mail.med.upenn.edu Submitted: 07/17/12; Accepted: 07/18/12http://dx.doi.org/10.4161/cc.21876Comment on: Beier UH, et al.",Non-OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
Sci Signal 2012; 5:ra45; PMID:22715468; http://dx.doi.org/10.1126/scisignal.2002873.,OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
Am J T ransplant 2004;  4:378-83; PMID:14961990; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
Kidney Int 2011; 79:1005-12;  PMID:21270769; http://dx.doi.org/10.1038/ki.2010.533.,Non-OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
Am J T ransplant 2012; 12:846-55;  PMID:22300534; http://dx.doi.org/10.1111/j.1600- 6143.2011.03929.x.,OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
Mol Cell Biol 2011; 31:2066-78; PMID:21444725; http://dx.doi.org/10.1128/ MCB.05155-11.,Non-OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
Mol Cell Biol 2011; 31:1022-9; PMID:21199917; http://dx.doi.org/10.1128/ MCB.01206-10.,Non-OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
Nat Med 2007; 13:1299-307; PMID:17922010; http://dx.doi.org/10.1038/nm1652.,OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
Sci Signal 2012; 5:ra45;  PMID:22715468; http://dx.doi.org/10.1126/scisig- nal.2002873.,OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
Blood 2010; 115:965-74; PMID:19996091; http://dx.doi.org/10.1182/blood- 2009-02-207118.,Non-OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
PLoS One 2012; 7:e29035; PMID:22247766; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
J Immunol 2012; 188:2712-21; PMID:22312127; http://dx.doi.org/10.4049/jimmu- nol.1100903.,Non-OADS,/arxiv_data1/oa_pdf/d2/8f/cc-11-3351.PMC3466538.pdf
"Cell Cycle 2012; 11:2660–71;   PMID:22732497; http://dx.doi.org/10.4161/cc.21015 Edward M. Johnson; Department of Microbiology and Molecular Cell Biology; Eastern Virginia Medical School; Norfolk, VA USA;   Email: johnsoem@evms.edu; http://dx.doi.org/10.4161/cc.21848 them, the LSU group tested fenofibrate, a drug  used frequently along with statins to lower lip - ids and cholesterol by stimulating fat metabo - lism.",OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Neuro Oncol 2012; 14:405- 15; PMiD:22351749; http://dx.doi.org/10.1093/neu- onc/nos005.,Non-OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
CA Cancer J Clin 2010; 60:166- 93; PMiD:20445000; http://dx.doi.org/10.3322/ caac.20069.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Cell Cycle 2012; 11:2660-71;  PMiD:22732497; http://dx.doi.org/10.4161/cc.21015.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
"Cell Cycle 2012; 11:2717–28;   PMID:22751435; http://dx.doi.org/10.4161/cc.21091 Lindsey D. Mayo; Herman B Wells Center for Pediatric Research; Indiana University School of Medicine; Indianapolis, IN USA;   Email: ldmayo@iupui.edu; http://dx.doi.org/10.4161/cc.21849 Macroautophagy is an ancient, evolutionarily  conserved catabolic process involving the  degradation of organelles and long-lived pro - teins, an important process for maintaining  cellular homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
"Cell Cycle 2012; 11:2864–75;   PMID:22801546; http://dx.doi.org/10.4161/cc.21196 Joshua M. Nicholson and Daniela Cimini*; Department of Biological Sciences; Virginia Tech; Blacksburg, VA USA;   *Email: cimini@vt.edu; http://dx.doi.org/10.4161/cc.21850 Aneuploidy is ubiquitous in cancer and  has been causally linked to tumorigenesis.1  Although many decades of intense research have provided invaluable information on  the causes and consequences of aneuploidy  (reviewed in ref.",Non-OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Cell Cycle 2012; 11:2717-28;  PMiD:22751435; http://dx.doi.org/10.4161/ cc.21091.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Cell Cycle 2008; 7:2519-28; PMiD:18719371; http://dx.doi.org/10.4161/ cc.7.16.6422.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Mol Cell 2006; 24:827-39.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Science 2012; 336:477-81;  PMiD:22539723; http://dx.doi.org/10.1126/sci-ence.1217032.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
J Biol Chem 2002; 277:50131- 6; PMiD:12393906; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Cell Cycle 2008; 7:222-31; PMiD:18264029; http://dx.doi.org/10.4161/ cc.7.2.5185.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
EMBO J 2009; 28:1926-39; PMiD:19521340; http://dx.doi.org/10.1038/ emboj.2009.154.,Non-OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Cimini D. Biochim Biophys Acta 2008; 1786:32-40;  PMiD:18549824;    http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Cell Cycle 2012; 11:2864-75;  PMiD:22801546; http://dx.doi.org/10.4161/cc.21196.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
PLoS One 2009; 4:e6564; PMiD:19668340; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Nature 2009; 460:278-82;  PMiD:19506557; http://dx.doi.org/10.1038/ nature08136.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Nat Genet 1999; 21:111-4; PMiD:9916802; http://dx.doi.org/10.1038/5056.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Nature 2005; 437:1043-7; PMiD:16222300; http://dx.doi.org/10.1038/ nature04217.8.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Neoplasia 2005; 7:944-56;  PMiD:16242077; http://dx.doi.org/10.1593/ neo.05358.,Non-OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
BMC Cell Biol 2005; 6:6; PMiD:15713235; http://dx.doi.org/10.1186/1471-2121-6-6.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
"Cell Cycle 2012; 11:2947–55;   PMID:22828653; http://dx.doi.org/10.4161/cc.21400 Chengfu Yuan,1 Ningzhi Xu2 and Joshua Liao1,*; 1Hormel Institute; University of Minnesota; Austin, MN USA; 2Laboratory of Cell and Molecular Biology; Cancer  Institute; Chinese Academy of Medical Science; Beijing, China; Email: djliao@hi.umn.edu; http://dx.doi.org/10.4161/cc.21852 Fanconi anemia (FA) is a rare inherited dis- ease.",Non-OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
"Cell Cycle 2012; 11:3011–8;   PMID:22871737; http://dx.doi.org/10.4161/cc.21398  Silvia Polakova,1 Miroslava Pozgajova2 and Juraj Gregan1,*; 1Department of Chromosome Biology; Max F .",OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
"Perutz Laboratories; University of Vienna; Vienna, Austria;  2Department of Genetics and Animal Breeding Biology; Slovak University of Agriculture; Nitra, Slovak Republic;   *Email: juraj.gregan@univie.ac.at; http://dx.doi.org/10.4161/cc.21851 Spindle assembly checkpoint (SAC) is a bio - chemical pathway that monitors the attach- ment state of kinetochores and delays  anaphase onset until all kinetochores are attached to spindle microtubules (Fig.",Non-OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Cell Cycle 2012; 11:2947-55;  PMiD:22828653; http://dx.doi.org/10.4161/cc.21400.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
J Clin i nvest 2010; 120:1524-34;  PMiD:20407210; http://dx.doi.org/10.1172/ JCi40908.3.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
Cancer Biol Ther 2011; 11:615-26; PMiD:21278493; http://dx.doi.org/10.4161/ cbt.11.7.14688.,Non-OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
FASEB J 2005; 19:161-9; PMiD:15677339; http://dx.doi.org/10.1096/fj.04- 2584hyp.,OADS,/arxiv_data1/oa_pdf/9a/ea/cc-11-3353.PMC3466539.pdf
